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Abstract 
 
Introduction 
Peri-implantitis is a bacterially induced inflammatory reaction surrounding dental 
implants leading to loss of supporting bone. Microbial biofilm development 
seems to play an important role in altering the biocompatibility of the implant 
surface leading to loss of the implant. 
Aims 
The aim of this study was to develop an in vitro model of peri-implantitis.  
Material and Methods 
Microcosm biofilms were grown on titanium discs in a constant depth film 
fermentor (CDFF). Artificial saliva and peri-implant sulcular fluid (PISF) were 
delivered to simulate three communities associated with dental implants (health, 
peri-implant mucositis and peri-implantitis). The intact biofilms were visualised by 
confocal laser scanning microscope (CLSM) at different time points. Biofilms 
were cultured on non-selective and selective media. PCR-cloning and 
comparative sequencing of the 16S rRNA gene was carried out to determine 
bacterial richness. To quantify bacterial species, multiplex qPCR was used for a 
range of important oral species; qPCR probes were designed, tested and used to 
quantify Capnocytophaga in the communities. Evaluation of current and novel 
treatment modalities, to eliminate the microcosm biofilm, on commercial titanium 
surfaces (polished, SLA and SLActive surfaces) was carried out. Furthermore, 
novel antimicrobial surfaces were prepared and initial biofilm formation assessed 
by cultural analysis and CLSM.   
Results 
The biofilms shifted from coccid dense communities, to those dominated by rods 
and long filaments. The clones shifted from healthy to mixed pathogens. The 
qPCR revealed significant differences between a healthy and disease conditions. 
The combined treatment (mechanical and chemical) revealed the greatest 
reduction of biofilm on all surfaces tested. The antibacterial surfaces showed 
promotion towards a healthy community on old mature biofilm.  
Discussion/Conclusion 
The CDFF allowed successful growth of microbial communities and the ability to 
monitor the bacterial shifts between three communities associated with dental 
implants. In addition, it has allowed the testing of a range of titanium surfaces 
and treatment modalities. This model will allow further understanding of the 
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microbiology of peri-implantitis and provide appropriate biofilm communities for 
testing surfaces infection and treatments. 
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Overview  
Peri-implantitis is defined as irreversible mucosal inflammation around a dental 
implant associated with the loss of supporting bone. Implants, like teeth, are 
susceptible to bacterial plaque accumulation and calculus formation. The various 
complex composition of the peri-implantitis microbiota has been extensively 
reviewed. The first part of this review will report the history of osseointegration, 
and the investigations into the peri-implantitis microbiota to highlight how certain 
species came to be regarded as pathogens in peri-implant infections. In recent 
years, new methods have become available based on the direct examination of 
DNA from samples, which will also be reviewed. An overview of current in vitro 
methods which may be applicable to model dental implant infections in a defined 
manner will be given and finally, an assessment made on the impact of treatment 
modalities on peri-implantitis infections.   
 
1.1 History of osseointegration 
In the last four decades, the development of osseointegrated titanium implants 
has led to countless changes in the field of restorative dentistry. Therefore, the 
use of dental implants represents one of the most rapidly expanding areas of 
dentistry. The birth of modern implantology can be found in the late 1950s and 
early 1960s. Brånemark discovered in 1952 that titanium irreversibly bonds to 
living bone tissue and called the phenomenon osseointegration. The first 
practical application of new titanium roots in an edentulous patient was in 1965 
(Adell et al., 1981). Zarb led the first international team to learn the principles of 
osseointegration, in the late 1970s. One implant described by Brånemark et al. 
(1977) and composed of commercially pure titanium has had considerable 
clinical success. The first published work in the area was by Adell et al. (1981) in 
the International Journal of Oral Surgery. The first commercial dental implants 
were called Biotes, but these were later renamed ‘Brånemark’ to reflect the 
inventor. Interestingly, these implants are still in use today. The term 
Osseointegration was originally coined by Brånemark, to describe direct contact 
between the implant and the bone tissue (Brånemark et al., 1983). In the early 
1990s, Zarb and Brånemark introduced a new description: “A process whereby 
clinically asymptomatic rigid fixation of alloplastic materials is achieved and 
maintained in bone during functional loading” (Albrektsson and Wennerberg, 
2005). Since the introduction of the Brånemark implant system (Nobel Biocare, 
Gothenburg, Sweden) in 1982, the number of patients with implant-supported 
prosthesis has grown exponentially.  
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Endosseous implants are available with various surface characteristics ranging 
from relatively smooth-machined surfaces to more roughened surfaces achieved 
by coating, blasting, acid treatments or a combination of these. The ultimate goal 
of modern implantology is satisfactory and fast osseointegration, which is largely 
dependent on the implant surface itself (Wennerberg and Albrektsson, 2000). 
Based on the scale of the features, the surface roughness of implants can be 
divided into macro-, micro- and nanosized topologies (Albrektsson, 1998). A 
bioinert surface is one which itself does not play a role in osseointegration. It 
merely forms a favourable substrate for the osseous deposition to occur, 
whereas, a bioactive surface is one which actively participates in the 
osseointegrative process due to the reaction between the chemically modified 
surface coating and the surrounding bone (Wennerberg and Albrektsson, 2000).  
Substrates such as calcium phosphate and hydroxyapatite (HA) coatings were 
classified as osteoindutive surfaces as they enhance bone regeneration and may 
even cause bone to grow or extend into an area where it is not normally found. 
Surface irregularities were produced through ablative/subtractive procedures or 
additives procedures. Ablative procedures include grit blasting, acid etching, 
anodizing and shot/laser peening (which is a mechanical method similar to 
sandblasting). Additive procedures include plasma spraying, electrophoretic 
deposition, sputter deposition, sol gel coating, pulsed laser deposition and 
biomimetic precipitation.  
Current trends in implant surfaces have various topographies with a wide range 
of thickness, from nanometers to millimetres. Nanotechnology may produce 
surfaces with controlled topography and chemistry that would help in 
understanding biological interactions and developing novel implants surfaces 
with predictable tissue–integrative properties. Many have been reported with 
nanometer-controlled surfaces that have an effect on early events, such as 
adsorption of proteins, blood clot formation and cell behaviour occurring upon 
implantation of dental implants (Stanford, 2008).  
 
1.2 Peri-implantitis (PI) 
1.2.1 Definition 
The term ‘peri-implantite’ occurred for the first time in the scientific literature as 
early as 1965 in a French article by Levignac: ‘L´osteolyse periimplantaire, 
Periimplantose – Periimplantite’. It was not until two decades later, in the late 
1980s, that the term appeared in English scientific literature (Mombelli et al., 
1987) to describe a destructive inflammatory process affecting the soft and hard 
tissues around osseointegrated implants, leading to the formation of a peri-
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implant pocket and loss of supporting bone. In the 1990s it was modified to 
describe an inflammatory disease that results in the loss of supporting bone 
around an implant (Mombelli and Mericske-Stern, 1990).  
1.2.2 Classification 
As with periodontitis and gingivitis, the term of ‘peri-implant mucositis’ has been 
defined as an inflammatory condition residing in the mucosa without clinical 
evidence of bone loss. Peri-implantitis is a general clinical term describing an 
inflammatory condition affecting mucosa around an osseointegrated implant in 
function (Lindhe and Meyle, 2008, Lindhe et al., 1992, Lang et al., 1993, 
Mombelli, 1999, Zitzmann and Berglundh, 2008).  
 
1.2.3 Diagnosis 
There are a number of clinical parameters used to evaluate periodontal 
conditions and these have also been used to assess peri-implantitis; these 
include: 
a) Peri-implant probing depth. 
b) Bleeding on probing. 
c) Exudation and suppuration from the peri-implant space. 
d) Swelling. 
Many studies have shown that a successful implant generally allows a plastic 
probe penetration of approximately 3 mm to 4 mm in the healthy peri-implant 
sulcus and is illustrated in Figure 1.1. (Mombelli and Lang, 1998, Zarb and 
Alberktsson, 1990). 
  
 
 
 
 
 
 
 
 
Figure 1.1. Plastic probe inserted around an implant 
abutment (Gattani and Ansari, 2010). 
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1.2.4 Clinical signs and symptoms 
The inflammation of the soft tissues is associated with bleeding after gentle 
probing with a blunt instrument. There may be suppuration from the pocket. 
Swelling and redness of the marginal tissues are not always very prominent and 
there is usually no pain associated with peri-implantitis (Leonhardt et al., 1992, 
Mombelli, 1994, 1999, Lindhe et al., 2008, Zitzmann & Berglundh, 2008, Lang 
and Berglundh, 2011). The typical bone defect is “crater-like” (a cup shape or 
cavity on the bone) and runs all around the implant (Mombelli and Lang, 1998) 
(Figures 1.2 and 1.3).  
 
 
Figure 1.2. A: Clinical photograph of early peri-implantitis around an implant at 
the maxillary left lateral incisor position. B: Peri-apical radiograph of maxillary 
lateral incisor with bone loss, depicting early peri-implantitis. C: Bleeding on 
probing was noted following removal of the probe (white arrow). D: Peri-apical 
radiograph depicting moderate peri-implantitis with bone loss (white arrow) 
(Froum and Rosen, 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
A 
C 
B 
D 
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Figure 1.3. A. Clinical view of a peri-implantitis lesion. B. Peri-apical radiograph 
exhibiting  peri-implantitis with crater shaped (cup or cavity) bone defects (yellow 
arrow) (Gattani and Ansari, 2010). 
1.2.5 Prevalence of peri-implantitis 
The use of dental implants has been widely recognized as a predictable 
treatment modality for the replacement of missing teeth (Aglietta et al., 2009). 
Bearing in mind that more than two million oral implants are placed annually 
(Klinge et al., 2005), peri-implant disease could affect more than half a million 
implants each year (Atieh et al., 2012). Several long-term studies have reported 
success rates greater than 90% over various time periods (Adell et al., 1981, 
1986, Albrektsson et al., 1986, Buser et al., 1990, 1991, 2012). Indeed, despite 
frequent complications, patients demonstrate a high satisfaction rate of close to 
90% with regard to cost. However, only around 24% of patients were ‘very 
satisfied’ (Simonis et al., 2010).  Various studies have published success and 
survival rates of dental implants, after at least 10 years of functional loading, to 
range from 89% to 95% (Simonis et al., 2010). An accurate estimation of the true 
prevalence of peri-implant disease however, remains unclear. This could be 
attributed to the lack of standardized criteria for diagnosis of peri-implant 
mucositis and peri-implantitis, different implant systems being used, and that 
there are no reliable parameters to assess the biological and prosthetic 
complications (Simonis et al., 2010). A study by Taguchi  et al. (2013) reported 
that  the cumulative survival rate for an implant supporting a single crown was 
97% after an observation period of 4 years (Taguchi et al., 2013). Success is 
defined as being free of all these complication over the entire observation period. 
Systematic reviews have shown a survival rate of 96.5% after 5 years for single 
tooth replacement, 95.4% for implant-implant fixed bridgework and 90.1% for 
implant reconstruction (Lang  et al., 2004). There are several published studies 
to date aiming to analyse the prevalence of mucositis and peri-implantitis. The 
literature reports that peri-implantitis affects 7.8% - 43.3% of all implants 
(Berglundh et al., 2002; Ferreira et al., 2006, Roos–Jansäker et al., 2006, 
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Zitzmann & Berglundh, 2008, Koldsland et al., 2010). Roos–Jansäker et al. 
(2006) found that 16% of patients had peri-implantitis in a study of 218 patients, 
which involved a follow up period of 9-14 years. Whilst Zitzmann & Berglundh et 
al. (2008) reinterpreted these results using different diagnostic criteria for peri-
implantitis and stated that the prevalence would be 55.6%. Mir-Mari et al. (2012) 
evaluated 524 implants placed in the maxilla and 440 implants placed in the 
mandible from 1-18 years post-implantation. The authors analysed the 
prevalence of patients with peri-implantitis and this ranged from between 12% 
and 22%, while 39% also had peri-implant mucositis. Another study by Ferreira 
et al. (2006) involving 221 patients over a 42 month period, showed the 
prevalence of peri-implantitis to be only 8.9%. Rinke et al. (2011) found the 
prevalence of peri-implantitis to be 11.2% and mucositis 44.9%. Kourtis et al. 
(2004) and Pjetursson et al. (2004) reported a peri-implantitis incidence of 8.6% 
within 5 years. Other studies by Berglundh et al. (2002) reported a prevalence of 
peri-implantitis of 6.4% in partially edentulous patients with a follow-up period of 
more than 5 years. Roos-Jansäker et al. (2003) reported that the prevalence of 
peri-implantitis varies between 1% and 19%. Jung et al. (2008) found peri-
implantitis as a frequent complication with an incidence of 8.6% after observation 
period of 5 years and 17% after 10-16 years of function. Koldsland et al. (2010) 
reported that the prevalence of peri-implantitis ranged between 11% and 47%. 
The percentage of peri-implantitis after the first year of loading has been shown 
to account for 10% to 50% of implant failures (Esposito et al., 1998). Some have 
argued that these figures are “the tip of the iceberg” and that with better 
diagnosis they will increase. Peri-implantitis and periodontal diseases share 
some risk factors such as tobacco use, levels of oral hygiene and diabetes 
mellitus. Many patients who had periodontitis and subsequently were treated 
with implants may have greater risk of peri-implant disease (Klinge et al., 2005, 
Donos et al., 2012, Safii et al., 2010). The risk of peri-implantitis was reported to 
be five times higher in patients with a history of chronic periodontitis. Moimaz et 
al. (2009) reported that smoking, a recognized risk factor for periodontitis, is also 
the most important risk factor for the development of mucositis. There are data 
that indicate that smoking considerably increases the risk of failure of dental 
implants (Bain and Moy, 1993, Moimaz et al., 2009). An increased prevalence of 
peri-implant disease in the form of suppuration and loss of bone has also been 
reported in smokers (Lindquist et al., 1997).  
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1.2.6 Etiopathogenesis  
The primary factor for peri-implantitis remains the colonization of the implant 
surface with pathogenic bacteria, similar to the aetiology of periodontitis (Heitz –
Mayfield & Lang, 2010). The lack of direct attachment between the dental 
implant and the mucosa may facilitate migration of the microbiota along the 
implant surface and increase the risk of peri-implantitis and eventually loss of 
implant (Meffert, 1988, Mombelli & Lang, 1998, Esposito et al., 1998). These 
failures are classified into early (failure to establish osseointegration) and late 
(failure to maintain osseointegration) (Mombelli, 1999). One way to differentiate 
early and late failures is to define the early group as implants removed before 
prosthetic restoration, while those occurring after prosthetic rehabilitation are 
classified as late (Esposito et al., 1998). Early failures are characterized by 
minimal bone loss and are predominantly in female and younger patients. 
According to a study by Manor et al. (2009), the most common causes of late 
failures were peri-implantitis, and implant overloading and fracture. However, the 
principal cause of early failure was the lack of osseointegration. Early failures are 
caused by the inability to establish a close contact between bone and implant 
due to the absence of bone apposition and the formation of scar tissue between 
the surface of the implant and surrounding bone (Esposito et al., 2000). Esposito 
et al. (1998), noted that surgical trauma, bone quality and bone quantity were the 
most important etiological factors involved in early implant failures. In the 
majority of studies, success rates are calculated from the time of implant loading 
and full functionality, therefore little information is available on implant failures 
prior to loading (Kronström et al., 2000, Kronström et al., 2001). The causes and 
mechanisms of early implant failure are unclear; different studies (Kronström et 
al., 2000, Kronström et al., 2001) have found a variety of statistically significant 
factors associated with early implant failure, these are: age and sex (Sverzut et 
al., 2008), systemic diseases (Alsaadi et al., 2008), smoking (Sverzut et al., 
2008), type of edentulous (Alsaadi et al., 2008), maxillary implant location (van 
Steenberghe et al., 2002), quantity and quality of bone (Shibli et al., 2007), and 
implant length and diameter (Noguerol et al., 2006). Immunological (Kronström 
et al., 2000) and genetic factors (Leite et al., 2008) have also been associated 
with early implant failure.  
The weak point of dental implants is inadequate attachment of the gingiva which 
may lead to rapid adhesion of bacteria and biofilm formation in this region. The 
implant surface is susceptible to infection because of two main reasons namely, 
formation of a surface biofilm and compromised immune ability at the 
implant/tissue interface (Mombelli and Décaillet, 2011). Biocompatibility of 
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titanium implants can be attributed to a surface protein layer formed under 
physiological conditions. This protein layer makes the surface suitable for 
bacterial colonization and biofilm formation. The host immune response in the 
implant is consequently impaired. In the early phase after implantation, the local 
defence system is severely disturbed by surgical trauma, and hence it is the 
most likely time for infection. Even after completion of tissue integration, the host 
defence at the implant/tissue interface is still compromised because of the small 
number of blood vessels in this area. The reduced defence mechanism facilitates 
colonization of bacteria and infection may result. Mombelli et al. (1987) 
suggested that persistent bacterial contamination and functional overloading 
were the two key aetiological factors for chronic inflammation which lead to peri-
implantitis and implant failure. Furthermore, bacterial peri-implant infections may 
arise as a result of non-microbial events which may subsequently favour the 
emergence of a pathogenic microbiota (Mombelli et al., 2012). For example, the 
fracture of an implant can give rise to secondary bacterial infection, and thus 
provoke peri-implant disease. Another example is peri-implant infection due to 
submucosal persistence of luting cement, where the presence of a foreign body 
gives rise to a bacterial infection. Wilson (2009) reported that excess dental 
cement was used in 81% of 39 of cases associated with clinical and/or 
radiographical signs of peri-implant infection.  
After plaque accumulation begins, neutrophils move to the peri-implant crevice in 
response to chemotactic peptides, released from the bacteria. Furthermore, as 
bacteria damage epithelial cells, they induce cytokines, thereby attracting 
leukocytes (predominantly neutrophils) to the crevice. The neutrophils within the 
crevice can then phagocytose and digest bacteria removing these bacteria from 
the pocket. If the neutrophil becomes overloaded with bacteria, it degranulates. 
This cause tissue damage from toxic enzymes released from the neutrophils. In 
such instances, the gingival tissue will become inflamed, a process termed peri-
implant mucositis. If the inflammation extends from the marginal gingiva into the 
supporting peri-implant tissues, this resulted in bone destruction and loss of 
attachment. The factors involved in bone destruction in peri-implant disease are 
bacterial and host mediated. Bacterial plaque products induce differentiation of 
bone progenitor cells into osteoclasts and stimulate gingival cells to release 
mediators that have the same effect (Norowski and Bumgardner, 2009).   
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1.2.7 Peri-implant microbiota 
1.2.7.1 Microbiota associated with healthy peri-implant tissues 
Most oral disease states, such as periodontal disease and peri-implantitis are 
related to dental plaque, a microbial biofilm consisting of a complex multispecies 
community of organisms formed on colonisable surfaces. Following exposure of 
the surface of the dental implant to the oral cavity, a biofilm is formed (Mombelli 
et al., 1987, Rosenberg et al., 1991, van Winkelhoff et al., 2000). The colonising 
organisms initially provide a surface for subsequent adhesion of periodontal 
pathogens and possible development of peri-implantitis (Heuer et al., 2007). 
Healthy peri-implant tissues are dominated by high numbers of coccoid cells, a 
low proportion of anaerobic species, a small number of Gram-negative species 
and a low proportion of periodontopathogenic bacteria (Ata-Ali et al., 2011). It is 
also possible to find low concentrations of anaerobic Gram-negative bacilli in 
some healthy implant sites (Heitz-Mayfield and Lang, 2010, Quirynen et al., 
2002). It has been shown that Gram-positive facultative anaerobes are 
predominate in healthy peri-implant crevices of successful implants (Mombelli 
and Mericske-Stern, 1990). The authors reported that 52.8% of the organisms 
cultured were facultatively anaerobic cocci and 17.4% were facultatively 
anaerobic rods, while Gram-negative anaerobic rods accounted for only 7.3%. 
Fusobacterium spp. and Bacteroides intermedius were both found in 8.8% of the 
samples. Shibli et al. (2008) analysed supragingival and subgingival plaque were 
taken from the deepest sites of each implant and analyzed for the presence of 36 
microorganisms by checkerboard DNA–DNA hybridization. The authors reported 
three host-compatible bacterial species including: Actinomyces naeslundii, 
Streptococcus intermedius and Streptococcus mitis and one putative periodontal 
pathogen (Fusobacterium periodonticum) were present at higher levels in the 
supragingival samples compared with the subgingival samples of the healthy 
implants. The authors also reported very similar pattern in terms of mean 
proportions of microbial complexes in the subgingival biofilm of subjects with 
chronic periodontitis has been described previously.  
 
1.2.7.2 Microbiota associated to peri-implant infection 
Generally, numerous different bacterial species are important in the aetiology of 
peri-implant mucositis and peri-implantitis (Pontoriero et al., 1994, Augthun and 
Conrads, 1997, Salcetti et al., 1997, Leonhardt et al., 1999, Quirynen et al., 
2002).  
Clinical studies have documented that sites of peri-implant infections present a 
microbiota very similar to that found in periodontal disease (Hultin et al., 2002). 
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High levels and proportions of periodontal pathogens including Prevotella 
nigrescens, Campylobacter rectus, Aggregatibacter actinomycetemcomitans, 
Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola have 
been identified. Interestingly, some studies have identified organisms associated 
with peri-implantitis which are not commonly found in the oral cavity, including 
Staphylococcus aureus, enteric bacilli and frequently found in the oral cavity 
such as Candida albicans (Botero et al., 2005, Fürst et al., 2007). Chloroflexi, 
Tenericutes, and Synergistetes phyla were only detected at peri-implantitis sites 
(Koyanagi et al., 2010). Also Parvimonas micra, Peptostreptococcus stomatis, 
Pseudoramibacter alactolyticus, and Solobacterium moorei were only observed 
at peri-implantitis sites (Koyanagi et al., 2010). Fusobacterium nucleatum and 
Granulicatella adiacens were identified at all of the peri-implantitis sites 
(Koyanagi et al., 2010). Microbiological DNA-probe analysis has revealed that 
patients with peri-implantitis harbour high levels of periodontal pathogens like A. 
actinomycetemcomitans, P. gingivalis, Prevotella intermedia, T. forsythus and T. 
denticola. Also, subgingival spirochete levels in healthy implants have been 
reported to be low or even totally absent compared to that of failing implants 
(Hultin et al., 2002). Lower levels of the genera Leptotrichia, Propionibacter and 
Prevotella and higher levels of Actinomyces, Peptococcus, Campylobacter, non-
mutans Streptococcus, Butyrivibrio and Streptococcus mutans were identified in 
peri-implantitis by 454 pyroesequencing techniques (Kumar et al., 2012).  It has 
been reported that Gram–negative obligate anaerobes predominantly comprise 
the microbiota in peri-implantitis pockets as well as in periodontal pockets 
(Mombelli et al., 1987). The existing dental biofilm is an important source of 
bacteria colonizing the new inserted implants in partial edentulous patients. 
Periodontal bacteria around natural teeth act as a reservoir for spread to the 
whole oral cavity (Kolenbrander et al., 2006). In a complete edentulous cavity, 
the peri-implant microbiota source was from the oral mucous membranes 
(Danser et al., 1996) or could not be detected after full mouth extraction (Danser 
et al., 1994, Kocar et al., 2010). Recently, it has been confirmed that there is a 
predominance of Firmicutes and Bacteroidetes in peri-implantitis. Dialister spp. 
and Eubacterium spp. belonging to Firmicutes have a high prevalence and 
proportion at peri-implantitis sites (Koyanagi et al., 2013). Also 
Peptostreptococcus spp. were more abundant in peri-implantitis. Heavy 
colonization of Fusobacterium spp. and Streptococcus spp. were observed at 
peri-implantitis sites (Koyanagi et al., 2013). These bacteria are frequently 
observed in both peri-implantitis and periodontitis biofilms (Mombelli et al., 1987). 
The recent clinical study by Thierbach and Eger (2013) found that the distribution 
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of red complex periodontal pathogens (F. nucleatum, T. forsythia, Treponema 
denticola, P. gingivalis) in patients with peri-implantitis and suppuration had a 
higher prevalence than in patients with peri-implantitis and no suppuration 
formation. Although numerous studies have examined the presence of 
periodontopathic bacteria at PI sites, the prevalence varies between reports 
(Mombelli and Décaillet, 2011). 
 
1.3 Importance of saliva in oral hygiene 
Saliva is an important resource for evaluating physiological and pathological 
conditions in humans. The advantages of using saliva in laboratory diagnosis are 
that it is readily available, easy to collect, non-invasive, and has a simple low-
cost storage when compared to blood collection. With the addition of modern 
techniques and chemical instrumentation equipment, there has been an increase 
in its use for laboratory investigations, applicable for basic and clinical analyses 
in the field of dentistry. It has been used as a diagnostic and monitoring method 
for periodontal disease (Kaufman and Lamster, 2000).   
Water is the greatest component of saliva, representing 99% of its composition. 
Organic and inorganic molecules dissolved in the aqueous component vary 
widely from one individual to another, and also in the same individual at different 
of the day. Approximately 90% of saliva volume is produced by the salivary 
glands, and the remaining 10% is produced by minor salivary glands (Napeñas 
et al., 2009). Saliva contains several inorganic ions including sodium, potassium, 
calcium, chloride, bicarbonate and phosphate. Some of these ions can reduce 
the cariogenic effect of acids produced from bacterial metabolism of dietary 
carbohydrates by buffering system.  
Other nitrogenous compound present in saliva are, for example, urea. The major 
organic constituents of submandibular/sublingual saliva are proteins and 
glycoproteins, such as mucin. Mucin are the glycoproteins primarily responsible 
for lubrication and may also bind to toxins, agglutinate bacteria, interact with host 
cells, and are important components of the acquired pellicle and plaque matrix 
formation (Dodds et al., 2005). Several antibacterial factors are present in saliva 
such as lysozyme, lactoferrin and the sailoperoxidase system which are 
important in controlling bacterial and fungal colonization of the oral cavity (Dodds 
et al., 2005). In the mouth, saliva participates in the activities of chewing, 
speaking and swallowing, as well as taste sensitivity, lubrication of tissues, 
mucosal protection and regulation of pH. Hog gastric mucin has been used as a 
model substitute of saliva because this mucin possesses the highest similarity in 
glycoprotein structure to human mucin (Bradshaw et al., 1994). Saliva harbours 
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as many as 108 bacteria per ml (Saxton, 1973). Bacteria found in saliva reflect 
the number and types of bacteria present on the teeth supragingivally as well as 
on the lateral and dorsal surfaces of the tongue (Asikainen et al., 1991). 
 
1.4 Peri-implant sulcular fluid (PISF) 
The gingival crevicular fluid (GCF) is a serum transudate that exudes through the 
sulcular and junctional epithelium. The GCF contains most of the components of 
serum which are present within the circulation, but in periodontitis it is selectively 
enriched with certain components as it passes through the resident inflammatory 
cell infiltrate, such as immunoglobulin which is secreted locally by the plasma cell 
population (Offenbacher, 1996). Since the GCF originates from plasma, its 
chemical composition corresponds to that of blood serum (Ficara et al., 1975). 
Several enzymes and cytokines have been associated with gingival inflammation 
and alveolar bone loss. Offenbacher (1996), found an increase in GCF levels of 
cytokines and prostaglandin E2 in periodontitis patients. The Peri-implant 
crevicular fluid (PICF) has its origin at the base of the marginal gingival sulcus 
(Casado et al., 2013b). Periodontitis and peri-implantitis share similar features of 
inflammatory processes and both are associated with resorption of alveolar bone 
(Meffert, 1996). Adonogianaki et al. (1995) reported that both peri-implant 
sulcular fluid (PISF) and GCF are produced via similar mechanisms, have similar 
immune and inflammatory responses, and both contain components related to 
the nature of the bone. Several studies support a correlation between peri-
implant infections and an increase of inflammatory mediators in the PISF (Heitz-
Mayfield, 2008a). During inflammation the flow of crevicular fluid increases into 
the pocket. Apse et al. (1989) reported that the volume of GCF did not differ 
between implant sites and natural teeth, and the features of inflammation were 
similar. Another study by Behneke et al. (1997), confirmed the positive 
correlation between PISF volume and peri-implant bone loss. Several studies 
from the literature have supported the evidence that there is an increased 
volume of GCF (Rüdin et al., 1970) and PISF (Tözüm et al., 2008, Güncü et al., 
2012) with inflamed implants/gingivitis compared to non-inflamed/healthy sites. 
The GCF flow rate in vivo per day is only a few millilitres (Wilson, 1999). For 
example, gingivitis subjects have GCF flow rates of 0.087 µl/min, whereas for 
moderate periodontal pocket depth, a rate of 0.4 µl/min has been reported 
(Goodson, 2003, Uitto, 2003). Another study by Heitz et al. (2004) showed that 
there was no significant change in GCF volume (week 1 = 0.14 µl, week 2 = 0.09 
µl, week 3 = 0.07 µl) on early healing following periodontal surgical procedures, 
including one-stage implant installations. PISF was shown to be a promising 
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medium for the detection of peri-implant activity; in addition it has successfully 
been used as a biochemical marker in peri-implant disease (Heitz-Mayfield, 
2008b). It seems to reflect the degree of inflammatory reaction affecting the 
surrounding tissues, bone and mucosa, and the presence of biomechanical 
stress (Heitz-Mayfield, 2008b, Casado et al., 2013a).  
 
1.5 Biofilms 
Biofilms are defined as aggregations of microorganisms attached to each other 
or to a surface and enclosed in extracellular polymeric substance (EPS) 
produced by the bacteria themselves (Marsh, 2010). Dental plaque is a soft 
tenacious deposit forming on the surfaces of teeth, denture, restorations or the 
oral mucosa (Busscher et al., 2010). The oral cavity differs from all other human 
microbial habitats by the simultaneous presence of two types of surfaces for 
microbial colonization: shedding (mucosa) and non-shedding surfaces (teeth or 
restorative materials and dentures) (Busscher et al., 2010). The oral cavity is an 
open system. In the oro-phyrngeal areas, a dynamic equilibrium exists between 
the adhesion capacity of microorganisms and a variety of removal forces such as 
swallowing, frictional removal by diet, tongue and oral hygiene intervention, and 
the cleansing actions of saliva. 
In order to survive within the oro-phyrngeal area, bacteria need to adhere either 
to the soft or hard tissues in order to resist shear forces (Marsh, 2005). The high 
turnover of the oral epithelial lining (shedding 3x /day) is an efficient defence 
mechanism as it prevents the accumulation of large masses of microorganisms. 
On the other hand, teeth, dentures, or endosseous implants provide non-
shedding surfaces, which allow the formation of thick biofilms (Listgarten, 1994). 
The first step in the formation of a biofilm after the formation of a conditioning film 
has been studied on solid surfaces in the oral cavity. Microbial biofilms in the oral 
cavity are involved in the aetiology of various oral diseases such as caries, 
periodontal and endodontic disease and dental implant failures (Lee et al., 2012). 
It consists of a large aggregation of microorganisms embedded in an organic 
matrix comprised of material derived from the diet, the biological fluids and 
products of bacterial metabolism. Many biofilms are bathed by fluids, such as 
saliva flowing over dental plaque on a tooth surface in oral cavity. The mature 
plaque composed of approximately 70% of microbial contents with a 
concentration of organisms which may average 1.7 × 1011 organisms/g wet 
weight (Socransky, 1970). It has been reported that (EPS) matrix forms 75-80% 
volume of the biofilm (Haffajee and Socransky, 2005). EPS plays a prominent 
role in bacterial retention at a surface. Not only does the EPS form the sticky 
Chapter 1: Literature review 
 
48 
 
matrix that can ultimately regulate the structural component of the biofilm, but it 
may also affect initial attachment. It is estimated that of the total organic carbon 
content of biofilms, 50%-90% comes from the EPS (Flemming et al., 2000) with 
40% of the dry weight of dental biofilms being polysaccharide in nature (Paes 
Leme et al., 2006). There are different bacterial species in the mouth and 
species mainly colonize the teeth, tongue, oral mucosa, hard palate, carious 
lesions, periodontal pocket and peri-implant pocket. The distribution of 
microbiota in the oral cavity is not random and depends on the particular 
environment those sites provide, for example the anaerobic environment 
provided by the periodontal pocket. 
 
1.5.1 Oral biofilm formation 
The first step of oral biofilm formation is the attachment of acquired pellicle to a 
clean tooth surface (Marsh and Percival, 2006). The pellicle is a thin protein 
containing film derived from salivary glycoproteins. The second step of biofilm 
formation is bacterial adhesion to the pellicle. In this stage, the attachment is 
reversible and those organisms initially attached can easily be detached from the 
pellicle. As soon as the pioneer bacteria attach to the pellicle, EPS begins to be 
made, which helps the bacteria remain bound together. The main pioneer 
bacterial genera attaching to the tooth surface are Actinomyces spp., 
Streptococcus spp., Haemophilus spp., Capnocytophaga spp., Veillonella spp., 
and Neisseria spp. (Marsh, 2010). The early colonizing bacteria provide specific 
binding sites for subsequent bacterial colonisation and promote biofilm 
development. Later colonizing bacteria recognize polysaccharide receptors or 
proteins on the bacterial cell surfaces of early colonisers and attach to them 
(Kinniment et al., 1996a). When bacteria coaggregate (bacteria attach to one 
another via specific molecules) in a mature oral biofilm (Rickard et al., 2004), 
different morphological forms such as  corn cob’, bristle brush, or other forms 
may develop (Marsh and Percival, 2006). The attached bacterial species include 
F. nucleatum, Treponema spp., T. forsythensis, P. gingivalis, and A. 
actinomycetemcomitans. The mature biofilm microbial components are quite 
different from the initial biofilm. The shifts that occur during biofilm development 
include a reduction in streptococci and Neisseria spp. and an increase in 
Actinomyces, Corynebacterium, Fusobacterium and Veillonella species (Marsh, 
1994). Dispersion of biofilm cells can occur when bacteria leave the biofilm by 
single cell detachment or a cluster of cells detaching in a mature biofilm. The 
dispersion model of biofilm takes place in different ways and includes erosion, 
sloughing and seeding. The possible reasons for detachment could be due to 
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limited nutrients present at the original site necessitating for bacteria to relocate, 
or it might be due to fluid shear force of saliva (Figure 1.4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. This diagram represents the stages in oral biofilm formation. 
(A) Pellicle formation. The pellicle is a thin film derived from salivary 
glycoproteins attached to a clean tooth surface. (B) Initial adhesion. 
Pioneer bacteria in saliva recognize the binding proteins in acquired 
pellicle and attached to them. This adhesion is reversible. (C) Maturation. 
Different bacterial species coaggregate and mature biofilm forms. (D) 
Dispersion. Bacteria disperse from the biofilm surface and disseminate to 
colonize a new site. 
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1.5.2 Supragingival biofilm architecture on natural teeth 
The complex architecture of oral biofilms in nature was highlighted by the work of 
Listgarten et al. (1963) who used light and electron microscopy on epoxy resin 
crowns and extracted teeth. The term “supragingival plaque” refers to those 
biofilms that form on the tooth surface above the level of the gingival margin (this 
also includes interdental biofilms). As this surface, unlike any other in the body, 
is non-shedding physical and chemical means are required to remove 
accumulated plaque. The initial plaque formation starts with the salivary pellicle 
adsorbed to the tooth surface. The acquired pellicle is rapidly adsorbed to the 
enamel surface within seconds of cleaning and continue to accumulate for 
approximately 2 hours to form a tenacious layer 0.1-1 µm thick (Listgarten, 
1994). This pellicle conditioning film affects the order of microbial colonisation 
(Marsh, 2004). Figure 1.5, highlights the localisation and stratification of bacteria 
within supragingival plaque, with respect to the tooth surface. Within the first 24 
hours of colonisation, oral streptococci have been shown to make up 60-90% of 
supragingival plaque (Nyvad and Kilian, 1987). The streptococci are joined by 
other initial colonizers such as Actinomyces spp., and Lactobacillus spp. 
(Listgarten, 1994). Streptococcus salivarius is often associated with building 
stability in the biofilm matrix via lactose uptake and urease enzymes (Sissons 
and Yakub, 2000). The earliest foci of bacterial accumulation is localized to 
surface pits and fissures, but can also be found on isolated protected portions of 
smooth surfaces (Newman, 1972a, Newman, 1972b). In time, the bacteria 
spread over larger sections of smooth surfaces with thicker accumulations at 
protected sites. Plaque development on smooth surfaces is favoured on 
interdental surfaces and on the gingival margin, where plaque is more protected 
from the frictional effects of the tongue and cheek.  
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1.5.3 Subgingival biofilm architecture on natural teeth 
Subgingival plaque is formed in the protected environment between the gingival 
margin and the tooth surface. Due to this location, the main nutrition comes from 
gingival crevicular fluid (GCF), as well as potentially blood. An anaerobic 
environment can develop and lead to a predominance of more asaccharolytic 
species (Darveau et al., 1997). Figure 1.6, shows the stratification of the 
organisms that can occur in subgingival plaque within the periodontal pocket. 
The undisturbed growth of supragingival plaque on the gingival margins begins 
to cause inflammation, redness, and swelling. These changes result in the 
creation of a deepened gingival sulcus (pseudo-pocket), which provides a 
relatively anaerobic environment suitable for the growth of motile rods, Gram-
negative filamentous bacteria and spirochetes (Listgarten, 1994). Much of the 
microbiota of the gingival sulcus area is motile and the structural organization of 
this microbial population is different from that seen in the supragingival region 
(Listgarten, 1994). The author observed formation of columnar micro-colonies 
with their long axis perpendicular to the crown surface. After one day of growth, 
Gram-positive cocci dominated these columns long with some isolated branching 
filaments. After one week, filaments appeared on top of the columns. After three 
weeks, filaments were seen fully colonising the biofilm and subsequently 
Figure 1.5. Localisation of the main bacteria found in supragingival 
biofilms. Bacteria double stained with probe EUB338 labelled with FITC 
or Cy3. Bars are 10 μm, taken from Zijnge (2010).  
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replacing the coccus dominated population. Most of the subgingival microbiota 
were Gram-negative bacteria such as P. gingivalis, P. intermedia, and P. 
nigrescens. Most Prevotella sp. and Parvimonas micra colonize the biofilm in 
micro-colonies which are located on top or within the top layer of the biofilm. P. 
gingivalis and Porphyromonas endodontalis also appear mainly as micro-
colonies within the top layer.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Different aggregate morphologies have been observed by Fluorescent in situ 
Hybridisation (FISH), for example, fine “test-tube brushes” composed of T. 
forsythia and F. nucleatum were arranged perpendicularly around lactobacilli or 
test-tube brushes composed of a complex mixture of cells like T. forsythia, 
Campylobacter sp., P. micra and F. nucleatum (Zijnge et al., 2010).  
Al-Ahmad et al. (2010) found that the composition of the biofilm was not 
influenced by which material surface it was grown on. The authors suggested 
that the acquired pellicle had a greater impact on the composition of the 
adherent bacteria and formed biofilm in vivo than the actual material of the 
surface itself and concluded that the biofilm formation on tooth enamel is similar 
to that which takes place on the implant materials. This is in accordance with 
Figure 1.6. Showing the stratification and location of commonly found 
organisms in subgingival plaque. Biofilms were double-stained with probe 
EUB338 labelled with FITC or Cy3. The yellow colour results from the 
simultaneous staining with FITC and Cy3 labelled probes. Bars are 10 μm, 
taken from (Zijnge et al., 2010). Showing stratification that occurs from the 
base of the sulcus towards the gingival margin. 
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Tanner et al. (1997) who showed that the sequence of microbial colonization and 
biofilm formation on oral implants was similar to that of teeth.   
A diagrammatic representation can be found in Figure 1.7 (Socransky et al., 
1998). This complex microbiota can be further defined into clusters of organisms. 
The study reported that their term “red complex‟ microbiota, are indicative of 
increased periodontitis lesions in adults (Umeda et al., 1996). It has been shown 
that the species found in this red complex have been found to produce 
proteolytic enzymes, a contributing factor to periodontitis disease progression 
(Loesche, 1992), and have a strong capacity to coaggregate (Onagawa et al., 
1994).  
The “Orange complex‟ has been strongly associated with periodontitis. The 
authors found bacteria associated with a healthy gingival crevice such as 
Streptococcus spp., Actinomyces spp., Capnocytophaga spp., Eubacterium spp., 
Fusobacterium spp. and Veillonella spp. were predominant (Listgarten, 1994). 
 
 
 
 
 
 
 
   
 
 
 
 
Figure 1.7. A diagrammatic representation of subgingival microbiota complexes 
(Socransky et al., 1998). 
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1.6 Identification of organisms in peri-implant disease 
The detection of organisms associated with peri-implant disease has included 
numerous techniques ranging from electron microscopy (Rams and Link, 1983), 
culture dependent techniques (Rams et al., 1984), polymerase chain reaction 
(PCR), 16S rRNA gene cloning and comparative sequencing (Koyanagi et al., 
2010), checkerboard DNA-DNA hybridization (Máximo et al., 2009, Al-Radha et 
al., 2012), through to 454 pyroesequencing (Kumar et al., 2012).  
 
1.6.1 Culture dependent techniques 
Bacterial culture is the traditional basis of identification and has been widely used 
in epidemiological and clinical studies. The main advantages of culture are its 
ability to detect multiple bacterial species and the possibility of obtaining relative 
and absolute counts of cultured species (Kazor et al., 2003). These techniques 
are effective when reliable selective media for a particular species or genera are 
available (Spratt, 2004).  
Initial assessment of the microbial population involves the use of non-selective 
media such as blood agar, and fastidious anaerobic agar that allows the growth 
of a wide range of species. As many oral species have complex nutritional 
requirements, supplements such as serum, haemin, and menadione are often 
added to encourage the growth of a wider range of species. To enumerate 
specific species or genera, many selective media have been developed for oral 
species. These include mitis salivarius (MS) agar for the isolation of 
Streptococcus spp., and cadmium fluoride acriflavine telluirite (CFAT) agar for 
the isolation of Actinomyces spp. (Zylber and Jordan, 1982). Other examples of 
selective media are Gram-negative anaerobe medium supplemented with 
vancomycin to allow growth Gram negative rods and inhibit Gram-positive 
bacteria, and mannitol salt media for isolation of Staphylococcus and 
differentiation of Staphylococcus aureus.  
A variety of special media and prolonged incubation periods under anaerobic 
conditions has allowed isolation of more diverse bacteria. The major problem of 
this technique is that requires highly skilled personnel with an extensive 
knowledge of bacteria culture and isolation techniques. Once cultured, the 
bacterial isolates need to be characterised and identified. There are various 
biochemical tests available to achieve this (Gram staining, oxidise test, catalyse 
test, coagulase test). However, these are very labour intensive but have been 
used in the study of the composition of dental plaque and are still generally used 
as the gold standard when determining the performance of new microbial tests in 
periodontal microbiology (Mombelli et al., 1990). Culture techniques have been 
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used comprehensively in early experimental peri-implantitis studies (Augthun 
and Conrads, 1997, Alcoforado et al., 1991, Sanz et al., 1990, Rams and Link, 
1983, Rams et al., 1984, Nakou et al., 1987, Mombelli et al., 1988, Rosenberg et 
al., 1991, Nakazato et al., 1989, Danser et al., 1997, Ong et al., 1992). Isolated 
bacteria can be identified by molecular approaches. 16S rRNA gene analysis 
has been accepted as the current standard in definitive identification of oral 
bacteria (Tanner et al., 1994).  
 
1.6.2 Culture independent techniques 
1.6.2.1 Polymerase chain reaction (PCR) and 16S rRNA genes 
The polymerase chain reaction (PCR) is a method first described by Kary Mullis 
in the late 1980s (Spratt, 2004). The application of PCR and sequencing 
revolutionized the detection and identification of bacteria. PCR is a technique, 
which uses a DNA polymerase enzyme to make a large number of copies of 
virtually any given piece of DNA or gene. The particular stretch of DNA to be 
amplified, called the target sequence, is identified by a specific pair of DNA 
primers, oligonucleotides usually about 20 nucleotides in length which designate 
the outer limits of the amplification product (Spratt, 2004). 
There are a number of advantages and indeed disadvantages associated with 
the comparative sequencing technique. One advantage is that the single protocol 
is easily learned has relatively high through put and a good level of identification 
could be expected (Spratt, 2004). However, the misidentification of isolates can 
be an issue. For example, new un-named isolates can be placed into species 
isolates from very closely related groups can be misidentified, such as mitis 
group streptococci. Some bacterial groups are very closely related and the 
sequence information within the gene is not sufficient to resolve these taxa with 
any certainty (Spratt, 2004). Difficult groups to resolve which are relevant in 
endodonotic infections include: mitis group streptococci (S. mitis, S. oralis, S. 
sanguinis, and S. gordonii), Actinomyces spp, (A. naeslundii, A. israelii, A. 
meyeri, A. odontolyticus, A. viscosus, A. gerencseriae and A. radicidentis), 
coagulase-negative staphylococci (S. epidermidis, S. warneri, S. lentus etc) and 
Veillonella spp (V. parvula, V. atypica and V. dispar) (Spratt, 2004). The 
candidate genes have been proposed and used for comparative sequence 
analysis studies. Manganese dependant superoxide dismutase (sodA) is one 
such gene that has been successfully used to identify the oral streptococci, 
including the mitis group (Poyart et al., 1998) and the coagulase-negative 
staphylococci (Poyart et al., 2001). The 16S (small subunit) rRNA gene was 
selected as a candidate molecule for a number of reasons: it is present in all 
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organisms, it is sequence sufficiently conserved and contains regions of 
conserved, variable and hypervariable sequence, it is of sufficient size (ca. 1500 
bases) to be relatively easily sequenced but large enough to contain sufficient 
information for identification and phylogenetic analysis (Spratt, 2004). The use of 
16S rRNA gene makes it is possible to recognize phylogeny of all organisms on 
earth. For bacterial identification, 16S rDNA sequencing is particularly important 
in cases of bacteria with unusual phenotypic profiles, rare, slow growing bacteria, 
uncultivable bacteria and Gram-negative infections (Koyanagi et al, 2010). It 
presents some advantages when compared to other microbiologic tests because 
it is fast and simple means to produce relatively high numbers of copies of DNA 
molecules obtained from minimal amounts of fragments of microorganisms DNA. 
This approach allows the detection of almost every species in a given sample 
and is able to indicate the presence of previously uncultivated and unknown 
bacteria (Aas et al., 2005). It is the best method available at present for 
determining the diversity of microorganisms without cultivation. The method is 
based on isolation of DNA from the target environment or based on nucleic acids 
extracted directly from clinical samples. Polymerase chain reaction (PCR) 
amplification of the ribosomal rRNA gene, cloning the amplicons into Escherichia 
coli, and sequence analysis of the cloned 16S rRNA gene inserts (Woo et al., 
2008). The use of specific PCR is equivalent to the use of selective media in 
culture dependent technique. It is use is increasing as result of ribosomal gene 
sequencing allowing identification of novel bacteria species from human sample. 
This approach allows working with samples containing many different species 
(mixed PCR products). 16S rDNA sequencing has played a pivotal role in the 
accurate identification of bacterial isolates and the discovery of novel bacteria in 
clinical microbiology laboratories (Spratt, 2004).  
These approaches have been used for evaluation of peri-implant microbiota in 
edentulous patients and showed that the longer the implants were in the oral 
cavity, the higher the occurrence of A. actinomycetemcomitans, P. gingivalis, 
and P. intermedia in the peri-implant sulci of completely edentulous patients 
(Devides and Franco, 2006). It has been used for analysis of microbiota 
associated with peri-implantitis and showed that peri-implantitis sites had a more 
complex microbiota compared to periodontitis/healthy implant sites and that 
these were mainly composed of Gram-negative anaerobic bacteria (Koyanagi et 
al., 2010, Koyanagi et al., 2013). The main drawback of using the 16S rRNA 
gene for amplification is that the universal primers used in the PCR are not as 
universal as once hoped, for example selective amplification can arise with 
templates with a low GC content (Polz and Cavanaugh, 1998).  
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Overall, a major drawback with most of these techniques is that they do not 
provide access to the whole genome (Spratt, 2004). Spratt (2004) stated that 
these techniques (culture dependant and culture independent) are not exclusive 
to each other and should be used together by microbiologists in an informed 
polyphasic manner to understand the complex nature of dental infections. 
 
1.6.2.2 Quantitative polymerase chain reaction (qPCR) 
A recent advance in PCR technology has been the development of real-time 
PCR systems. The development had been facilitated by the earlier combination 
of the 5 nuclease assay developed by Holland et al. (1991) with fluorescence 
detection following cleavage of an internal (TaqMan) DNA probe (Livak et al., 
1995), enabling the accumulation of amplicons to be monitored after each cycle 
and hence facilitating quantitative determination of the initial template gene (or 
transcript) numbers. The target specificity of any qPCR assay is determined by 
the design of the primers (and in some cases an internal probe), allowing 
quantification of taxonomic or functional gene markers present within a mixed 
community from the domain level down to the quantification of individual species 
or phylotypes (Smith and Osborn, 2009).  
The qPCR works in essentially the same manner as end-point PCR. Multiple 
amplification cycles in which template DNA is initially denatured is followed by 
annealing of oligonucleotide primers (targeting specific sequences) is further 
followed extension of a complementary strand from each annealed primer. This 
is performed by a thermostable DNA polymerase. The multiple cycling, resulting 
an exponential increase in amplicon number. However, in contrast to end-point 
PCR, the increase in amplicon numbers is quantified in “real-time” during the 
PCR via detection of a fluorescent reporter that indicates amplicon accumulation 
during every cycle.  
Two reporter systems are commonly used, namely, the SYBR green assay 
(Wittwer et al., 1997) and the TaqMan probe system (Holland et al., 1991, Livak 
et al., 1995). Since SYBR green binds to all double-stranded DNA, it is essential 
to use primer pairs that are highly specific to their target sequence to avoid 
generation of nonspecific products that would contribute to the fluorescent signal, 
resulting in an overestimation of the target. Primer pairs that exhibit self-
complementarity should also be avoided to prevent primer–dimer formation. A 
post-PCR melting curve analysis should be carried out to confirm that the 
fluorescence signal is generated only from target templates and not from the 
formation of nonspecific PCR products. A melting curve is constructed, and 
fluorescence levels are measured at each discrete temperature point. As the 
Chapter 1: Literature review 
 
58 
 
double-stranded template is heated, it denatures, resulting in a corresponding 
decline in fluorescence due to SYBR green dissociation from the double-
stranded product (Giglio et al., 2003). The TaqMan Real Time PCR assay is 
based on Taq Polymerase 5´–3´ nuclease activity (Lyons et al., 2000, Asai et al., 
2002, Nadkarni et al., 2002, Suzuki et al., 2004, Yoshida et al., 2004). The 
TaqMan Real Time PCR probe, which is labelled with two fluorescent dyes, is 
created within the amplicon defined by a gene-specific PCR primer pair. The 5’ 
end is labelled with a reporter dye (usually 6-carboxy-fluorescein, FAM), while 
the 3’ end is labelled with a second fluorescent dye (6-carboxy-tetramethyl-
rhodamine, TAMRA). The TaqMan probe method utilizes a fluorescently labelled 
probe that hybridizes to an additional conserved region that lies within the target 
amplicon sequence. During the annealing step of each cycle of the PCR, primers 
and the intact probe bind to their target sequences. During subsequent template 
extension, the 5 exonuclease activity of the Taq polymerase enzyme cleaves the 
fluorophore from the TaqMan probe and a fluorescent signal is detected as the 
fluorophore is no longer in close proximity to the quencher.  
The qPCR amplification curve can be subdivided into four stages, namely 
background noise, where the background fluorescence still exceeds that derived 
from initial exponential template accumulation, exponential amplification, linear 
amplification and a plateau stage. During the exponential phase of the 
amplification, the amount of target amplified is proportional to the starting 
template and it is during these cycles that gene numbers are quantified using the 
CT method.  
The CT is reached when the accumulation of fluorescence (template) is 
significantly greater than the background level. During the initial cycles, the 
fluorescence signal due to background noise is greater than that derived from 
the amplification of the target template (Smith and Osborn, 2009). Once the CT 
value is exceeded, the exponential accumulation of product can be measured. 
When the initial concentration of the target template is higher, the CT will be 
reached at an earlier amplification cycle (Becker et al., 2000). The absolute value 
of CT depends on the initial template copy number, the efficiency of both DNA 
amplification and cleavage of the TaqMan Real Time PCR probe (Price et al., 
2007). For each standard curve, the r2 value, the amplification efficiency, E 
derived from the slope of the standard curve and the y-intercept value indicates 
the sensitivity of the reaction; lower values indicate greater sensitivity of the 
qPCR amplification (Becker et al., 2000).  
The gene and transcript numbers of the target gene of interest have been 
normalized to the numbers of 16S rRNA gene or transcripts (Kandeler et al., 
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2006). 16S rRNA gene copy and transcript numbers are highly variable, with the 
number of 16S rRNA genes per operon varying dramatically between species 
(1–15 copies). A number of studies have reported that 16S rRNA gene numbers 
from environmental samples cannot be converted to cell numbers as the exact 
number of copies of the 16S rRNA gene in any given bacterial species varies 
(Klappenbach et al., 2001, Klappenbach et al., 2000). The quantification of gene 
copy number from an environmental DNA template should not be carried out if 
the resulting CT values are greater than or equal to those of the no template 
control (NTC) (Suzuki et al., 2000). The sensitivity of qPCR allows quantification 
of very low numbers of target genes, with detection limits as low as two copies of 
a gene in a qPCR (Fey et al., 2004) although routinely this is perhaps 10 of 
copies. 
The key considerations and recommendations for the use of qPCR are: the 
amplicons should be short, ideally between 50 and 150 bp in length, the GC 
content of the primers may range between 20% and 80% (although paired 
primers should have similar melting temperatures (Tm), a high GC content will 
increase the specificity of the reaction. When designing a TaqMan probe, the 
probe should be situated as close as possible to the forward primer without 
overlapping. The probe sho ld not have a g anine n cleotide at the 5 end or 
have more g anines than cytosine’s as g anine resid es are nat ral q enchers. 
The Tm of the probe should be 8–10 °C above the Tm of the primers. A full 
description of the standard curve (r2, slope, efficiency and y-intercept value) 
should be given when reporting gene and/or transcript numbers. Biological (not 
just technical) replication (at least n = 3) is essential for qPCR to enable 
statistical investigation of differences in gene or transcript numbers between 
samples or treatments (Smith and Osborn, 2009). 
Multiple TaqMan probes and primer sets can be used in different qPCR assays 
to differentiate between closely related sequences (Smith and Osborn, 2009), or 
alternatively, probes can be labelled with different fluorophores, facilitating the 
development of multiplex qPCR protocols whereby different targets can be 
coamplified and quantified within a single reaction For example, Baldwin et al. 
(2003) developed a multiplex qPCR assay targeting a number of different 
aromatic oxygenase genes using bacterial strains and then subsequently applied 
the assay to simultaneously quantify aromatic oxygenase genes in contaminated 
groundwater. The multiplex qPCR has also been used to identify and quantify 8 
key taxa associated with health, gingivitis and dental caries (Ciric et al., 2010).  
The qPCR, with species-specific primers and probes, represents a specific, 
sensitive, and quantitative tool to study periodontal pathogens (Boutaga et al., 
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2007). The qPCR assays offer significant advantages over traditional culture 
techniques that can be both labour and time intensive and over conventional 
PCR assays that will only determine presence or absence. The methods allow 
quantitative identification of any bacterial species of interest including bacteria 
that may be very difficult to culture (Paster and Dewhirst, 2009). The TaqMan 
Real Time PCR significantly increases the specificity of the detection.  
For the quantitative detection of DNA, specific sets of primers were designed that 
amplify unique nucleotide sequences of the target organism and a fluorescent 
signalling DNA probe was used for quantification and differentiation of 
periodontopathogens from subgingival plaque samples (Nonnenmacher et al., 
2004).  
The qPCR is more rapid, reliable and able to detect absolute number of bacterial 
cells from known standards (Paster and Dewhirst, 2009). Furthermore, they do 
not require post amplification handling of PCR products and results are obtained 
within hours from a wide variety of sample types.  
The qPCR technique has been used for the identification of P. gingivalis (Lyons 
et al., 2000, Sakamoto et al., 2001, Boutaga et al., 2003), A. 
actinomycetemcomitans (Sakamoto et al. 2001), T. denticola (Sakamoto et al. 
2001, Asai et al. 2002, Yoshida et al. 2004) and T. forsythensis (Sakamoto et al. 
2001). Many studies have reported the usefulness and acceptance of this 
system for the identification of oral bacteria, detection and quantification (Maeda 
et al., 2003, Boutaga et al., 2007, Yoshida et al., 2004). Furthermore, qPCR can 
be used to quantify specific bacterial populations in plaque samples before and 
after treatment for monitoring therapeutic efficacy (Yoshida et al., 2004). The 
qPCR technique can provide results in 2 hours, whereas anaerobic cultures 
require 7-8 days to confirm the presence of putative periodontopathogens (Price 
et al., 2007).  
The TaqMan probes are more expensive than using SYBR green chemistry and 
the former requires the presence of an additional conserved site within the short 
amplicon sequence to be present. Identification of three conserved regions within 
a short region (typically ca. <100 bp) may not always be possible, especially 
when primer/probe combinations are being designed to target divergent gene 
sequences. More advances in TaqMan probe technology have involved the 
introduction of the minor groove binder (MGB) probe (Kutyavin et al., 2000). The 
MGB molecule is attached to the 3 end of the probe and essentially folds back 
onto the probe. This will increases the stability of the probe, allowed the design 
of shorter probes (13–20 bp) than are required for traditional TaqMan probes 
(20–40 bp), and maintaining the required hybridization annealing temperature 
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(Kutyavin et al., 2000). Since molecular analysis of environmental 
microorganisms has repeatedly shown that the majority of microorganisms (and 
their genes) in the environment are highly divergent from those of most cultured 
organisms, this represents the development of new PCR-based assays.  
Recently, ultra-high-throughput sequencing approaches such as pyrosequencing 
(Edwards et al., 2006). This pyrosequencing approach particularly, offers 
considerable benefits both in terms of providing much larger data sets than can 
be generated via library-based approaches, and as importantly, by avoiding 
potential sequence-specific cloning biases. Moreover, where pyrosequencing is 
used to target-specific genes (rRNA genes); (Sogin et al., 2006), such data sets 
provide only semi quantitative assessments of the diversity. 
 
1.6.2.3 Pyrosequencing  
Pyrosequencing is defined as a sequencing method based on real-time 
monitoring of the DNA synthesis. It is a four-enzyme DNA sequencing 
technology monitoring the DNA synthesis detected by bioluminescence 
(Ahmadian et al., 2000).  
Pyrosequencing is becoming a common method used for determining richness 
and diversity complex bacterial communities. The identification of bacterial 
strains usually involves sequencing of the 16S rRNA gene. Several studies have 
reported the usefulness of pyrosequencing technology for bacterial typing by 
sequencing various the variable regions of the 16S rRNA gene. In the 454 
pyrosequence system (Roche) (Wade, 2013), 16S rRNA genes are amplified by 
PCR from samples with universal primers and then mixed in equal proportions. 
The mixture is then amplified in an emulsion and distributed among wells on a 
plate to which are added beads containing the sequencing reagents. Nucleotide 
incorporation is detected by a CCD camera imaging system and around 0.8 
million sequences, up to 750 base pairs long can be obtained in a single run. To 
enable multiple samples to be sequenced in the same run, primers with unique 
barcodes are used, typically 8–12 nucleotides, incorporated into the initial PCR 
primer. These barcodes are then incorporated into the final sequences obtained 
and can be easily sorted and assigned to source samples after sequencing 
(Wade, 2013). The use of pyrosequencing and alternative high throughput 
methods such as the Illumina system, which provides a higher numbers of 
sequences, although of shorter length, has revolutionised culture-independent 
analyses and has been the cornerstone of that part of the Human Microbiome 
Project devoted to determining the composition of the microorganisms at 
different human body sites (Consortium, 2012). These studies have shown that 
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each body site studied was colonised by a microbiome characteristic of that site 
but that the individual was the primary factor influencing the composition of the 
microbiome i.e. each individual is colonised by a unique microbiome (Segata et 
al., 2012). Within the mouth, samples from seven different surfaces were found 
to be colonised by three distinct bacterial communities: the buccal mucosa, 
gingiva and hard palate had similar microbiota while the saliva, tongue, tonsils 
and throat, and supra- and sub-gingival plaque each had distinctive communities 
(Segata et al., 2012). The use of recently developed molecular methods has 
greatly expanded our knowledge of the composition and function of the oral 
microbiome in health and disease. Technical advances in DNA and RNA 
sequencing will provide vast amounts of new data but analysing and interpreting 
the data will be extremely challenging (Wade, 2013). 
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1.7 Structural analysis of dental plaque 
1.7.1 Electron microscopy 
The electron microscope is a type of microscope that uses a beam of electrons 
to create an image of the specimen. It is capable of much higher magnifications 
and has a greater resolving power than a light microscope, allowing it to see 
much smaller objects in finer detail. Electron microscopy has been used 
previously for studying biofilm composition and structure because of these 
properties (Listgarten, 1976, Theilade et al., 1976). The disadvantages of this 
approach are that specimens require dehydration, fixing, embedding, and 
staining/coating which causes considerable distortion of the biofilm structure 
(cells, matrix and fluid filled spaces), leading to shrinkages of 50% during fixation 
and may change the relationship of one component with respect to another 
(Wood et al., 2000). It is laborious and can produce artefacts resulting from 
sample preparation. A significant amount of training is required in order to 
operate an electron microscope successfully. The samples need to be specially 
prepared by sometimes lengthy and difficult techniques to withstand the 
environment inside an electron microscope. In the life sciences, it is still mainly 
the specimen preparation that limits the resolution of what we can see in the 
electron microscope, rather than the microscope itself. The technique has 
however revealed a microscopic world previously unknown to us. 
 
1.7.2 Transmission electron microscopy (TEM) 
The original form of electron microscopy, Transmission Electron microscopy 
(TEM) involves a high voltage electron beam emitted by a cathode and formed 
by magnetic lenses. The electron beam that has been partially transmitted 
through the very thin (and so semi-transparent for electrons) specimen carries 
information about the structure of the specimen (Crawford and Burke, 2004). The 
spatial variation in this information (the "image") is then magnified by a series of 
magnetic lenses until it is recorded by hitting a fluorescent screen, photographic 
plate, or light sensitive sensor such as a CCD (charge-coupled device) camera. 
The image detected by the CCD may be displayed in real time on a monitor or 
computer. TEM produce two-dimensional, black and white images (Sugiyama 
and Sigesato, 2004). TEM resolution is about an order of magnitude better than 
the SEM resolution. The TEM can easily resolve details of 0.2 nm. The ability to 
determine the positions of atoms within materials has made the TEM an 
indispensable tool for nano-technologies research and development in many 
fields. For the TEM, samples are generally prepared by exposure to many 
chemicals, in order to give good ultra-structural detail which may result in 
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artefacts purely as a result of preparation (Sugiyama and Sigesato, 2004).This 
gives the problem of distinguishing artefacts from genuine structures within the 
specimen, particularly in biological samples.  
There are a number of drawbacks to the TEM technique. Many materials require 
extensive sample preparation to produce a sample thin enough to be electron 
transparent, which makes TEM analysis a relatively time consuming process with 
a low throughput of samples (Sugiyama and Sigesato, 2004). The structure of 
the sample may also be changed during the preparation process. Also the field 
of view is relatively small, raising the possibility that the region analysed may not 
be characteristic of the whole sample (Sugiyama and Sigesato, 2004). There is 
potential that the sample may be damaged by the electron beam, particularly in 
the case of biological materials. Previous studies on dental plaque structure 
carried out at high resolution by TEM suggested that the biofilm architecture 
appeared to be relatively dense, although it was not easy to attribute inter-
bacterial space to either matrix or fluid-filled space with this technology (Wood et 
al., 2000).  
 
1.7.3 Scanning electron microscopy (SEM) 
The first true SEM was described and developed in 1942 by Zworykin. In 1965 
the Cambridge Scientific Instr ments Mark I ‘‘Stereoscan’’ was developed as the 
first SEM. Resolution of 30 Ångstroms (1 Ångstrom is equal to 0.1 nm or 1x1010 
metres) under optimal conditions is possible (EVO SEM, Carl Zeiss product 
literature). However, for biofilm structure the resolution is greatly reduced without 
initial fixation, staining, drying and metal sputter coating, which deposits a thin 
layer of either gold or platinum on the surface (Crawford and Burke, 2004). 
Electrons can penetrate uncoated biological samples, giving an image of low 
resolution, however, if the samples are sputter coated, the electrons are reflected 
to the detectors, thus giving greater resolution of the surface topography 
(Kämper et al., 2004). It allows straightforward transmission observations of wet 
samples compromising of nano-scale objects in a liquid layer. Low-vacuum 
technology allows imaging samples in their native state. Particularly, adapted for 
suspension-type samples and characterizations in materials science as well as 
life-science at the nano-scale (Bogner et al., 2007). SEM has been used to 
investigate the morphological features of supragingival plaque development 
using six bonded enamel block on buccal surface of canine, premolar and molar 
teeth (Zee, 1996), and it has also been used to study the development of dental 
plaque at different stages (Novaes et al., 1991), and has also been used to 
describe certain structural details of naturally occurring approximal plaque and to 
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compare them with features of the bacterial film on enamel surfaces (Newman, 
1972). SEM has also been used to evaluate biofilm formation and composition 
on different implant materials in vivo (Al-Ahmad et al., 2010), as well as the 
characterisation of the surface chemistry, hydration, topography and roughness 
of a hydrophilic sandblasted and acid-etched titanium dental implant (SLActive) 
(Zinelis et al., 2012). 
 
1.7.4 Confocal laser scanning microscopy (CLSM) 
The application of CLSM to biofilms began in the early 1990s (Lawrence et al., 
1991). Confocal microscopy in conjunction with fluorescent probes has been 
widely used for biofilm research. A simple and effective use of CLSM is when it is 
used in conjunction with freshly grown biofilms and a live/dead fluorescent stain 
(Baclight™). SYTO 9 and propidium iodide staining has proven superior, because 
it provides a clear differentiation between dead and active microorganisms 
without interference of background fluorescence (Decker, 2001). SYTO stains 
have become available to stain specific organisms within the biofilm. Most 
commonly utilised stains are the LIVE/DEAD® staining where SYTO 9 stains all 
bacterial cells (independent of cell viability), whereas charged propidium iodide 
penetrates dead cells due membrane damage, thus allowing the stain to be 
internalised within the bacterial cell and when both dyes are present, reduce 
SYTO 9 to fluoresce red. This allows for differentiation of live and dead cells 
within the biofilm. Visualisation of biofilms helps to understand structural 
differences and similarities that may be seen in comparison with those in vivo. 
CLSM exhibits more advantages over conventional optical microscopy due to its 
ability for direct non-invasive serial optical sectioning of intact and living 
specimens and the possibility of generating 3D images of thick transparent 
objects such as biological cells and tissues (Lawrence et al., 1991). It also 
enables the examination of biofilm cultivated on non-transparent surfaces for 
example minerals, metals, gels and synthetics. It also allows sagittal (xz) 
sectioning of biofilms (vertical thin sections) cut through the biofilm from the 
substratum to the exterior surface. In addition, it allows quantitative visualizations 
of 2D, 3D, and potentially 4D (time course) reconstructions of biofilm 
characteristics. This technique has been used to analyse the biofilm architecture 
of several bacterial species grown in continuous-flow cultures (Lawrence et al., 
1991), to examine the structure of intact oral biofilms in vitro (Pratten et al., 2000) 
and in vivo (Auschill et al., 2001), to examine the spatial distribution of both 
viable and non-viable bacteria within microcosm dental plaques grown in vitro 
(Hope et al., 2002) and to assess the immediate bactericidal effect of 
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chlorhexidine (CHX) on biofilms (Zaura-Arite et al., 2001). In addition, structural 
changes and differences in the distribution of viable and non-viable bacteria 
associated with the change in environmental conditions can be observed (Dalwai 
et al., 2006). In general, CLSM offers the opportunity to visualize bacteria directly 
on the substrata and in the state of adherence (Hannig et al., 2007).   
 
1.8 Treatment of peri-implantitis 
Since dental implant predictability, functionality, and durability makes them an 
attractive option for patients and clinicians, complications can arise at any stage 
from patient assessment to maintenance therapy (Becker and Sennerby, 2012). 
As the use of dental implants continues to increase, the frequency with which 
clinicians will be confronted with peri-implant diseases can be expected to 
increase (Simonis et al., 2010). Thus, it is important to consider the treatment 
options available for the management of peri-implant diseases. The development 
of a biofilm on dental titanium implants associated with peri-implantitis may 
specifically include pathogens that are therapy resistant and is one of the most 
challenging implant complications to deal with (Simonis et al., 2010, Mombelli, 
2012, Lang et al., 2011). Several factors may explain the limited clinical 
successful outcomes of therapy. It is likely that the instruments available for 
debridement around implants are not properly designed to reach the affected 
area. Thus, the design of implants and placement of the dental titanium implants 
and their superstructures might have made it difficult to maintain a plaque free 
and inflammation free environment around the dental titanium implants (Schwarz 
et al., 2011). Several treatment modalities have been proposed for the 
management of peri-implant diseases based on the evidence available from the 
treatment of periodontitis (Leonhardt et al., 1999). The treatment modalities that 
have been suggested to achieve this objective can be broken down into two 
broad categories: non-surgical and surgical (Aljateeli et al., 2012).  
 
1.8.1 Non-surgical therapy 
The current non-surgical therapeutic strategies for managing peri-implant 
infections still appear to be largely based on the evidence available for treating 
periodontitis (Mombelli and Lang, 1992). The dental community has failed to 
develop effective non-surgical therapeutic measures for peri-implant mucositis 
and peri-implantitis. This failure is partially based on the lack of sufficient 
scientific data on the effect of conventional anti-infective therapies on biofilms on 
titanium implant surface (Renvert et al., 2008). The basic and common element 
for treating peri-implantitis seems to be debridement of the affected surface 
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(implant). The surfaces of modern implants are highly micro-structured and 
macro-structured, which are considered favourable for osseointegration (Byrne, 
2012). Such surfaces characteristics (such as threads and roughness) of an 
implant may facilitate initial microbial adhesion, formation of complex aggressive 
biofilms and may complicate debridement (Bürgers et al., 2010). Therefore, 
antiseptics and antibiotics have been tested for removing pathogenic biofilms 
(Mombelli and Lang, 1992, Lindhe et al., 2008).  
 
1.8.1.1 Antiseptic agents 
Several traditional antiseptics have been proposed for the non-surgical therapy 
of periodontitis as well as peri-implant mucositis and peri-implantitis. There are 
many chemotherapeutic agents such as chlorhexidine (CHX). Chlorhexidine 
gluconate (CHX; 0.2%) has been proven in many studies to be the most efficient 
antimicrobial solution, and is still considered by many as the gold standard 
(Moshrefi, 2002, Slots, 2002). 
CHX is a diphenyl compound that shows a wide spectrum of antibacterial activity 
by altering the bacterial cell membrane, which results in leakage and cell 
destruction, encompassing Gram-positive and Gram-negative bacteria. CHX was 
shown to inhibit plaque formation and improve gingival indices around natural 
teeth and dental implants (Quirynen et al., 2002).  
Another agent is sodium hypochlorite (NaOCl; household bleach) with its active 
agent undissociated hypochlorous acid (HOCl). NaOCl is a traditional 
disinfectant in dentistry because of its bactericidal, fungicidal, and tissue 
dissolving properties. HOCI is mainly used in endodontic therapy, and its 
proposed concentrations range from 0.5% to 5.25% (Slots, 2002, Izu et al., 
2004). HOCI is effective against bacteria because of its oxidizing action and has 
been successfully used as a supportive antimicrobial agent in surgical peri-
implantitis therapy (Slots, 2002, Izu et al., 2004). 
In contrast to sodium hypochlorite, which is known for its extreme cytotoxicity, 
hydrogen peroxide (H2O2) is a relatively non-toxic agent in commonly used 
concentrations and shows broad antimicrobial activity and rapid bactericidal 
action. 
Citric acid has frequently been used for the removal of bacterial endotoxin in root 
treatments and has also shown to exert antibacterial activity against microbial 
plaque deposits on periodontally diseased root surfaces. In patients with peri-
implantitis, citric acid was used to detoxify plaque-infected implant areas (before 
regenerative treatments), and its efficacy in this respect has been shown in many 
in vitro and in vivo studies (Zablotsky et al., 1992).  
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Listerine (a combination of essential oils) was shown to have antimicrobial 
activity against bacteria colonizing teeth, tongue, and saliva. Listerine has 
successively been used under different clinical conditions, such as during post-
surgical periods and in implant dentistry, because of its anti-plaque and anti-
mucositis effectiveness in comparison to CHX (Cortelli et al., 2009, Mandel, 
1994). Listerine’s mechanism of action involves bacterial cell membrane 
destruction, bacterial enzymatic inhibition, and extraction of bacterial 
lipopolysaccharides. This bactericidal effect of essential oils, such as eucalyptol, 
thymol, menthol, and methyl salicylate, has been affirmed against A. 
actinomycetemcomitans, A. viscosus, S. mutans, and S. sanguinis (Ross et al., 
1989).  
Triclosan (5-chloro-2-(2, 4-dichlorophenoxy)-phenol) is effective in reducing 
subgingival microbiota both quantitatively and qualitatively and has served as a 
antimicrobial and plaque-reducing additive in many oral hygiene products, such 
as tooth pastes and mouth-rinses, for more than 20 years  (Rosling et al., 1997a, 
Rosling et al., 1997b). Clinically, triclosan has been found to be effective in 
inhibiting dental biofilms, calculus, caries progression, and gingivitis (Arweiler et 
al., 2002). 
A study by Bürgers et al. (2012) investigated a 60 s treatment time on oral 
biofilms of CHX 0.2%, H2O2 3%, sodium hypochlorite 1%, citric acid 40%, 
Listerine cool mint (alcoholic based), and triclosan 0.3%. Sodium hypochlorite 
had only broad-spectrum antimicrobial effect against either C. albicans, S. 
epidermidis, and S. sanguinis on machined pure titanium substratum (median 
surface roughness Ra = 0.15 µm). However, sodium hypochlorite has a 
potentially toxic effect to both infectious agents and host cells. Also it has limited 
application in human infected wounds, skin, and mucosa (Slots, 2002, 
Spangberg et al., 1973). Other clinical studies have used adjunctive antiseptic 
agents including Listerine mouthrinses twice daily (Ciancio et al., 1995), 
chlorhexidine CHX rinsing 0.06% (Felo et al., 1997), and CHX (0.12%) rinsing 
plus CHX (0.12%) gel application for 30 s (Porras et al., 2002).  
Ramberg et al. (2009) showed that the regular use of dentifrices containing 
triclosan (0.3%) may reduce the clinical signs of inflammation in the mucosa 
adjacent to dental implants. It has shown that the decontamination of machined 
discs with H2O2 (5 min), saturated citric acid (pH = 1, 1 min) or CHX gel (5 min) 
did not harm the surfaces and epithelial cells would still grow in the Ti surface. 
The use of 3% H2O2 and citric acid treated surfaces allowed better epithelial cells 
growth than the CHX gel treatment (Ungvári et al., 2010). Other work has shown 
that “CHX chips” at implant’s sites res lting in a significant improvement of 
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periodontal parameters (probing depth-PD and bleeding on probing-BOP) at 
peri-implantitis sites (Machtei et al., 2012). Augthun et al. (1998) treated implants 
with CHX solution 0.1.% for 60 s. The authors showed no damaging effect on 
any implant surface after application and found that the CHX 0.1% solution rinse 
did not remove plaque deposits on all implant surfaces (smooth, plasma sprayed 
implant surfaces). Another clinical study was conducted from three consecutive 
peri-implantitis cases treated with non-surgical debridement and subgingival 
CHX irrigations (Nibali and Donos, 2011). All cases were exposed for subgingival 
debridement. The implants were scaled with a piezoelectric device at 200 rpm 
(on the implant neck) and with plastic curettes on the exposed implant threads 
for 15 min. this was followed by subgingival irrigations with approximately 15 ml 
of 0.2% CHX. Patients were instructed to rinse twice a day for two weeks with 
CHX 0.2% after treatment. The results showed that after 12 months, the bone fill 
of the peri-implant infrabony defects was evident. 
 
1.8.1.2 Antibiotic use in peri-implantitis  
The use of locally delivered antibiotics in the treatment of peri-implantitis was 
described in the review of van Winkelhoff (2012). The theoretical advantages of 
locally administered antibiotics in comparison to systemically delivered antibiotics 
are:   
 The therapy can be achieved at a high concentration in the infected site. 
 The risk for side and adverse effects are reduced. 
 There is no interaction with other medicines. 
 
Mombelli et al. (2001) used tetracycline HCl polymeric fibres and applied these 
to partially edentulous patients with peri-implantitis lesions. The study showed 
that local application was effective in improving the clinical condition. This 
therapy reduced the mean total number of cultivable bacterial counts and 
significantly decreased the recovery of several periodontal pathogens (Mombelli 
et al., 2002). Salvi et al. (2007) used mechanical debridement in conjunction with 
local delivery of minocycline microspheres in the treatment of peri-implant 
infection. They found that after 12 months, the mean PD decreased from 5.9 mm 
to 4.2 mm and BOP scores reduced from 92 to 44 at sites with the deepest peri-
implant.  
Renvert et al. (2008) used mechanical debridement in conjunction with 
minocycline HCl 1 mg placed subgingivally/submucosal at implant sites and 
microbiota were detected by checkerboard DNA-DNA hybridization method. The 
authors showed a low prevalence of the target bacteria (P. gingivalis, P. 
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intermedia, P. nigrescens, T. forsythensis, A. actinomycetemcomitans, and 
Treponema denticola) with minocycline HCl treatment and the authors found 
moderate improvement in plaque scores. 
Azithromycin® has been used in the treatment of peri-implant mucositis 
(Hallström et al., 2012) as an adjunct to mechanical therapy (Ericsson et al., 
1996). The pharmacokinetics of Azithromycin® is characterized by a fast drug 
transfer from blood into intra-cellular compartments. Data have shown that 
Azithromycin® concentrations in gingival fluid (GCF) are higher and more 
sustained than in serum. The authors failed to identify microbiological 
advantages for the adjunct treatment with Azithromycin® in combination with 
debridement in cases with peri-implant mucositis. The authors showed that the 
use of systemic antibiotics in the treatment of peri-implant mucositis did not 
demonstrate better clinical results up to 3 months after treatment (Hallström et 
al., 2012).  
Although local antibiotic therapy of peri-implantitis has a positive effect on clinical 
and microbiological findings, there are limitations including microbiological 
parameters shifting back towards pre-treatment values after 1 month of 
treatment, particularly in deep advanced peri-implantitis (Mombelli et al., 2001) 
lesions. Additional issues are that clinically, it is difficult to deliver local antibiotic 
therapy to the very base of deep defects (Mombelli et al., 2001). The values and 
needs for antibiotics in the treatment of peri-implant mucositis is questionable 
and must be considered in relation to the overall community risk of antibiotic 
resistance development. It could be concluded that non-surgical debridement of 
peri-implant mucositis without the adjunct use of systemic antibiotics should be 
the first choice of treatment (Hallström et al., 2012). The antibiotic treatment of 
peri-implantitis may not allow sufficient bone filling or reosseintegration in deep 
peri-implant bony defects. Therefore, surgical therapy may be necessary to treat 
peri-implant defects. 
 
1.8.1.3 Mechanical therapy for peri-implantitis 
Mechanical therapy alone proven be effective in treating bacterial infections 
around teeth and has been suggested as a treatment for implants (Lang et al., 
2000). However, reduction of bacterial load at peri-implantitis sites by means of 
mechanical debridement alone remains difficult, largely due to the design of the 
suprastructure and the topography of the implant surface (Schär et al., 2013). 
Implant surface decontamination is the basic goal in the treatment of peri-
implantitis. Numerous tools are available to achieve this such as use of polishing 
brushes, rubber polishers, Teflon, plastic, carbon or titanium curettes, and 
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special modified tips for ultrasonic systems and air powder flows. Studies 
evaluating some of these methods have shown that mechanical debridement 
alone with subgingival carbon fibre curettes or with the ultrasonic Vector® system 
showed no differences (Karring et al. 2005). Augthun et al. (1998) evaluated  
implants with the following treatments: Gracey curette, plastic curette, diamond 
polishing device, ultrasonic scaler, air powder abrasive system with sodium-
hydrocarbonate solution for 60 s. They found that treatment with the diamond 
polishing device, ultrasonic scaler, and steel curette caused severe surface 
damage in all implant surfaces. However, the plastic curette and the air-powder-
water abrasive system caused none to medium surface damage. The clinical 
study revealed differences in the efficacy of the cleaning methods and also 
showed that the plastic curette had a limited cleaning efficacy due to difficulties 
in removing plaque from the depths of the screw threads or from the plasma 
sprayed surfaces. The air-abrasive system on implant surface yielded completely 
plaque-free surfaces and revealed a high biocompatibility (Schwarz et al., 
2009b). However, there are limitations in the clinical application of air powder 
flow (amino acid glycine or sodium bicarbonate) because of an increased risk of 
subcutaneous emphysema. This is a clinical condition arising from the 
penetration of air into causing deformity and swelling. It in the vicinity of the oral 
cavity this may include tissues spaces of the fascial plane (Brown et al., 1992) 
and may lead to visible alterations of the implant surface (Kreisler et al., 2005, 
Cochis et al., 2012). A study by Persson (2010) demonstrated that there was no 
change in the microbiota in pockets around implants with a diagnosis of peri-
implantitis in dogs after treatment with hand instruments and ultrasonic device. 
Also they found that the trends of bacterial reduction were similar before and 
after 6 months of treatment. Although the results of the studies mentioned above 
showed an improvement in the healing of peri-implantitis lesions, a complete 
resolution of peri-implant mucosal inflammation was rare (Schär et al., 2013).  
 
1.8.1.4 Laser application for treatment of peri-implant infections 
As lasers can perform excellent tissue ablation with high bactericidal and 
detoxification effects, they have been proposed to be one of the most promising 
new technical modalities for the treatment of failing implants. Laser has been 
used as a substitute to conventional mechanical debridement (Romanos et al., 
2009).  
The physical properties of the laser energy and its interaction with tissues, due to 
reflection, scattering, transmission, and absorption, may explain why the implant 
surface can be decontaminated in all areas, including within the threads. The 
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light may induce these antibacterial effects due to its absorption by the implant 
and the surrounding tissues, or it may be reflected by the metal surface, causing 
a slight elevation in tissue temperature. The temperature changes seen during 
CO2 laser irradiation have been studied extensively (Mouhyi et al., 1999, 
Romanos et al., 2009). Linear increases to temperatures >50°C were observed 
with increases in power levels and exposure times (Kreisler et al., 2002b).  
The CO2 laser has been reported to be safe and resulted in enhanced bone 
regeneration when utilised for decontamination of implants in the treatment of 
peri-implantitis. The limitations of clinical application of CO2 laser are the 
increase in temperature on the implant surface and carbonisation of the adjacent 
bone tissue (Kreisler et al., 2002c, Schwarz et al., 2009a) and associated 
change at all implant surfaces. Therefore, the power output and irradiation time 
must be limited to avoid any unintentional thermal damage. Similar problems 
may arise when a diode laser is used (Kreisler et al., 2002b). The Nd:YAG 
(neodymium-doped yttrium aluminum garnet) laser was contraindicated for 
treatment of peri-implantitis because of irradiation of the implant surface and the 
production of  morphological changes such as melting, cracks and crater 
formation on all titanium surfaces (Kreisler et al., 2002b). Er:YAG laser (erbium-
doped yttrium aluminium garnet) has been used for the removal of subgingival 
calculus from periodontally diseased root surfaces without producing major 
thermal side effects to adjacent tissue. The Er:YAG laser has high absorption of 
emission wavelength at 2940 nm by water, and exhibits no thermal damage to 
tissue (Kreisler et al., 2002a) and its irradiation does not influence the 
attachment rate of osteoblasts. The Er:YAG laser was proposed as an 
alternative to mechanical scaling and root planning because it has the ability to 
remove hard deposits from the root surface. It is strong bactericidal and 
detoxification activity (Folwaczny et al., 2003), it is able to debride the root 
surface with minimal removal of tooth substance (Schwarz and Becker, 2005), it 
is ability to ablate without producing a smear layer has the ability to remove 
smear layers and cementum bound endotoxin (Folwaczny et al., 2003). In 
addition, periodontal ligament fibroblasts show enhanced adhesion and 
proliferation on laser treated root surfaces. Furthermore, the laser light beam has 
enhanced access to grooves and concavities compared with mechanical 
instruments, as access is not limited by the physical size of the instrument. 
Er:YAG can effectively have been found to remove calculus and plaque on 
contaminated abutments and biofilms grown on sandblasted and acid-etched 
titanium surfaces (SLA) at low energy densities.  In vitro studies showed Er:YAG 
laser irradiation removed P. gingivalis contaminated SLA implant surfaces and 
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resulted in similar fibroblast proliferation when compared with sterile specimens, 
and greater fibroblast proliferation when compared with untreated contaminated 
specimens (Friedmann et al., 2006). It was investigated that the mean value of 
residual plaque biofilm was significantly lower after treated by this laser on 
sandblasted and acid-etched titanium discs compared with hand instrumentation 
using plastic curettes and ultrasonic instrumentation treated groups. However, 
the formation of an oral biofilm at structured titanium surfaces interfered with the 
adhesion and proliferation of osteoblasts in vitro, and its removal using either 
conventional treatment procedures or Er:YAG laser was not sufficient for 
achievement of an acceptable biological surface (Schwarz et al., 2005). 
 
1.8.1.5 Photodynamic therapy (PDT) 
Recently, PDT has received increasing attention in dentistry (Konopka and 
Goslinski, 2007). PDT basically involves three nontoxic ingredients: visible 
harmless light; a nontoxic photosensitizer; and oxygen (Hass et al., 1997). The 
principle is that a photosensitizer binds to the target cells and is then activated by 
light of a suitable wavelength. Following activation of the photosensitizer through 
the application of light of a certain wavelength, singlet oxygen and other reactive 
oxygen species are produced. These are very toxic to the bacteria and certain 
cells. The bactericidal effect of photodynamic therapy can be explained by two 
mechanisms, DNA damage and damage to the cytoplasmic membrane of the 
bacteria by cytotoxic species. The latter leads to inactivation of the membrane 
transport system, inhibition of plasma membrane enzyme activities and lipid 
peroxidation (Wilson et al., 1995). For the elimination of bacteria in supragingival 
and subgingival plaque, antimicrobial PDT has been employed with various 
combinations of lasers and photosensitizing agents. Photodynamic therapy has 
been suggested as an alternative to chemical antimicrobial agents to eliminate 
subgingival species and treat periodontitis. The application of methylene blue-
mediated photodynamic therapy in clinical studies using the Periowave treatment 
kit is as follows: methylene blue is applied directly in the dental pockets for 60 s 
followed by exposure to red light via a fiberoptic probe for 60 s per pocket or per 
tooth (10 s per site, six sites in total) (Figure 1.8). 
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The phenothiazine dyes (toluidine blue O and methylene blue) are the major 
photosensitizers applied clinically in the medical field. It has been reported that 
methylene blue and toluidine blue O are very effective photosensitizing agents 
against Gram-positive and Gram-negative periodontopathic bacteria (Chan and 
Lai, 2003). However, Gram-negative organisms seem to be generally more 
resistant to PDT than Gram-positive bacteria, as a result of the differences in the 
outer membrane. It has been shown that toluidine blue O has a greater ability for 
killing Gram-positive and Gram-negative bacteria than methylene blue (Chan 
and Lai, 2003). For example, it has been demonstrated that A. 
actinomycetemcomitans, P. gingivalis and F. nucleatum were more susceptible 
to toluidine blue O than methylene blue. This is perhaps linked to the fact that 
toluidine blue O interacts with lipopolysaccharides more effectively than 
methylene blue (Chan and Lai, 2003).   
PDT is an attractive treatment option as is already use in the field of periodontics 
(Chondros et al., 2009) and implant dentistry (Schär et al., 2013). PDT can be 
applied locally and PDT allows efficient bacterial elimination with high 
concentrations of chemical agent without producing any side effects on the host 
tissues, this technique could offer the rapid non-invasive topical in vivo 
application of the drug to the lesion; rapid bacterial killing after a short exposure 
to light; unlikely development of resistance considering the widespread generic 
toxicity of reactive oxygen species; and confined killing by restricting the field of 
A 
B 
C 
Figure 1.8. Clinical application of antimicrobial 
photodynamic therapy in the treatment of peri-
implantitis. A. Application of the photosensitizer. 
The photosensitizer was placed in the peri-
implant pocket. B. Irradiation with the diode 
laser. C. The clinical situation of therapy after 6 
months. The treated site showed limited clinical 
improvement of peri-implant pocket and 
bleeding on probing occurred (Takasaki et al., 
2009). 
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irradiation and the inherently short diffusion radius of reactive oxygen species 
(Sigusch et al., 2005).  
Recently, antimicrobial PDT was proposed as an adjunctive method for bacterial 
elimination in the treatment of peri-implantitis, based on successful application in 
the treatment of periodontitis. Currently, there are few studies reporting the 
efficiency of PDT in treatment of peri-implantitis. In an in vitro study by Hass et 
al. (1997) the efficacy of antimicrobial in killing bacteria associated with peri-
implantitis was examined. A. actinomycetemcomitans, P. gingivalis or P. 
intermedia, were all adhered to different surfaces (machined surface, 
hydroxyapatite, plasma-flame-sprayed surface, corundum-blasted and etched) 
and subject to PDT. This treatment completely eliminated the strains tested for 
all surfaces. Electron microscopic inspection of the treated surfaces revealed 
that combined dye/laser treatment resulted in the destruction of bacterial cells, 
but no damage to the titanium surface (Hass et al., 1997).   
Hayek et al. (2005) compared the effects of PDT with CHX irrigation. The 
authors showed a significant reduction of Prevotella sp., Fusobacterium sp., and 
beta-haemolytic Streptococci in ligature-induced peri-implantitis in dogs. The 
authors also emphasised that the application of photosensitizer in a paste 
instead of in liquid was more favourable as it allowed easy removal after 
treatment. Similar antimicrobial results were also reported by Shibli et al. (2003), 
Hass et al. (2000) and Dortbudak et al. (2000). Indeed Hass et al. (2000) 
reported improvements of bone defects after 9.5 months in 21 of 24 implants 
studied. PDT (with mechanical debridement) has also been shown to reduce 
mucosal inflammation as well as minocycline microspheres (with mechanical 
debridement) for up to 6 months (Schär et al., 2013). The authors concluded that 
adjunctive PDT represents an alternative treatment modality in the non-surgical 
management of initial peri-implantitis. However, complete resolution of 
inflammation was not achieved with either of the adjunctive therapies.  
Not all laboratory photodynamic therapy studies have been effective in reducing 
caries organisms (Haas et al., 2000). For example, methylene blue-induced 
photodynamic therapy was not able to reduce significantly the load of 
microorganisms in an in vitro multispecies biofilm model comprising cariogenic 
bacteria. Furthermore, biofilms that colonize tooth surfaces and epithelial cells 
lining the gingival sulcus (subgingival dental plaques) are among the most 
complex biofilms that exist in nature (Soukos and Goodson, 2011). In the 
majority of these studies, photodynamic therapy as an adjunct to scaling and root 
planning did not show any beneficial effects over scaling and root planning 
alone. Other study, have demonstrated incomplete destruction of oral pathogens 
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in multispecies biofilms (Müller et al., 2007, O'Neill et al., 2002) using methylene 
blue (Müller et al., 2007) and toluidine blue O (Qin et al., 2008). It has been 
suggested, in studies of model systems, that water channels can carry solutes 
into or out of the depths of a biofilm, but they do not guarantee access to the 
interior of the cell clusters (Stewart, 2003) whose diameter may range from 20 to 
600 µm (Rani et al., 2005).  
 
1.8.2 Surgical therapy 
Periodontal regenerative therapy aims at complete periodontal regeneration, 
formation of new cementum, new periodontal ligament (PDL) and new alveolar 
bone. During chronic infection, bone loss persists and surgical debridement of 
the implant soft tissue may be required. To restore the lost bone, 
decontamination of implant surfaces and application of bone regeneration 
techniques is required (Ata-Ali et al., 2011). A recent literature review (Mombelli 
et al., 2012) recommended surgical access by a full-thickness flap and 
decontamination of implant surfaces by an appropriate debridement method, 
combined with systemic antibiotics and oral chlorhexidine rinses during the 
healing phase. Then stabilisation of the defect with a bone substitute (placement 
of a membrane after grafting) may be advantageous.  
The evidence exists that periodontal regeneration may be induced using the 
principles of guided tissue regeneration (GTR). Various bone graft techniques 
and GBR; even in conjunction with platelet rich plasma (PRP), have been used 
successfully for the regeneration of lost bones in peri-implantitis. Intra-oral 
autogenous bone grafts are the most preferred types of grafts for GBR therapies. 
Other bone graft materials like demineralized freeze-dried bone and 
hydroxyapatite were also been used (Tomson et al., 2004). GTR is based on 
selective cell repopulation; the cell type that first repopulates the wound 
determines the nature of the regenerated tissue. A membrane covers the 
periodontal defect to prevent epithelial down growth and to seclude space for 
cells with regenerative potential to repopulate the defect site (Bosshardt and 
Sculean, 2009). Guided bone regeneration (GBR) is based on the same 
principle, creating a secluded space, in a bone environment, to regenerate bone 
(Hämmerle and Jung, 2003). GBR is often employed for subsequent implant 
installation in an originally deficient ridge (Hämmerle and Jung, 2003). 
Different membranes are available, among which collagen-based membranes 
are mostly applied. Collagen appears to be suitable for GTR, as it is chemotactic 
for PDL fibroblasts, may serve as a barrier for migrating epithelial cells (Pitaru et 
al., 1987), and acts as a fibrillar scaffold for early vascular in growth (Blumenthal, 
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1993). However, membranes act mainly as physical barriers and have to be 
considered biologically inactive. Membranes alone are not capable of enhancing 
cellular events during the regeneration process. Furthermore, GBR-studies using 
collagen membranes showed limited bone formation (Hämmerle and Jung, 
2003). Moreover, the collapse of the membrane, due to lack of mechanical 
stability, compromises the amount of new tissue. Therefore, as an adjunct to 
GTR/GBR procedures, a grafting material is placed into the defect to prevent this 
collapse (Hämmerle and Jung, 2003). Schwarz et al. (2008) compared BioOss® 
(bone substitute) and collagen membrane after 6 months, 2 years and 4 years. 
After 6 months they found that both materials performed equally well. After 2 and 
4 years, BioOss® afforded greater benefits than collagen material alone. The 
difficulty of surgical manipulation is that the exposure of threads surgically will 
result in permanent exposure of the threads of the implant. Despite treatment 
and retreatment of areas affected with peri-implantitis, supporting bone may also 
be lost, exposing more of the surface of the implant. This is a complication in the 
anterior zone that leads to patient’s dissatisfaction (Schwarz et al., 2008). 
Other measures have been designed to improve and accelerate osseous healing 
by increasing the bone-to-implant contact. These include the application of 
platelet-rich plasma (PRP). Marx et al. (1998) reported in their data on the use of 
PRP for promoting bone graft healing. These showed greater bone density and 
quality in grafts with PRP added during pre-implant augmentation. Local PRP 
administered during dental implant placement thus enhances bone regeneration 
at implant host sites in the posterior mandible during early healing (Zechner et 
al., 2004). 
 
1.8.3 Cumulative interceptive supportive therapy (CIST) 
Cumulative interceptive supportive treatment (CIST) is an excellent guide for the 
clinician to follow (Lang et al., 1997). The main goal of this approach is to 
diagnose peri-implant infections as early as possible to prevent explantation 
(extraction of dental implants) due to loss of osseointegration. The basis of this 
system depends on the regular recall of patient after implant placement with 
follow up assessment using accepted clinical periodontal parameters including:  
1. The presence of plaque. 
2. The bleeding tendency of the peri-implant mucosa. 
3. Suppuration.  
4. The presence of peri-implant pockets. 
5. Radiological features of bone loss.  
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If the implant gives negative results for all of these above parameters, no therapy 
is needed. If plaque and/or an increased tendency of the peri-implant mucosal 
tissues to bleed is detected then the implants are mechanically cleaned (rubber 
cup and polishing paste used). Oral hygiene practices should be checked, and 
the proper plaque control technique should be instructed and reinforced (A). In 
the presence of pus, or if first signs of peri-implant tissue destruction is detected 
(pockets in the range of 4 to 5 mm and slight bone loss) regimen A should be 
combined with the application of a local antiseptic (B). Peri-implant pockets are 
then irrigated with 0.2% CHX and the patient is advised to rinse twice daily with 
0.1- 0.2% CHX. If the peri-implant sulcus allows more than 5 mm of penetration 
of a periodontal probe then a radiograph is taken. If there is clear evidence of 
bone loss, then a microbiological sample is taken. Should there be evidence of 
anaerobic microbiota, the patient is given treatments A and B, and, in addition, is 
placed on systemic antimicrobial therapy (C) with an agent specifically effective 
against strict anaerobes (ornidazole, 1000 mg for 10 consecutive days). If the 
bone destruction has advanced considerably, surgical intervention to correct the 
tissue morphology or to apply guided bone regeneration techniques may be 
necessary (D). Such treatment would, however, only be given in addition to the 
other measures (A, B and C) (Mombelli and Lang, 1998, Lang et al., 1997, 
Okayasu and Wang, 2011).   
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1.9 Modelling dental plaque and plaque related diseases 
Studying oral biofilms in vivo can be difficult, time consuming and constrained by 
ethics. Modelling such biofilms is however important for studying development 
and perturbation. Numerous models have been described and range from simple 
single species to complex microcosms. 
1.9.1 Microplates 
Biofilm models designed upon microplates were first described in 2001 by 
Guggenheim (Guggenheim et al., 2011, Guggenheim et al., 2001). Simple 
methods such as these are preferred to obtain results rapidly when several tests 
and conditions need to be addressed. It allows for the short-term exposure of 
biofilms to selected substances. It is a sensitive and reproducible method to 
verify early biofilm changes and the variation in response of different substrata. 
Besides simplicity of design, the media can be applied to and removed from the 
system virtually instantaneously. This model allows for controlled substance 
exposure times resembling those encountered during mouth rinsing. Moreover, 
exposure times during oral hygiene procedures are very short. The 
concentrations of mouth rinsing, inhibiting bacterial growth in the biofilm model 
were of the same as those required for plaque inhibition in vivo. This method has 
been used to establish microcosm biofilms for enamel demineralization and 
antimicrobial dose-response studies (van de Sande et al., 2011). This method 
has been used for the modelling of supragingival plaque biofilm for the study of 
plaque formation, structure and antimicrobial susceptibility (Guggenheim et al., 
2001), and also used to compare the antimicrobial effects of CHX and mouth 
rinses available on the Swiss market (Guggenheim et al., 2011). 
 
1.9.2 Flow cells 
The flow cell model was developed by Caldwell and Lawrence (1988) and is a 
powerful tool for examining the early stages in biofilm formation, as it enables the 
observation of non-destructive biofilm development in real time (Busscher and 
van der Mei, 1995). It has been used for study of short-term adhesion and 
colonisation. The flow cells consist of a transparent chamber of fixed depth 
through which passes of growth medium. Figure 1.9, shows the system can be 
inoculated either by adding an inoculum to the medium reservoir or passing a 
culture through the flow cells to allow the cells to adhere before feeding with 
sterile medium (Busscher and van der Mei, 1995). 
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1.9.3 The constant depth film fermentor (CDFF) 
The CDFF was developed by Peters and Wimpenny in 1988 (Figure 1.10). The 
CDFF is one of the most suitable in vitro methods for growing reproducible 
biofilms that are appropriate for st dying oral microbiology. The CDFF’s main 
characteristic is that microbial growth is periodically removed to maintain 
constant depth. It is particular suited to studying environments like the oral cavity 
(Peters and Wimpenny, 1988, Wilson, 1999, Pratten et al., 2000) and has a 
number of advantages: 
 It can operate in a septic environment by allow any mixture of medium 
flow and gas composition. 
 It affords good reproducibly. 
 It allows multiple biofilms to be produced on any given substratum. 
 It allows biofilm thickness to be limited by mechanical shear forces, 
such as those in the oral cavity that would limit the accumulation of dental 
plaque.  
 It can be run for unlimited periods of time. 
 
The CDFF has been used comprehensively in a variety of applications such as: 
 To investigate biofilm formation by a nine-membered community of oral 
bacteria (Kinniment et al., 1996a). 
 
 
 
 
6 
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Figure 1.9. Schematic of the flow cells models; 1: saliva-supplemented 
medium. 2: Tissue culture medium. 3: flow cells. 4: Peristaltic pump. 5: lower 
chamber effluent. 6: upper chamber effluent. Reproduced and image taken 
from (http://Flow+cells model source). 
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 To evaluate antimicrobial agents for use in clinical dentistry (Kinniment et 
al., 1996b). 
 To determine the effect of pulsing chlorhexidine gluconate, at 
concentrations commonly used in mouthwashes on Streptococcus 
sanguinis biofilms and microcosm dental plaques in vitro (Pratten et al., 
1998). 
 To investigate the structure of intact oral biofilms (Pratten et al., 2000). 
 Modelling oral malodour in a longitudinal study (Pratten et al., 2003). 
 To develop a bacterial demineralization model (Deng and ten Cate, 
2004).  
 To examine biofilm structure and cell vitality in a laboratory model of 
subgingival plaque (Hope and Wilson, 2006) 
 Modelling shifts in microbial population associated with health or disease 
(Dalwai et al., 2006). 
 For the assessment of bacterial community structure in oral populations 
(Ciric et al., 2010) by novel multiplex qPCR approach. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10. Constant depth film fermentor with power supply 
(Pratten, 2007). 
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1.10 Aims of study 
The aim of this study was to generate an in vitro model of peri-implantitis. The 
success criteria for this would be:   
1. To model microcosm biofilms on titanium discs in a CDFF which contained the 
microorganisms associated with peri-implantitis.  
2. To develop a model to allow progression from health-associated bacterial 
community to a peri-implant mucositis-associated community and finally to a 
peri-implantitis-associated community. 
3. To develop microscopic and molecular biology methods to characterise these 
communities. 
4. To test whether treatment modalities are successful at perturbing the bacterial 
communities.  
5. To use the model to test both commercially available and novel antimicrobial 
surfaces for the inhibition of bacterial growth or succession to a disease state. 
 
1.11 Schematic plan of study 
A brief outline of the multifaceted study is presented in (Figure 1.11). The first 
step of this study was to develop an in vitro model of peri-implantitis. The CDFF 
was used as an in vitro model and biofilm development characterised by using 
different culture methods (Chapter 2). Biofilms were grown on titanium discs and 
a model of health progressing to peri-implant mucositis (Chapter 3) was 
developed. This model was then modified to progress from health to peri-implant 
mucositis than to peri-implantitis (Chapter 4). Further characterising of this model 
was developed using microscopic techniques and, 16S rRNA gene cloning and 
sequencing methodologies (Chapter 4). Identification and quantification of 
bacterial number and proportions using multiplex qPCR approach was performed 
(Chapter 5). Novel TaqMan probes and primers for quantification of 
Capnocytophaga species were designed (Chapter 6). Biofilms were grown on 
three commercial titanium (Ti) surfaces (polished, SLA and SLActive) with a 
range of decontamination techniques used to clean the three infected Titanium 
surfaces (Chapter 7). Biofilm development was assessed on novel nano-coated 
antibacterial Ti surfaces (Chapter 8).  
 
1. The constant depth film fermentor (CDFF) will be used. 
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Figure 1.11. A summary schematic of the study. 
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2.1 Growth media 
A range of non-selective and selective media were used to culture bacteria from 
microbiological samples. The constituents for one litre of each agar are listed 
below. Once prepared, molten agar was poured into petri dishes. 
The total anaerobic count was carried out on fastidious anaerobic agar. The agar 
was prepared as follows: 46.5 g of fastidious anaerobic agar powder (Lab M, 
Bury, UK), was added to 950 ml of deionised water and mixed thoroughly. This 
was then autoclaved at 121°C for 15 min, left to cool to 50-55°C in a water bath 
before 50 ml (5%) of defibrinated horse blood (E and O Laboratories, 
Bonnybridge, UK) was added.  
The total aerobic count was performed on columbia blood agar. The agar was 
prepared as follows: 39.5 g of agar powder (Lab M) was mixed with 950 ml of 
deionised water. This was autoclaved at 121°C for 15 min, cooled to 50-55°C 
and 5% defibrinated horse blood added.  
Actinomyces spp. were isolated on cadmium fluoride–acreflavin-tellurite agar 
(CFAT), the composition and preparation of which is described below. Trypticase 
soy broth (Lab M), 30 g; Agar no. 3, 12 g was mixed with 950 ml of deionised 
water. This was autoclaved at 121°C for 15 min, cooled to 50-55°C and 25 ml of 
glucose added (Sigma-Aldrich, Poole, UK), 13 mg/ml cadmium sulphate (Sigma-
Aldrich), 42,5 mg/ml; sodium fluoride (Sigma-Aldrich), 1.2 mg/ml neutral 
acreflavin (Sigma-Aldrich), 10 mg/ml; potassium tellurite (Difco Laboratories, 
Oxford, UK); 0.2 g/ml of basic fuchin (Sigma-Aldrich); and 5% defibrinated horse 
blood added.  
Gram-negative anaerobic rods were isolated on Gram-negative anaerobic agar. 
This was prepared by adding 46.5 g of fastidious anaerobic agar (FAA-Lab M) 
powder to 950 ml of deionised water and mixed thoroughly. This was autoclaved 
at 121°C for 15 min before being cooled to 50-55°C. Five percent defibrinated 
horse blood and a supplement containing 0.5 ml of a 10 mg/ml vancomycin 
hydrochloride (Sigma-Aldrich) solution were added. 
Streptococcus spp. were isolated on mitis salivarius agar (Difco Laboratories). 
Ninty gram of the agar powder was added to deionised water and mixed 
thoroughly before being autoclaved at 121°C for 15 min. This was then cooled to 
50-55°C and 1% (w/v) potassium tellurite was added aseptically.  
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Staphylococcus spp. were isolated on mannitol salt agar (Oxoid, Hampshire, 
UK). This was prepared by adding 65 g of mannitol salt powder to deionised 
water and mixed thoroughly before being autoclaved at 121°C for 15 min. This 
was then cooled to 50-55°C.  
Candida spp. was isolated on sabourauds dextrose agar (Oxoid, Basingstoke, 
UK). This was prepared by adding 41 g of the powder to deionised water and 
mixing thoroughly before being autoclaved at 121°C for 15 min. This was then 
cooled to 50-55°C.  
Veillonella spp. were isolated on Veillonella agar (Difco Laboratories) which was 
prepared by adding 5 g of tryptone (Difco Laboratories), 3 g yeast extract (Oxoid) 
and 15 g of technical agar no.3 (Oxoid) to 950 ml of deionised water and mixing 
thoroughly. This was then autoclaved at 121°C for 15 min and allowed to cool to 
50-55°C. Following this, 0.75 g of sodium thioglycollate (Sigma-Aldrich), 0.002 g 
of basic fuchin (Sigma-Aldrich), 21 ml of 60 % sodium lactate and 0.5 ml of 10 
mg/ml vancomycin hydrochloride (Sigma-Aldrich) were aseptically added.  
Luria Bertani (LB) agar was used for isolating and growing E. coli clones. It was 
prepared by adding 10 g of tryptone (Oxoid), 5 g yeast extract (Oxoid); 10 g NaCl 
and 15 g of technical agar no. 3 (Sigma-Aldrich) to 950 ml deionized water. This 
was mixed thoroughly, autoclaved at 121°C for 15 min and cooled to 50-55°C. 
Following this 1 ml of 50 µg/ml kanamycin (Sigma-Aldrich) was added.  
Once cooled all of the media was poured into petri dishes in a laminar flow 
cabinet and allowed to set. All plates were stored at 4°C for up to 2 weeks until 
needed. Once inoculated, plates were incubated as appropriate either in an 
anaerobic atmosphere (5% Carbon dioxide, 5% Hydrogen and 90% Nitrogen) at 
37°C for 4-5 days or aerobically (with the addition of 5% Carbon dioxide) at 37°C 
overnight.  
Artificial saliva and artificial tissue fluid was prepared for the growth of microcosm 
plaque biofilms as follows: 
To make 1 l of artificial saliva 0.5 g 'Lab-Lemco' powder (Oxoid), 1 g yeast extract 
(Oxoid), 2.5 g protease peptone (Oxoid), 1.25 g hog gastric mucin type III, 
partially purified from porcine stomach (Sigma Chemicals Co., Poole, UK), 0.18 g 
sodium chloride (BDH Chemicals Ltd, Poole, UK), 0.1 g calcium chloride (BDH) 
and 0.1 g potassium chloride (BDH) was added to deionised water. After 
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autoclaving at 121°C, 0.625 ml of a 40% urea (Sigma-Aldrich) solution was 
added. 
Peri-implant sulcular fluid (PISF) was prepared as follows; 60% RPMI tissue 
culture medium (Sigma-Aldrich) (600 ml) was supplemented with 40% (v/v) horse 
serum (Sigma-Aldrich), 0.1 ml of a 5 µg/ml menadione (Sigma-Aldrich) and 1 ml 
of a 5 µg/ml haemin (Sigma-Aldrich).  
Reduced transport fluid (RTF) was prepared according to Syed and Loesche  
(1972). The composition was follows: Stock solution I was made by adding 0.6 g 
dibasic potassium phosphate (Sigma-Aldrich) to 100 ml of deionised water 
followed by autoclaving. Stock solution II was made by mixing 2.5 g MgSO4 
(Sigma-Aldrich) with 100 ml of deionised water then autoclaving. Stock solution 
III was made by mixing 1.2 g potassium chloride (Sigma-Aldrich), 1.2 g 
ammonium sulphate (Sigma-Aldrich), 0.6 g monobasic potassium phosphate 
KH2Po4 (Sigma-Aldrich), 1 ml  of stock solution II solution and 99 ml deionised 
water and autoclaved. Stock IV was made by mixing 0.8 g Sodium carbonate 
(Sigma-Aldrich) and 10 ml deionised water and autoclaved. To prepare 100 ml of 
RTF the following were mixed together 7.5 ml of Stock I with 7.5 ml of Stock III, 
0.5 ml of Stock IV and 80 ml of deionised water. 5 ml of freshly made, filter 
sterilised 0.02 g DL-Dithiothreitol (Sigma-Aldrich) was then added to the solution.  
2.2 Constant depth film fermentor set up 
Briefly, the CDFF apparatus consisted of a glass vessel (18 cm in diameter, 15.0 
cm depth) with stainless-steel end plates, the top one of which has ports for the 
entry of medium, nutrients, gas and for sampling, whereas the bottom end plate 
has a medium outlet (Figure 2.1). The CDFF was maintained at a constant 
temperature of 37°C in an incubator as shown in figure 2.2. The fermentor was 
sealed using silicon vacuum grease which was applied to both of the 
polytetrafluoroethylene (PTFE) seals, this prevented leakage of the medium and 
also helped to maintain the atmospheric conditions within the fermentor. The 
tubing was then connected to the CDFF to enable delivery of nutrients, gases 
and to allow the removal of waste through to an effluent reservoir. The rotating 
turntable holds 15 PTFE pans. Each pan contains 5 cylindrical holes (5 mm in 
diameter) containing PTFE plugs upon which discs of appropriate substrata, for 
example, commercial, coated/and or turned titanium can be held and recessed to 
a desired depth. The turntable in which the pans fit rotates at 3 rpm (Wilson, 
1999). The speed is controlled by a 15-V DC power supply unit. The turntable 
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rotates at a constant rate as the growth medium is pumped in via the inlets in the 
top plate. Attached to the top plate are two scraper blades which sweep the 
inocula and growth media into the recesses and once biofilms are formed 
prevents them from exceeding the desired depth. Silicone tubing (Fisher 
Scientific Ltd., UK) was attached to the inlets in the top plate and the outlet for 
effluent in the base plate and secured in place using cable ties. This tubing was 
fitted with connectors which could be attached to tubing coming from growth 
medium reservoirs or the inoculum, gases and also for connection to the waste 
medium vessel. Marprene tubing (Fisher) was also required to run through a 
peristaltic pump (UK) in order to maintain the desired flow rate. The whole 
apparatus was autoclaved at 121°C for 15 min prior to use. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. The constant depth film fermentor (CDFF): Diagram of 
vertical section through the fermentor (Pratten et al, 1998). 
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2.2.1 Microcosm biofilms 
In order to produce microcosm biofilms to be used in the CDFF experiments, 
saliva was collected aseptically from ten members of the Microbial Diseases 
Research Department, UCL Eastman Dental Institute, who had no signs of 
periodontal disease (Ethical approval for the project was obtained from the UCL 
Ethics Committee; Project no. 1364/001). This was pooled and resuspended in 
10% (v/v) glycerol and vortex mixed vigorously for 1 min to homogenize the 
sample. Aliquots of 1 ml were then dispensed and stored at 80°C for subsequent 
use for all experiments so far in 1.5 ml cryotubes.   
2.2.2 In vitro model parameters 
The biofilms were grown on moderate smooth titanium discs grade 23 (A C 
Service Group, Fordingbridge, UK, 5 mm in diameter and 2 mm height). Grade 
23, is the higher purity version of Ti 6Al-4V. The Titanium discs were sonicated 
with acetone for 20 min at 50 Hz to remove adherent debris or dust then 
autoclaved before inserted in to sterile PTFE plugs. The discs sit on sterile PTFE 
plugs and are held in place by using vacuum silicone grease (Dow Corning, 
USA) and recessed to a depth of 600 µm. The pan was tapped down to the level 
of the turntable with a flat ended tool. Biofilms were removed during experiments 
via a port in the top plate using a flat ended tool inserted into a tapped hole in the 
centre of the pan. 
Figure 2.2. The constant depth film fermentor (CDFF) set-up. 
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2.2.3 Inoculation of the CDFF   
A vial of stored pooled saliva (section 2.2.2) was thawed and 900 µl used to 
inoculate 500 ml of artificial saliva (see culture media section). This was mixed 
and pumped into the CDFF for 6 h at a rate 1.38 ml/min. After this time, the 
inoculation flask was disconnected and the CDFF fed from a medium reservoir of 
sterile artificial saliva. The artificial saliva was delivered via a peristaltic pump 
(Watson-Marlow, Falmouth, UK) at a rate of 0.5 ml/min (0.72 L/day). An aerobic 
atmosphere was maintained by exposure to the environment via a 0.22 µm 
membrane filtered air (Hepa Vent filters, Whatman, Maidstone, UK) inlet in the 
upper end plate. Some experiments used other gaseous environments (section 
2.2.5). 
2.2.4 Biofilm sampling 
To sample, the turntable was stopped so as the pan wanted for sampling was 
directly under the sampling port. The sampling port was then swabbed with an 
alcohol (70% v/v) moistened swab, and opened. A sterile sampling tool was then 
inserted into the fermentor and screwed into the pan. The pan was removed from 
the CDFF was subsequently placed in a sterile universal tube and discs from 
each pan used for determining the bacterial composition of the biofilms. The 
titanium discs were aseptically removed and placed into 1 ml of reduced 
transport fluid (RTF) containing five autoclaved glass beads (3 mm in diameter) 
and then vortexed for 1 min to disrupt the biofilm. This suspension was then 
serially diluted up to seven 10-fold dilutions and 20 µl aliquots spread in duplicate 
onto appropriate media using a sterile blue plastic spreader. All plates were 
incubated aerobically for 48 h with 5% CO2 except fastidious anaerobic agar, 
Gram-negative, Veillonella agar and Cadmium fluoride–acreflavin-tellurite agar 
plates which were incubated for 4 to 5 days in an anaerobic cabinet.  
2.2.5 Conditions used for running the CDFF 
Initially, to provide conditions associated with healthy dental implant, with 
nutrition supplied solely by saliva, an artificial saliva formulation was pumped into 
the CDFF at a rate of 0.5 ml/min. Subsequently, the nutrient conditions were 
altered by adding both artificial saliva and an artificial tissue fluid. The tissue fluid 
was used to mimic peri-implant sulcular fluid (PISF). This was pumped into the 
artificial saliva formulation at a rate of 0.5 ml/min as it flowed into the CDFF at a 
rate of 40 µl/min. 
To provide conditions associated with peri-implant mucositis, artificial saliva was 
pumped into the CDFF at a rate of 0.5 ml/min. In addition, peri-implant sulcular 
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fluid was pumped into CDFF at a rate of 130 µl/min. This was accompanied by a 
switch to a more microaerophilic environment by pumping in a microaerophilic 
gas mixture (2% Oxygen, 3% Carbon dioxide, and 95% Nitrogen 200 bar) via a  
0.22 µm membrane filtered air inlet (Hepa Vent filters)  in the top plate at a rate 
of 200 cm3/min. 
To provide conditions associated with peri-implantitis, only PISF was pumped 
into the CDFF at a rate of 130 µl/min. This was accompanied to a switch to a 
more anaerobic environment by pumping in a CO2 gas mixture (5% Carbon 
dioxide and 95% Nitrogen) via a  0.22 µm membrane filtered air inlet (Hepa Vent 
filters) in the top plate at a rate of 200 cm3/min as shown in figure 2.3. 
  
 
Figure 2.3. Schematic summary for development of the in vitro model of peri-
implantitis showing the three stages of development (health, peri-implant mucositis 
and peri-implantitis). 
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2.3 Identification of cultivable species by comparative 16S rRNA gene 
sequencing 
 
2.3.1 DNA extraction 
A titanium disc was removed from the CDFF at six time points, 6 h, 96 h, 246 h, 
438 h, 540 h and 714 h. The biofilm was suspended in 1 ml of sterile RTF 
containing five glass beads (3 mm in diameter) and vortexed for 1 min to create a 
homogenous suspension. This suspension was centrifuged for 1 min at a speed 
of 14600 x g. The pellet was resuspended in 50 µl phosphate buffer and 
subsequent DNA extraction was performed as described by (Griffiths et al., 
2000). One disc from each time point was used for DNA extraction.  
2.3.1.1 DNA extraction procedure 
Total nucleic acid was extracted from all samples according to a previously 
described protocol (Griffiths et al., 2000); this method was found to be the least 
biased towards the extraction of nucleic acids from Gram-negative organisms. 
Bacterial biofilm was resuspended in 50 µl phosphate buffer. Twenty five µl of 
suspension and 0.2 ml of cetyltrimethylammonium bromide (CTAB) extraction 
buffer were added to 2 ml screw top tube containing zirconium/ silica beads 0.1 
mm (Biospec Products, 454 g). To this was added 0.5 ml phenol: chloroform: 
isoamyl alcohol (25:24:1) and the lids were then tightened. The tubes were 
placed into a ribolyser bead beater (Thermo Electron Corporation, Delft, The 
Netherlands) and lysed for 30 s at a speed of 5.5 m/s. The lysed cells were then 
centrifuged at ≥14,000 x g for 10 minutes at 4ºC. The top layer of the bilayer was 
carefully removed and transferred to a new tube. A 0.5 ml aliquot of chloroform: 
isoamyl alcohol (24:1) was added and mixed well by vortexing for 6 s. The mix 
was centrifuged for 3 min at ≥14,000 x g. A 0.3 ml aliquot was extracted from the 
top layer. The nucleic acids were precipitated by adding 2 volumes of 30% 
polyetheneglycol 6000 (PEG) solution and mixed well. These were left overnight 
at 4ºC to precipitate. The preparation were then centrifuged at ≥14,000 x g for 15 
minutes. The supernatant was removed and the pellet was washed twice with 0.2 
ml of ice cold 70% ethanol. This was repeated and any remaining ethanol was 
removed and the pellet was allowed to air-dry for 10 min at room temperature. 
The pellet was then resuspended in 0.1 ml Tris EDTA (TE) buffer (1.0 M Tris-
HCl, pH approx. 8.0) (Sigma-Aldrich) with RNAse 10 µg (Sigma-Aldrich) and 
incubated at room temperature. The preparation was then left on the bench for 1 
hour. The DNA concentration was measured using a Nanodrop 1000 
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Spectrophotometer (V3.7, Thermo Fisher Scientific, USA) and by agarose gel 
electrophoresis section (2.3.1.3).  
 
2.3.1.2 Polymerase chain reaction (amplifying the DNA) 
PCR amplification was carried out in a reaction volume of 50 l consisting of 5 l 
of 10 µM buffer, 1 l each of 10 mM dATP, dCTP, dGTP and dTTP (all deoxy 
nucleoside triphosphates from Bioline, London, UK), 2.5 l of 50 mM MgCl2, 1 l 
of 100 µM of each PCR primer (diluted 1:10) and 0.5 l of 2000U/µl Taq 
polymerase (Bioline) and 34 l of sterilized deionised water. The PCR primers 
used were: 27f (5' AGAGTTTGATCMTGGCTCAG 3'; Sigma-Genosys) and 
1492r (5' TACGGYTACCTTGTTACGACTT 3'; Sigma-Genosys). The negative 
control was 45 µl reaction mixed with 5 µl of sterilized deionised water. The 
positive control contained 5 µl of genomic DNA from Escherichia coli and the 
DNA template 5 l in 45 µl of reaction mixture added to bring the volume to 50 µl. 
PCR thermocycling was performed in a Biometra (T3000 thermal cycler, 
Glasgow, UK) and conditions for all samples were: (i) an initial denaturation for 5 
min at 94C, (ii) 29 amplification cycles of denaturation at 94C for 1 min, 
annealing of primers at 54C for 1 min and primer extension at 72C for 1 min 
followed by (iii) a final extension step at 72C for 5 min. The reaction products 
were either stored at -20C or analysed immediately. Negative and positive 
controls were included in each batch of samples being analysed by PCR.  
2.3.1.3 Agarose gel electrophoresis 
PCR amplicons (1500 bp) were assessed by loading 5 l of the PCR product into 
wells of a 1% (w/v) agarose powder (Sigma-Aldrich) containing gel red (2 
l/100ml) (Qiagen, Manchester, UK). Hyper ladder I marker ranging from 200-
10,000 bp (Qiagen) 5 l was loaded into the first well. The PCR mixture 5 l from 
each sample was mixed with 2 l of the loading buffer and loaded into the 
appropriate wells of the gel. The gel was immersed in Tris-acetate EDTA buffer 
(Tris base 240 g, Glacial acetic acid 75.1g/ml, 100 ml 0.5 M EDTA, water to 1000 
ml; Oxoid) and subjected to a voltage 100 V that led to separation of the 
fragments. The gel was visualised after excitation under UV transillumination by 
placing it in a multi-image light cabinet and the resulting image was captured 
using computer software programme (AlphaEase™, AlphaInnotech, Ringmer, UK) 
and stored the PCR products at -20 °C. 
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2.3.1.4 Purification of PCR products 
PCR products were purified using the (Qiagen) purification kit. Briefly, 1 volume 
(45 µl) of PCR reaction product was added to 225 µl of Buffer PB in a QIAquick 
spin column placed in a 2 ml collection tube, then centrifuged at 14,000 x g for 1 
min to bind the DNA. The flow–through was discarded and 0.75 ml of diluted PE 
buffer (ethanol) was added into spin column to wash the DNA; this was 
centrifuged at 14,000 x g for 2 minutes. The flow–through was discarded and the 
column centrifuged for an additional minute to remove residual ethanol. The 
QIAquick spin column was placed into a sterile 1.5 ml tube, 30 l of sterilized 
water was applied to the centre of the column and each tube was kept at room 
temperature for 1 min. The column was centrifuged at 14,000 x g for 1 min to 
give 30 µl of eluted DNA. The sample was checked by Nanodrop device 
(Qiagen) and run on 1% agarose gel to confirm the presence of DNA before 
cloning.     
2.3.2 16S rRNA gene cloning 
The six CDFF biofilms for each sample (6 h, 96 h, 246 h, 438 h, 540 h and 714 h) 
of the PCR products generated were subjected to TOPO® cloning (Invitrogen, 
UK) and transformation into chemically competent E. coli cells. Four microlitres of 
fresh PCR product was mixed with 1 l of salt solution and 1 l of Topo vector 
and made up to a volume with 6 µl sterilized water. This was then mixed gently 
and incubated for 30 min at room temperature (22-23°C). The reactions were 
then placed on ice. The transformation was then performed by adding 2 l of the 
TOPO® cloning reaction to a 50 l of vial of chemically competent E. coli and 
mixed gently by thumb flushing. This was then incubated on ice for 30 min. The 
cells were then heat shocked for 30 sec at 42°C and immediately incubated on 
ice. Two hundred and fifty microlitres of super optimal broth (at room 
temperature) with catabolite catabolite repression (S.O.C.) medium (bacterial 
growth medium) was then added and the tubes horizontally in a shaker (200 rpm) 
at 37°C for 1 h.  
2.3.2.1 Culturing  
Transformed clones were plated out on to three pre-warmed LB agar plates 
using 3 different volumes (20, 50, and 100 l). After plates were warmed at 37°C, 
each plate spread with 40 µl of 40 g/ml X-gal (5-bromo-4chloro-3indoyl-B-D-
galactoside) and kept warm (37°C) until ready for use. 
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2.3.2.2 Colony counting of isolates 
After overnight incubation, all LB plates for each sample (6 h, 96 h, 246 h, 438 h, 
540 h and 714 h) were placed in the refrigerator (4°C) for 1 hour to intensify the 
potential blue colouration of the colonies. All white colonies were sampled using 
sterile tips and inoculated onto a new LB agar plate on a numbered grid to 
identify individual colonies. The newly inoculated plates were incubated overnight 
at 37°C and transferred to the refrigerator for storage for subsequent use. 
2.3.2.3 Extraction of DNA from clones 
For PCR analysis, DNA was extracted from 180 bacterial clones by a 5 min 
boiling procedure. Briefly, colonies were suspended in sterile nuclease free water 
in 1.5 l tubes. The tubes were then boiled for 5 min. immediately after boiling; 
the tubes were placed on ice. This was later used as a DNA template for the 
PCR amplification. A positive control was prepared using E. coli. After subculture 
of an E. coli strain on blood agar plates, a small portion was taken with a sterile 
wooden toothpick from the plate and placed into 50 l of sterile distilled water 
and boiled for 5 min as above. The negative control included 5 l distilled water 
and 45 l of PCR master mixer (Bioline). DNA amplifying, PCR cycling, agarose 
gel electrophoresis and PCR purification procedures were the same as above. 
2.3.2.4 Sequencing reactions 
The final step in identifying the cloned sequence was to sequence the PCR 
product. The DNA was sequenced and aligned by Sanger technique at the UCL 
Cancer Institute and Wolfson Institute for Biomedical Research. The 16S rRNA 
PCR products were partially sequenced using primer 357F of 2-5 pmoles/µl (59-
CTCCTACGGGAGGCAGCAG-39; Lane, 1991) and the ca. 1500 bp sequences  
submitted to the Ribosomal Database Project RDP 
(http://rdp.cme.msu.edu/index.jsp) for identification. Further analysis was 
performed and compared using Blast (http://ncbi/Blast/) in order to find the 
closest match with the 16S rRNA gene. More than 98% identity in the 16S rRNA 
gene sequence was the criterion used to identify bacteria at the species level.  
2.4 Quantitative PCR analysis of biofilm samples 
2.4.1 Preparation of DNA for standard curve generation 
Depending on the specific target of the primers used for each PCR assay a 
standard curve of bacterial genomic DNA from a known number of bacterial cells 
was created. One swab from a plate of each organism was suspended in 1 ml of 
RTF. The viable bacterial numbers in this culture was than enumerated by serial 
dilution and plating on fastidious anaerobic media. In order to produce standard 
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curves for the enumeration of organisms, DNA was used in the optimisation 
reactions from the following reference strains: Fusobacterium nucleatum (NCTC 
10562), Lactobacillus casei (ATCC 334), Veillonella dispar (NCTC 11831), 
Neisseria subflava (DSM 17610), Actinomyces naeslundii (DSM 17233), 
Prevotella intermedia (DSM 20706), Streptococcus sanguinis (NCTC 02863) and 
Streptococcus mutans (ATCC 700610).  
Total nucleic acid was extracted from all samples according to the protocol of 
Griffiths and colleagues (2000) using a bead-beating phenol: chloroform: isoamyl 
alcohol (25:24:1) extraction followed by 30% PEG 6000 precipitation and 70% 
ethanol wash (section 2.3.1.1).  
  
2.4.2 QPCR assay set up 
The three triplex qPCR assays were performed using 2 µl of extracted DNA to 
enumerate eight oral taxa as well as the total number of organisms. All reactions 
were run in triplicate in a final volume of 25 µl. Sensimix Probe (Bioline) qPCR 
mastermix was used and the Rotor-gene 6500 (Qiagen) cycler using the green, 
yellow and red channels for data collection. Each reaction contained the 
previously described concentrations of the oligonucleotides. The reaction 
conditions were performed as specified by the manufacturer with the 
annealing/extension temperature ranging from 60°C to 64°C. Species specific 
primers and dual-labelled fluorogenic probes were designed for all organisms 
using 16S rRNA gene sequences. It was essential to have enough points to 
generate a standard curve containing at least six 10-fold dilutions of reference 
DNA for each sample with at least three replicate wells to ensure the accuracy. It 
was also essential to have control wells which contained no template to ensure 
purity of all the reagents used.  
 
2.4.3 PCR conditions 
The standard PCR conditions for qPCR were an initial step of 95°C for 10 min, 
followed by 40 cycles of 95°C for 15 s, x°C for 60 s (x= 60°C for FLV & SSU, x= 
64°C for NAP) (Ciric et al., 2010). 
 
2.4.4 Analysis of qPCR results 
The amount of fluorescence detected by the qPCR machine as the reaction 
proceeded was plotted as an amplification plot using the Rotor gene 6000 
(Qiagen). From this plot, a threshold line was set as the level of detection where 
the fluorescence intensity exceeded any back ground fluorescence. This line was 
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within the exponential phase of detection. The point at which the fluorescence 
detected in a particular sample crossed this line was the cycle threshold (Ct). 
This value was important in calculating the amount of bacterial DNA in sample. 
 
2.4.5 Standard curve 
To generate a standard curve from DNA extracted from known quantities of 
bacterial cells, this Ct number was plotted against the log number of bacteria. By 
grouping replicate samples together, the rotor gene 6000 (Qiagen) software 
automatically calculated the mean and the standard deviations so it was possible 
to immediately see the reproducibility between replicate samples. 
 
2.5 Biofilm imaging 
2.5.1 Confocal laser scanning microscopy (CLSM) 
2.5.1.1 Sample preparation 
Biofilm samples from the CDFF were usually flat and could be mounted and 
stained with relative ease. The titanium discs supporting the biofilms were placed 
in a 5 cm (diameter) tissue culture wells, with flat bases, and held in place by 
silicon vacuum grease. 1 µl of each of the components A and B of BacLightTM 
Live/Dead viability stain (Molecular Probes, Invitrogen) was added to 5 ml of 
RTF. Five ml of this solution was carefully added to the biofilm in the wells and 
incubated in the dark for 15 min. The biofilms were examined with a Radiance 
3000 confocal Laser scan head (Bio-Rad, Jena, Germany) in conjugation with a 
BX51 stereomicroscope (Olympus, Southhall, UK), equipped with a x40 water 
immersion lens which was used to visualise the naturally hydrated state of 
biofilms. The scan area was resolution 1024×1024 pixels. The size of field of 
view range 74.50, 119.9 to 215 Microns. The resulting collection of confocal 
optical sections was merged by BioRad (Bio-Rad) Lasersharp software as stacks 
of images. 
2.5.1.2 Image analysis 
All images were analysed by Image J software (rsb.info.nih.gov/ij). Three–
dimensional images were created from the live (green) and dead (red) colour 
channels using the 3D project tool of Image J and then combined to create a 
single RGB (red-green-blue) stack using RGB merge. This allowed the spatial 
visualization of live and dead bacteria within the biofilm structure. The CLSM was 
calibrated on 500 speed/step1micron/1024 resolution/1-2.5 zoom /(x-y) level. 
 
98 
 
 
 
 
 
 
                                          
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
Development of an in vitro biofilm model of health and peri-implant 
mucositis 
 
 
Chapter 3: Development of an in vitro model of health and peri-implant mucositis 
 
99 
 
3.1 Introduction 
The oral cavity represents a fluid system in which the microbiota present in saliva 
may colonize teeth and any artificial surfaces following the deposition of 
glycoprotein containing pellicle. Bacterial biofilms accumulate in specific 
ecological niches which provide the optimal ecological conditions for 
colonisation, such as at periodontal pockets, tonsils, and the crypts and folds of 
the tongue. Biofilms will form on all surfaces in this fluid system including fixed 
and removable prostheses, and implants.  
Oral implants are hard non-shedding surfaces anchored in the jawbone and 
penetrating the mucosa. A few minutes after implant installation, single bacterial 
cells attach to the pellicle layer. Over time, these colonies mature and form a 
complex microbiota (Mombelli, 1998). Findings from clinical and experimental 
studies have shown that the formation of a submucosal biofilm plays an essential 
role in the initiation and spread of inflammation and eventually, leads to the loss 
of marginal bone (Lindhe et al., 1992, Lang et al., 1993).  
Peri-implantitis is a bacterially induced inflammatory reaction that results in the 
loss of supporting bone around an implant, which may eventually leads to loss of 
the implant fixture (implant failure) (Lindhe and Meyle, 2008). 
The weakness of dental implants comes from the lack of direct attachment 
between the dental implant and the mucosa which may facilitate migration of 
bacteria along the implant surface and increase the risk of peri-implantitis and 
implant failure (Meffert, 1988, Mombelli and Lang, 1998, Esposito et al., 1998, 
Hardt et al., 2002).  
Peri-implant tissues are susceptible to bacterial infections in a similar manner to 
periodontal infections (Fürst et al., 2007). Although the main source of nutrients 
for many microbial inhabitants of the oral cavity is from saliva and the diet 
(Wilson, 1999), there are a number of other nutrient sources, for example, 
microbes adhering to mucosal surfaces, which may obtain their nutrients directly 
from the products secreted and excreted by the cells to which they are attached. 
Furthermore, microbes colonising the gingival crevice are likely to obtain many of 
their nutrients from gingival crevicular fluid (GCF) rather than from saliva 
(Loesche, 1968). Since GCF originates from plasma, its chemical composition is 
thought to mirror that of blood (Ficara et al., 1975). Adonogianaki et al. (1995), 
found no differences in PISF and GCF in healthy and inflamed sites, and 
concluded that the inflammatory and immune responses were similar around the 
tooth and implant. Furthermore, Apse et al. (1989) reported that the volume of 
GCF did not differ between implant sites and natural teeth, and the features of 
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inflammation were similar. The flow rate of GCF at healthy sites is thought to be 
in the region of 0.3 µl per tooth per hour. It is reported that the flow rate 
increases during inflammation of the gingival margin by up to 30 fold (Goodson, 
2003, Uitto, 2003). Flow rates of GCF and PISF have been shown to be similar 
around teeth and implants, respectively (Adonogianaki et al., 1995).  
Well-maintained titanium implants usually harbour low amounts of plaque and 
little marginal inflammation. Supragingival and subgingival plaque at successful 
implant sites seems to resemble the microbiota associated with gingival health. 
However, an increased proportion of putative periodontal pathogens have been 
documented at implant sites of dentate patients as compared to edentulous 
individuals, suggesting that the periodontal pocket serves as a reservoir for 
colonization of titanium implants (Quirynen and Listgarten, 1990, Mombelli and 
Mericske-Stern, 1990, Becker et al., 1990). Furthermore, peri-implantitis lesions 
are associated with the presence of subgingival plaque which contains a large 
diversity of Gram–negative anaerobic rods, fuisiform bacteria, motile and curved 
rods and spirochetes (Mombelli et al., 1987). The lesions are well vascularised 
and contain a large amount of densely packed inflammatory cells such as 
neutrophils, macrophages, lymphocytes and plasma cells and frequently the 
contaminated dental implants are surrounded by ‛crater–like’ bone defects 
(Lindhe et al., 1992, Leonhardt et al., 1992).  
There are several limitations when analyzing the natural extent of inflammation 
around dental implants, these may often hinder access for adequate clinical 
examination. Experiments on the probing depths show that with deep peri-
implant bone pockets, the pocket is not always accessible to its full depth. 
Therefore, probing of peri-implant pockets may fail to reach the very deep areas 
of the bone pocket. As a result, the species at the base of the pocket cannot be 
sampled and may remain undetected (Apse et al., 1991). Additionally, implants 
have a more complex anatomy that impairs adequate probe measurements 
(Máximo et al., 2009). Practical and ethical issues arise when carrying out 
clinical studies in patients and the historical dogma that probing around implants 
should be avoided (Gould et al., 1981). There is therefore a need to develop in 
vitro models to help in the fundamental understanding of the microbiology 
associated with peri-implantitis. One of the most suitable in vitro methods of 
growing reproducible biofilms for modelling dental plaque is the constant depth 
film fermenter (CDFF) developed by Peters and Wimpenny (1988). This model 
originally used a plaque inoculum and reached a steady state after 4 days 
(Kinniment et al., 1996). The CDFF model has been used to study the structure 
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and spatial distribution of viable and non-viable supragingival plaque bacteria 
(Pratten et al., 2000) and bacterial shifts associated with health and disease 
(Dalwai et al., 2006). The aim of this part of the study was to develop an in vitro 
model for evaluating the bacterial populations associated with healthy dental 
implants progressing to peri-implant mucositis assessed by bacterial culture and 
CLSM. 
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3.2 Materials & Methods 
The constituents for the microbiological culture media used are described in 
chapter 2. The CDFF was set up was as described in section 2.2.1, Microcosm 
biofilms were generated as described in section 2.2.2 and the in vitro model 
parameters were as described in section 2.2.3.  
 
3.2.1 Inoculation of the CDFF   
A vial of frozen pooled saliva was thawed and 900 µl used to inoculate 500 ml of 
artificial saliva, this was mixed and pumped into the CDFF at a rate 1.38 ml/min 
for 6 h. Serial dilutions of the remaining 100 µl of pooled saliva were carried out 
and plated out on selective and non-selective culture media. All plates were 
incubated under appropriate conditions. 
 
3.2.2 Changes in environmental parameters from a healthy implant and 
progressing to peri-implant mucositis 
 
Experiment 1: In this study, microcosm biofilms were grown on titanium (Ti) 
discs, and artificial saliva was used as the sole nutrient source. Biofilms were 
grown for 348 h (17 days) and sampled throughout the period (8 sampling 
points). Samples were removed and grown on selective and non-selective 
culture media (and incubated under appropriate conditions) to assess the 
number of CFU per ml and structural biofilm analysis was carried out using 
CLSM.  
  
Experiment 2: The reproducibility of the model was assessed by repeating 
experiment 1. Biofilms were grown for 360 h (15 days) and sampled throughout 
this period (7 sampling points).  
  
Experiment 3: To model peri-implant mucositis, the environmental progression 
from a healthy dental implant to an implant with peri-implant mucositis the 
environmental conditions in this experiment were altered. Microcosm biofilms 
were grown for 438 h and sampled throughout this period (15 sampling points). 
For the first 7 days, the biofilms were grown with artificial saliva at a rate of 0.5 
ml/min plus, PISF introduced at a rate of 40 µl/min. After 222 h, peri-implant 
sulcular fluid was added at a rate of 130 µl/min and a microaerophilic gaseous 
mixture was supplied at a rate 200 ml/min. Samples were taken at set times and 
bacteria and fungi cultured from these on selective and non-selective culture 
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media to assess the number of CFU/ml. Structural analysis of biofilms was 
performed using CLSM at set time points. 
 
3.2.3 Structural analysis of biofilms using CLSM 
Analysis of the biofilm structure was performed by CLSM throughout this part of 
study. One titanium disc was examined under the CLSM at each time point for 
experiment 1 and experiment 3. The CLSM was carried out as described in 
2.5.1.2. 
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3.3 Results 
3.3.1 Inoculum analysis 
The microbial community present in the pooled saliva, used as the inoculum for 
the CDFF, was analysed using selective and non-selective culture media. The 
numbers of each of the bacterial groups analysed are shown in Table 3.1. In 
experiment 1, the anaerobic microorganisms and streptococci dominated with 
over ca. 107 cfu per ml recovered. In experiment 2, the most numerous were 
again, anaerobic species with slightly fewer aerobic microorganisms (ca. 107 
cfu/ml). In experiment 3, the most numerous were aerobic microbial species (ca. 
107 cfu/ml), with fewer anaerobic species (ca. 106 cfu/ml). 
 
 
 
 
 
 
 
 
 
Table 3.1. Composition of pooled saliva (inoculum) on selective and non-selective 
culture media for three experiments. Mean and ± standard deviation of (n = 2). 
 
Bacteria species 
(CFU/ml) Mean ± SD 
Exp.1 
(CFU/ml) Mean ± SD 
Exp.2 
(CFU/ml) Mean ± SD 
Exp.3 
Anaerobic spp. 3.5 x10
7
 ± 7 x10
4
 5.98 x10
7 
± 1.34 x10
5
 5.75 x10
6 
± 11.3 x 10
5
 
Aerobic spp.  2.5 x10
6
 ± 14.1 x10
4
 2 x10
7
 ± 7 x10
3
 1.30 x10
7 
± 1.4 x 10
4
 
Gram-negative anaerobic spp.  2.5 x10
6
 ± 14.1 x10
4
 6 x10
6 
± 0 1.25 x10
6
 ± 0 
Streptococcus spp.  2.78 x10
7
 ± 7.7 x10
4
 1.38 x10
6
 ± 2.8x10
4
 3.75 x10
6 
± 2.1 x 10
4
 
Actinomyces spp.  8 x10
6
 ± 5.6 x10
4
 6 x10
6
 ± 2.8 x10
4
 1.25 x10
6 
±
 
2.8 x 10
3
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3.3.2 Culture analysis 
Experiment 1: The microcosm biofilms were grown on titanium (Ti) discs and 
artificial saliva was used as a nutrient source. In this study, microcosm biofilms of 
were grown for 348 h and sampled 8 times, at 6 h, 24 h, 48 h, 72 h, 96 h, 168 h, 
192 h, and 348 h. Figure 3.1, shows biofilm growth over time on Ti discs (mean 
of 2 discs) as assessed by culture on selective and non-selective culture media.   
The total number of bacteria in the biofilm increased overtime from inoculation at 
6 h to around 96 h, with slight exception to this exhibited by Actinomyces species 
and Gran-negative anaerobic species which initially decreased in numbers at 
early sampling points to ca.103. CFU counts for all groups analysed increased by 
approximately 1 log10 at 192 h (ca. 10
9) and reduced again to a level similar 
(ca.107 – ca. 108) to the previous sampling point (168 h).   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experiment 2: To check the reproducibility of the system, experiment 1 was 
repeated. Microcosm biofilms were grown for 360 h (15 days) and sampled 
throughout this period at 6 h, 24 h, 48 h, 72 h, 96 h, 168 h, and 360 h (Figure 
3.2). Samples from three (Ti) discs were grown on selective and non-selective 
culture media. The total number of bacteria in the biofilm increased overtime 
from the inoculation at 6 h until around 96 h. Following this, the numbers seemed 
to stabilise from 72 h until the final sampling point at 360 h. The Actinomyces 
Figure 3.1. Composition of biofilms (viable count data from 5 different media) 
sampled from the CDFF at different time points (6 h – 348 h). Error bars 
represent standard deviations (n = 2). 
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species were present in fewer numbers at most points but recovered to 2.88 x107 
CFU/ml at 360 h.  
 
Figure 3.2. Composition of biofilms (viable count data from 5 different media) 
sampled from the CDFF at different time points (6 h – 360 h). Error bars 
represent standard deviation (n = 3). 
 
Comparing experiments 1 and 2, the total numbers of bacteria in the biofilms 
increased overtime from inoculation at 6 h to 96 h. There was a difference 
between both experiments in particular at 96 h (ca 108 vs. 107 Exp. 1 and Exp. 2, 
respectively) and overall, numbers were lower in experiment 2. 
 
Experiment 3:  Microcosm biofilms were grown for 438 h and sampled at 6 h, 24 
h, 48 h, 72 h, 96 h, 192 h, 216 h, 222 h, 246 h, 270 h, 342 h, 366 h, 390 h, 414 h, 
and 438 h. For the first 7 days, the biofilms were grown with artificial saliva 
introduced at a rate of 0.5 ml/min plus a peri-implant sulcular fluid (PISF) was 
added at a rate of 40 µl/min and after this, peri-implant sulcular fluid was added 
at a rate of 130 µl/min and microaerophilic atmosphere gas mixture, at a rate of 
200 ml/min, was supplied.  
The viable count data generated from the samples is shown in Figure 3.3. 
Samples from two (Ti) discs were grown on selective and non-selective culture 
media. The total number of bacteria in the biofilm increased over time from 
inoculation until 96 h. All groups of bacteria that were cultured seemed to broadly 
follow this pattern. Candida numbers increased at 192 h and reduced in numbers 
at 270 h, but recovered somewhat at 366 h later time points. Following the 
change to the peri-implant mucositis conditions, the numbers of anaerobic and 
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aerobic bacteria increased. Streptococcus species numbers initially reduced in 
populations at 270 h but recovered again at 366 h.  
 
Figure 3.3. Composition of biofilms (viable count data from 5 different media) 
sampled from the CDFF at different time points (6 h – 438 h). Red vertical line 
represent time of introduction of microaerophilic gas mixture and increased flow 
rate of peri-implant sulcular fluid at 222 h. Error bars represent standard 
deviation (n = 2). 
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3.3.3 Structural analysis of biofilms using CLSM data 
Confocal laser scanning microscopy images were obtained throughout this 
study. 
 
Experiment 1: During modelling of healthy dental implant conditions, different 
structural features could be observed (Figure 3.4).  After 6 h, the early biofilm 
covered only parts of the Ti surface. It was low in morphotypic diversity; the cells 
observed all appeared to be coccoid and very few rods were observed. In 
addition to the high numbers of cocci, the surfaces became completely covered 
with biofilm over time and by 72 h the biofilm showed opening void like 
structures. 
 
 
6 h 24 h 
48 h 72 h 
Figure 3.4. Images were taken through the z axis within the biofilm, 
vertical panels are xy voxels and horizontal panels are xz voxel. 
CLSM images along the z plane of microcosm biofilms were grown 
for 348 h. At 6 h, the young biofilm is characterised by the presence 
of viable and non-viable chains (rods and cocci). Scale bar (20 µm). 
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At 96 h, the titanium surface was covered completely with rods and large 
numbers of fusiform bacteria, as shown in Figure 3.5. Once the surface was 
covered, the biofilm appeared to expand to form closely packed microcolonies at 
168 h and 192 h. At 348 h, the biofilm formed a dense mat with a large spectrum 
of cell morphotypes, ranging from coccoid to small rods and filaments with the 
formation of columnar microcolonies with their long axis perpendicular to the 
surface. 
 
 
 
 
 
 
 
 
 
 
 
 
96 h 168 h 
192 h 348 h 
Figure 3.5. Images were taken through the z axis within the biofilm, 
vertical panels are xy voxels and horizontal panels are xz voxel. 
CLSM images were characterised by the presence of extensive 
numbers of filaments or 'fusiform-shaped' bacteria covering the Ti 
surface. Few rod or coccal shaped bacteria were evident beneath 
and those present appeared non-viable cells (red channel). Scale 
bar (20 µm). 
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Figure 3.6. Images were taken through the z axis within the biofilm, 
vertical panels are xy voxels and horizontal panels are xz voxel. CLSM 
images were characterised by the presence of fusiform shapes which 
covered the Ti surface, with few rod or coccal shaped bacteria being 
evident beneath these cells, and when present were non-viable (red 
channel) cells. Scale bar (20 µm). 
 
Experiment 3:  These biofilms appeared to be denser with voids and fewer 
numbers of non-viable cells at 96 h (Figure 3.6). At 192 h, the biofilms were 
observed to be covering a large area of substratum with viable and non-viable 
coccoid bacteria in particular, at the centre of the image with few filamentous 
bacteria. After 222 h, with an increased flow of peri-implant sulcular fluid (PISF) 
associated with a change in the environment from an aerobic to microaerophilic 
atmosphere, fusiform bacteria began to proliferate and form micro-colonies that 
were closely packed (at 246 h). At 342 h, non-viable cells were observed with a 
large spectrum of viable cells (cocci, small rods and filaments). 
 
 
 
 
 
 
246 h 342 h 
96 h 192 h 
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At 366 h, viable and non-viable chains of bacteria were observed (Figure 3.7). At 
414 h, the presence of different morphotypes (rods, cocci, filaments) with open 
void structures (non-stained black areas in the biofilm section) was evident. The 
large areas of non-viable bacteria observed at 414 h were replaced by mostly 
viable bacterial cells at 438 h.  
 
 
 
 
 
 
 
366 h 414 h 
438 h 
Figure 3.7. Images were taken through the z axis within the biofilm, 
vertical panels are xy voxels and horizontal panels are xz voxel. 
CLSM images showing microcosm biofilm grown under 
microaerophilic environment with increased flow of PISF represented 
by 366 h, 414 h and 438 h. Scale bar (20 µm). 
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3.3.4 Biofilm thickness analysis 
The thickness of one biofilm of each experiment 1 and 3 was measured at each 
sampling point and calculated using Image J software. 
 
Experiment 1: After 6 h the depth of the biofilm was 1 µm, approximately 1 cell 
thick increasing to ca. 19 µm at 348 h. (Figure 3.8). 
 
Experiment 3:  For the first 7 days, the biofilms were biofilms were growth using 
artificial saliva and PISF as sources of nutrients. After 6 h the depth of the biofilm 
was 1 µm. The depth of biofilm at 96 h was ca. 29 µm then reduced to ca. 26 µm 
at 192 h. After 222 h with an increased PISF flow, the biofilm depth reduced to 
ca. 20 µm (Figure 3.8). The biofilm in this experiment was a lot deeper than 
experiment 1 at comparable measurement points for example at 96 h in 
experiment 1 it was ca. 18 µm while in experiment 3 it was ca. 29 µm.  
 
 
Figure 3.8. The thickness of biofilm at different time points in µm. At 222 h, a 
change in the environment to a microaerophilic atmosphere was initiated with 
increased introduction of PISF for experiment 3.  
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3.4 Discussion  
Plaque mediated diseases are a result of a shift in the balance of the resident 
microbiota due to responses in local environmental changes (Marsh, 2003). The 
disease process that causes peri-implantitis is similar to the pathological process 
that occurs around natural teeth during gingivitis and periodontitis (Silverstein et 
al., 1994, Subramani et al., 2009). The aim of this part of study was to produce 
biofilms that mimicked those associated with healthy dental implant conditions 
and peri-implant mucositis conditions. In vitro biofilms were grown using a CDFF 
on titanium disc surfaces. A natural biofilm can often be complex and non-
reproducible (Kinniment et al., 1996) thus, the aim was to grow microcosm 
biofilms in various environments and make an effort to maintain good 
reproducibility. The parameters used in this study were based on those of 
(Dalwai et al., 2006). The CDFF is particularly suited to studies of biofilms of oral 
bacteria because it provides an environment similar to the oral cavity. A CDFF 
was used for the study of peri-implantitis for several reasons; it provides a 
reproducible manner of formation of biofilms overtime. It is a widely used and an 
accepted tool for simulating in vivo situation; it provides an environment similar to 
that found in the oral cavity. It is a sophisticated apparatus that can generate 
large numbers of biofilms. It has been used previously for the study of bacterial 
perturbation (Wilson, 1999), to successfully model supragingival dental plaque 
(Wilson et al., 1995) and modelling population shifts associated with health or 
disease (Dalwai et al., 2006). Furthermore, the removal of surfaces of the 
biofilms by the scraper blades mimics the continuous removal of the outermost 
layers of the dental plaque owing the shear forces present in the oral cavity 
(Lamfon et al., 2003). Furthermore, the used of saliva in all experiments had 
several advantages; it generated a biofilm that consisted of many complex and 
original organisms. Use of saliva also leads to the possibility in other studies to 
examine plaque behaviour, ecology, and pathology and for the testing of 
potential clinical interventions (Sissons et al., 1991).  
The nutrients which are available at the site of an implant in both health and 
disease are complex and dynamic. For modelling healthy dental implants, the 
main source of nutrients of biofilms growing above the gingival margin is saliva, 
in contrast, for biofilms growing subgingivally, the main source of nutrients is 
gingival crevicular fluid (GCF) (Wilson, 1999). Artificial saliva based on the 
formulation of Russell and Coulter (1975) was used throughout the experiments. 
A key feature of this formulation is the inclusion of hog gastric mucin (HGM), 
which functions not only as a major source of nutrients for oral bacterial 
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communities (Bradshaw et al., 1989), but also covers the surfaces of the 
substratum to form a conditioning film.  
For modelling peri-implant mucositis a changing nutrient regime was needed. 
The flow rates of peri-implant sulcular fluid used in the experiments were 
determined based on data from a number of papers. The gingival crevicular fluid 
flow rate, the amount of GCF produced in vivo per day is only a few millilitres, 
which would be impracticable to reproduce in vitro (Wilson, 1999). For example, 
gingivitis subjects have GCF flow rates of 0.087 µl/min, where as moderate 
periodontal pockets have a flow rate of 0.4 µl/min (Goodson, 2003, Uitto, 2003). 
Many factors are known to influence the flow rate of gingival crevicular fluid, and 
many studies have shown a correlation between the severity of gingival 
inflammation and gingival crevicular fluid flow rates. Furthermore, the results of 
these studies imply that alveolar bone resorption, in addition to gingival 
inflammation may be factors that influence GCF flow rates (Cimasoni, 1983). It 
has been shown that the amount of crevicular fluid around osseointegrated 
dental implants is similar to that around teeth in the same individual (Apse et al., 
1989). The results of this imply, that to grow the biofilm on these titanium discs it 
was necessary to supplement the medium with GCF in addition to artificial saliva. 
The artificial medium, mimicking sulcus fluid, used in this study consisted of both 
Roswell Park Memorial Institute medium (RPMI) and horse serum. RPMI is used 
to culture eukaryotic cells in tissue culture. Horse serum has been previously 
demonstrated to be suitable for the growth and maintenance of a pathogenic 
subgingival microbiota (Curtis et al., 1988). Haemin and menadione were added 
to the nutrient medium to simulate the effect of bleeding which is known to occur 
with inflammatory periodontal diseases (Loesche et al., 1983) and peri-implantitis 
(Berglundh et al., 2011). These two complex nutrients were added together to 
the CDFF: artificial saliva and crevicular fluid via one port. The combination of 
these constituents with their differing, but crucial nutrient properties was thought 
to produce a good representation of the nutrient milieu found around 
unsuccessful dental implants. The data from these studies was used to calculate 
the flow rate in healthy dental implants of 40 µl/min and in peri-implant mucositis 
one of 130 µl/min. These rates were used in this study.  
Despite the access of air to the oral cavity, there are few strict aerobic 
microorganisms within the plaque community (Wilson, 1999), as atmospheric air 
(O2) does not penetrate far into the biofilm due to diffusion issues and facultative 
taxa utilising it preferentially. The current model system was therefore 
maintained with appropriately low oxygen levels (2%). The majority of oral 
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bacteria are anaerobic or species whose growth is optimum under CO2-enriched 
conditions, such as streptococci (Loesche et al., 1983) or capnophilic 
microorganisms requiring CO2. As a result, a 5% gas mix of CO2 in nitrogen has 
been frequently used in the past (Bradshaw et al., 1997). Microaerophilic gas 
composed of 2% O2, 3% CO2 and 95% nitrogen was therefore introduced into 
the CDFF in experiment 3. 
The microbial community present in the pooled saliva used as the inoculum for 
the CDFF was analysed. Very low variation was observed in bacterial numbers 
between the three pooled saliva samples which were profiled. The first CDFF 
experiment modelled a healthy dental implant microcosm. The culturable 
microbiota was shown to increase in number to a limit at 96 h then plateaued at 
162 h. This growth was probably limited by environmental pressures such as 
nutrient limitation or toxic metabolites. Indeed, the total aerobic and anaerobic 
viable count was very similar. In experiment 2 here there were broad similarities 
in how the biofilms developed during both experiments as revealed by viable 
counts. The experiment showed an unexpected ‘spike’ in bacterial numbers at 
approximately 192 h which then reduced. There was a difference between both 
experiments in particular at 96 h (ca. 108 vs. ca. 107 Exp. 1 and Exp. 2, 
respectively).  Following this, the numbers seemed to stabilise are shown in 
Figure 3.1 and Figure 3.2. 
For experiment 3, a healthy implant progressing to peri-implant mucositis was 
modelled by increasing PISF (40 µl/min increased to 130 µl/min) and changing to 
microaerophilic conditions (2% O2, 3% CO2, 95 % nitrogen). The viable count 
data progressed as expected and early time points were similar to experiment 
one and experiment two. Following the change to the peri-implant mucositis the 
number of anaerobes increased in populations and the number of aerobes and 
streptococci reduced at later time points. The anaerobic bacteria were the 
dominant component throughout. This was perhaps expected as the biofilm 
gradually developed so the metabolism of pioneer species created conditions 
suitable for the colonization by bacteria with more demanding atmospheric 
requirements. Oxygen is consumed by the aerobic and facultatively anaerobic 
species and replaced with carbon dioxide and other gases generated as end 
products of microbial metabolism. The lowering of oxygen tension favours the 
growth of obligate anaerobes species. Additional nutrient sources also become 
available due to metabolism of the pioneer species and the complex molecules 
in the PISF. These would be expected to alter the composition of microbiota and 
alter the total viable count.  
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Confocal laser scanning microscopy is a useful method allowing the structure of 
dental plaque to be analysed without disruption. The biofilms obtained were not 
homogenous in structure, but presented a highly heterogeneous architecture in 
terms of distribution of cells and fluid filled space. Biofilms on other surfaces 
such as enamel have previously produced the same structure (Nyvad et al., 
1989). The biofilm obtained from experiment 1 appeared to contain large areas 
of voids and few bacteria at 6 h. The numbers of viable cells increased at 48 h 
with greater distribution of cells. Following 72 h, the dense biofilm completely 
covered the substratum. Later, the biofilm contained a mat of fusiform-like 
bacteria and few cocci at 168 h. At 348 h, the biofilm completely covered with 
highly organised, dense morphotypes (cocci, rods, filaments) bacteria. The 
results of this study are in accordance with Scarano et al. (2004) who reported 
high numbers of  bacteria adhered to titanium surface after 24 h of exposure in 
vivo. In experiment 3, the biofilm contained a dense structure of viable bacteria 
by 96 h. At 192 h the biofilm contain mixture of viable bacteria and non-viable 
bacteria. After a shift in the environmental conditions to favour peri-implant 
mucositis, the fusiform like organisms were observed at 246 h, and were denser 
at 438 h. These findings were in agreement with the previous study of Nyvad and 
Fejerskov (1989) who reported that if plaque was allowed to accumulate 
undisturbed then a shift of bacteria occured after 7 days from coccoid to 
anaerobic rods and filaments by 14 days. Also the structure of the biofilms 
seemed to follow the progression reported in a previous study (Pratten et al., 
2000) in which low nutrition biofilms had an open structure, but biofilms culture 
under high nutrient conditions, such as those with saliva or GCF, would be 
expected to have greater density in terms of their structure. The variation in 
biofilm thickness values is depicted in Figure 3.8. The biofilm thickness was 
between ca. 16 µm at 72 h and ca. 19 µm at 96 h. After 72 h, the thickness of the 
biofilm thickness was not seen to vary significantly. Under conditions emulating 
peri-implant mucositis (experiment 3) the biofilm depth increased to ca. 30 µm in 
a mature biofilm (96 h - 438 h). This was probably due to the introduction of 
additional nutrients PISF (40 µl/min increased to 130 µl/min) which may have 
provided the community with more carbon, nitrogen etc, thus facilitating a more 
dense, deeper biofilm. It has been suggested that the biofilm structure and 
composition are linked to substrate nutrients or nutrient concentration. A high 
nutrient environment like artificial saliva and artificial crevicular fluid might be 
expected to produce a biofilm of high density rather than one more open 
structure. In addition, biofilms of more than 4 old days may produce a different 
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structure than early biofilms. The results of this study were in accordance with Al-
Ahmad et al. (2010), where biofilm thickness were shown to be between 19.78 
µm and 36.73 µm after 3 days and between 26.11 µm and 32.43 µm after 5 days 
in vivo.   
 
3.5 Conclusion 
The results of this part of the study have shown that the culture data did not 
reveal changes in the bacterial community given that the CLSM data suggested 
large differences in the structure, morphotypes present and thickness of the 
biofilms. To understand this further, it was decided to analyse the biofilms by 
independent cultural techniques. 
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Chapter 4 
Development of an in vitro microcosm model to simulate a healthy dental 
implant, peri-implant mucositis and peri-implantitis 
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4.1 Introduction 
The Sixth European Workshop in Periodontics held in 2008, defined peri-implant 
diseases as follows: peri-implant mucositis is the presence of inflammation of the 
peri-implant mucosa without signs of loss of bone support, while peri-implantitis, 
in addition to inflammation of the mucosa, is characterized by a loss of bone 
support (Lindhe et al., 2008). Peri-implantitis is mediated by the microbiota within 
the plaque biofilm on the dental implant surface (Mombelli et al., 2011). 
Microbiological studies in healthy peri-implant tissues have demonstrated the 
presence of large proportions S. mitis, S. sanguinis and S. oralis with a low 
proportion of anaerobic species, a small number of Gram-negative species, and 
a low detection of periodontopathogenic bacteria (Heuer et al., 2007). However, 
there is also contrary literature showing low numbers of anaerobic Gram-
negative bacilli in some healthy implants sites (Shibli et al., 2008, Zitzmann and 
Berglundh, 2008, Quirynen et al., 2002).  
Peri-implant infections consist of a microbiota very similar to that found in 
periodontal disease, and species such as P. nigrescens, C. rectus and A. 
actinomycetemcomitans are common (Shibli et al., 2008). An imbalance between 
the bacterial challenge and host response (Esposito et al., 1998, Berglundh et 
al., 2002) results in changes in the soft and hard tissues. These changes in the 
composition of the local microbiota are characterized by an increase in pocket 
depth and bone loss (Quirynen et al., 2002). These changes include:  
 an increased total bacterial load (Shibli et al., 2008),  
 an increase in the proportion of A. actinomycetemcomitans, 
Fusobacterium species, P. intermedia and P. gingivalis,  
 a decrease in the proportion of all cocci,  
 an increase in the proportion of motile organisms and spirochetes 
(Quirynen et al., 2002).  
The oral cavity provides a habitat in which the resident microbiota is able to form 
a wide varitey of biofilms. After the placement of titanium implants, the rapid 
colonization of bacteria has been observed at the peri-implant sulcus (van 
Winkelhoff et al., 2000). Although there is a large diversity of species associated 
with peri-implantitis (Kumar et al., 2012), not all species can be detected using 
traditional culture techniques. It has been estimated that less than 2% of all 
bacteria can be cultured using artificial media (Pratten et al., 2003) and 
unculturable taxa probably exist in all multispecies communities. To overcome 
the potential shortfall of traditional culture used in the previous chapter, a 
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molecular biology technique was used here. From the literature review it was 
seen that there are studies that have used 16S rRNA cloning and sequencing to 
identify the bacterial diversity of peri-implantitis biofilms. For example, Koyanagi 
et al. (2010, 2013) analysed samples from the deepest lesion of peri-implantitis 
by 16S rRNA gene cloning and sequencing and found that Eubacterium spp., 
Fusobacterium spp. and Streptococcus spp. had the major predominance at 
peri-implantitis. Moreover, in this study a wide variety of unculturable and 
unrecognized bacteria were found around diseased implants. These authors 
(2010) also concluded that the biofilm in peri-implantitis had a more complex 
microbiota than that in periodontitis. Hence, there is a possibility, that 
unexpected bacteria not related to periodontitis could be involved in inflammation 
around peri-implant tissues. 
 
In this part of study, the aim was to: 
1. Develop an in vitro model using microcosm biofilm associated with healthy 
dental implant which can be progressed to mimic peri-implant mucositis and peri-
implantitis.  
2. Characterise the changes in three communities developed in this model using 
selective and non-selective culture techniques.  
3. Characterise biofilm structure, thickness and spatial distribution of viable and 
non-viable cells using confocal laser scanning microscopy (CLSM). 
4. Characterise the richness of the three communities using 16S rRNA gene 
cloning and comparative sequencing.  
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4.2 Materials & Methods  
4.2.1 Culture media 
The constituents for each medium used are described in chapter 2. Growth 
media is described in section 2.1, constant depth film fermentor set up is 
described in section 2.2.1, microcosm biofilms were generated as described in 
section 2.2.2 and the in vitro model parameters are described in section 2.2.3.  
 
4.2.2 Inoculation of the CDFF   
Whole human saliva was used as an inoculum; this was mixed and pumped into 
the CDFF. The nutrient source used was artificial saliva and artificial tissue fluid 
(PISF). The compositions of artificial saliva used is described in chapter 2, 
section 2.2.3.  
 
4.2.3 Production of the biofilm 
Titanium discs were placed into a constant depth film fermentor which was 
operated at 37˚C. After the inoculum was disconnected, the CDFF (Exp. 4 and 
Exp. 5) was fed from a reservoir of sterile artificial saliva using a peristaltic pump 
at a flow rate 0.5 ml/min.  
 Peri-implant sulcular fluid was pumped into the CDFF at a flow rate 40 µl/min 
to simulate healthy conditions. 
 Peri-implant sulcular fluid was pumped into the CDFF at a flow rate 130 
µl/min as well as a microaerophilic gas mixture to simulate peri-implant 
mucositis. 
 Peri-implant sulcular fluid was pumped into the CDFF at a flow rate 130 
µl/min as well as an anaerobic gas mixture to simulate peri-implantitis conditions. 
The sampling pans were aseptically removed from the CDFF at different time 
points: 
 Under healthy conditions at 6 h, 48 h, 96 h and 216h.  
 Under peri-implant mucositis at 222 h, 246 h, 366 h, 390 h, 438 h and 510 h.  
 Under peri-implantitis conditions at 516 h, 540 h, 588 h, 612 h and 714 h.  
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4.2.4 Culture methods 
In order to maintain the populations present in pooled saliva. Serial dilutions of 
100 µl pooled saliva were plated out on mitis salivarius agar (Difco), blood agar 
(LABM), fastidious anaerobic agar (Oxoid), cadmium fluoride–acreflavin-tellurite 
agar, mannitol salt agar plates (Oxoid), sabouraud’s dextrose agar plates and, 
Gram-negative anaerobic agar (Oxoid) for both experiments. A Veillonella spp. 
agar plate was used for experiment 5 only. Serial dilutions were carried out on 
each type of culture medium and 20 µl (in duplicate) was spread on each plate. 
Plates were incubated in an anaerobic atmosphere (5% carbon dioxide, 5% 
hydrogen and 90% nitrogen) at 37°C for 4-5 days, except mitis salivarius agar 
plates, mannitol salt agar plates, sabouraud’s dextrose agar plates and blood 
agar plates where were incubated aerobically (plus 5% carbon dioxide) at 37°C 
for 48 hours.  
 
4.2.5 Confocal laser scanning microscopy, viability mapping and image 
analysis 
CLSM was carried throughout this study period on biofilms grown on Ti discs. 
The CLSM images were acquired with a water immersion objective lens (x 40) 
and image were obtained with a zoom factor of 1 to 2.5, and a field resolution of  
1024 x 1024 µm. CLSM image were obtained from a total 3 – 7 randomly 
selected sites per disc. To measure the distribution of viable and non-viable 
bacteria within the depth of the biofilm, fluorescence intensity profiles were also 
obtained using image J analysis software and orthogonal views. To create an 
orthogonal view, image stacks, comprising of both red and green channels were 
merged together then re-combined as a single RGB. To measure the thickness 
of biofilms, the “free hand” tool on Image J toolbar was used to manually draw on 
xz – voxel and yz - voxel sections mean measurement.  
   
4.2.6 16S rRNA gene cloning and sequencing 
DNA was isolated and purified at six time points: 6 h, 96 h, 246 h, 438 h, 540 h 
and 714h. One disc from each time point was used for DNA extraction. The 
pellet was resuspended in 50 µl phosphate buffer and subsequent DNA 
extraction was performed as described in section 2.3.1. PCR amplification, 
produced isolation, purification, cloning and sequencing was then carried out. All 
sequencing was performed at (The Wolfson Institute for Biomedical Research, 
UCL. The 16S rRNA PCR products were partially sequenced using primer 357F 
(59-CTCCTACGGGAGGCAGCAG-39; Lane, 1991) and the sequences checked 
using the Chromas LITE program, submitted to the Ribosomal Database Project 
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RDP (http://rdp.cme.msu.edu/index.jsp) and identified using blast. Further 
analysis was performed in order to find the closest match with the 16S rRNA 
gene. More than 98% sequence identity in the 16S rRNA gene sequence 
database was the criterion used to identify bacteria at to the species level.  
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4.3 Results 
4.3.1 Culture analysis     
The composition of the salivary inoculum was assessed using selective and non-
selective culture media for specific species detection and for total bacteria 
enumeration in experiment one and experiment two. The culture data of pooled 
saliva was populated by a range of species as shown in table 4.1.  
 
Experiment 4: the salivary inoculum had high numbers of Gram-negative 
anaerobes (ca. 106 CFU/ml), anaerobes (ca. 105 CFU/ml), aerobes (ca. 105 CFU/ 
ml) and streptococci (ca. 105 CFU/ml). 
 
Experiment 5:  this study was a repeat experiment; the inoculum had high 
numbers of aerobes (ca. 107 CFU/ml; anaerobes (ca. 107 CFU/ml), streptococci 
(ca. 106 CFU/ml), Gram-negative anaerobes (ca. 106 CFU/ml) and Actinomyces 
spp. (ca. 106 CFU/ml).  
 
 
 
 
 
 
 
 
 
 
 
Table 4.1. Composition of pooled saliva (inoculum) on selective and non-selective 
culture media. Error bars represent standard deviation (n = 2). 
 
Bacteria species 
Mean ± SD 
Exp. 4 
Mean ± SD 
Exp. 5 
Anaerobe spp. 2.4 x 10
5
 ± 0 1 x 10
7
 ± 2.33 x 10
5
 
Aerobe spp. 2 x 10
5
 ± 5.6 x 10
2
 1.08 x 10
7
 ± 1.06 x 10
5
 
Gram–negative anaerobe spp. 2.4 x 10
6
 ± 3.11 x 10
4
 1.78 x 10
6
 ± 5.16 x 10
4
 
Streptococcus spp. 1.70 x 10
5
 ± 1.13 x 10
3
 2.85 x 10
6
 ± 2.40 x 10
4
 
Actinomyces spp. 2.51 x 10
4
 ± 0 1.65 x 10
6
 ± 1.98 x 10
4
 
Candida spp. 2.5 x 10
4 
± 1.27 x 10
3
 6.75 x10
5 
± 7.78 x 10
3
 
Staphylococcus spp. 1.4 x 10
4 
± 1.41 x 10
2
 5.07 x 10
2  
± 3.54 x 10
1
 
Veillonella spp. - 7 x 10
5 
± 1.2 x 10
4
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4.3.1.1 Aerobe and anaerobe viable counts 
For both experiments 4 and 5, microcosm biofilms were grown for 714 h and 
sampled 15 times throughout this period. The viable counts obtained for both 
aerobes and anaerobes (Figure 4.1) showed a rapid increase from ca. 105 
CFU/ml to ca. 107 CFU/ml at 48 h and fluctuated around this number for the 
duration of the experiment.  
 
4.3.1.2 Selective media 
For both experiments 4 and 5, similar patterns of growth were observed for the 
microorganisms assessed. Briefly, the total viable counts increased from the time 
of inoculation until 72 h. this was evident for each bacterial group (Figures 4, 2 
and 4.3). Following the change to peri-implantitis a reduction in all bacterial 
numbers occurred, followed by a gradual increase in the levels of Gram-negative 
anaerobic bacteria (Figure 4.2). 
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Figure 4.1. Viable counts of aerobe and anaerobe spp. of microcosm biofilm 
under health, peri-implant mucositis and peri-implantitis conditions. First black 
dash line represents the switch over to microaerophilic gas mixture and 
increased flow of PISF, second black dash line represents switch over to an 
anaerobic gas mixture and PISF only. Error bars represent standard deviation (n 
= 4). Graphs show data from experiments 4 and 5. 
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Figure 4.2. Viable counts of Streptococcus spp., Actinomyces spp., Gram 
negative anaerobe spp. and Veillonella spp. of microcosm biofilm under health, 
peri-implant mucositis and peri-implantitis conditions. First black vertical dash 
line represents the switch over to microaerophilic gas mixture and increased flow 
of PISF, second black dash line represents switch over anaerobic gas mixture 
and PISF only. Error bars represent standard deviation (n = 4). Graphs represent 
combined data from experiments 4 and 5.  
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Figure 4.3. Viable counts of Candida spp. and Staphylococcus spp. from 
microcosm biofilms under health, peri-implant mucositis and peri-implantitis 
conditions. First vertical black dash line represents the switch over to 
microaerophilic gas mixture and increased flow of PISF, second black dash line 
represents switch over anaerobic gas mixture and PISF only. Error bars 
represent standard deviation (n = 4). Graphs represent combined data from 
experiments 4 and 5.  
 
 
Chapter 4: Development of an in vitro microcosm model   
 
129 
 
4.3.2 Structural analysis of biofilm using CLSM 
4.3.2.1 CLSM and image analysis of experiment CDFF 4 and 5 
CLSM imaging was carried throughout the two experiments. Representative 
images from health, peri-implant mucositis and peri-implantitis are shown in 
figures 4.4 to 4.12.  
 
Under health conditions: for the first 96 h, the “early” biofilm consisted of both 
viable and non-viable cells with an open structure (Figure 4.4).  
 
Under peri-implant mucositis conditions: at 246 h, the biofilm appeared to be 
denser but still showed an open structure (Figure 4.5). At 366 h, there was a 
reduction in the number of viable cells. Numerous cell morphotypes were also 
present (rods, cocci, filaments) (Figure 4.6). At 390 h in experiment 5 the biofilm 
was characterised by a high density of viable and non-viable cells and numerous 
different cell morphotypes (Figure 4.7). At 438 h, images showed a mature 
biofilm characterised by predominately filamentous organisms and rods in 
chains, some of these organisms were surrounded by cocci (Figure 4.8) with an 
abundance of viable rods and non-viable filaments in both experiments.  
 
Under peri-implantitis conditions: the biofilm structure showed almost 
complete titanium surface coverage with areas of multilayers of microorganisms 
at 540 h (Figure 4.9).  At 588 h, the biofilm showed an abundance of viable rods 
and non-viable filaments (Figure 4.10). At 612 h the biofilm showed an 
abundance of both viable and non-viable rods and filaments (4.11). At 714 h, the 
biofilm showed numerous morphotypes of cells (cocci, rods, filaments and 
fusiform bacteria) (Figure 4.12). When biofilms were examined in the z-plane (x–
y), parallel sections showed circular areas of densely packed bacteria, 
representing “chimneys” of multilayered complex microcolonies. However, the 
central part of these protruding microcolonies varied with regard to their 
composition. These included cocci (Figure 4.4) or rod-shaped (Figure 4.7), 
fusiform (Figure 4.11) and filamentous bacteria (Figure 4.12).  
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4.3.2.1.1 Health conditions 
 
 
96 h 96 h 
4 4 
2 
5 
96 h 
5 
96 h 
Figure 4.4. Representative CLSM images of healthy dental implant biofilms 
sampled at 96 h with x, y and z planes presented. Scale bar (20 µm). 
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4.3.2.1.2 Peri-implant mucositis conditions 
 
 
246 h 246 h 
4 4 
5 
246 h 246 h 
5 
Figure 4.5. Representative CLSM images of peri-implant mucositis biofilms 
sampled at 246 h with x, y and z planes presented. Scale bar (20 µm). 
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366 h 
4 
366 h 366 h 
5 5 
366 h 
4 
Figure 4.6. Representative CLSM images of peri-implant mucositis biofilms 
sampled at 366 h with x, y and z planes. Scale bar (20 µm). 
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Figure 4.7. Representative CLSM images of peri-implant mucositis biofilms 
sampled at 390 h with x, y and z planes presented. Scale bar (20 µm). 
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Figure 4.8. Representative CLSM images of peri-implant mucositis biofilms 
sampled at 438 h with x, y and z planes presented. Scale bar (20 µm). 
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4.3.2.1.3 Peri-implantitis conditions 
 
Figure 4.9. Representative CLSM images of peri-implantitis biofilms sampled at 
540 h with x, y and z planes presented. Scale bar (20 µm). 
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Figure 4.10. Representative CLSM images of peri-implantitis biofilms sampled at 
588 h with x, y and z planes presented. Scale bar (20 µm). 
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Figure 4.11. Representative CLSM images of peri-implantitis biofilms sampled at 
612 h with x, y and z planes presented. Scale bar (20 µm). 
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714 h 714 h 
5 5 
714 h 
4 
714 h 
4 
Figure 4.12. Representative CLSM images of peri-implantitis biofilms sampled at 
714 h with x, y and z planes presented. Scale bar (20 µm). 
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4.3.2.2 Viability mapping   
The fluorescent intensity profiles from both the green and red channels, for 
image stacks were calculated using Image J software. The data were analysed 
through open image and the relative intensity (fluorescence) values were 
obtained for each channel for both experiments 4 and 5. 
 
Under health conditions:  
In experiment 4, CLSM analysis of a 96 h biofilm (health) was performed (Figure 
4.13). It can be seen that the viable bacteria were dominant in the peripheral 
portion (slice 53) and declined in numbers on progression through the biofilm to 
slice 79 (Ti surface). This can also be observed in a subjective manner in figure 
4.16. CLSM analysis of a 96 h biofilm from experiment 5 is also shown in figure 
4.13. The viable bacteria were dominant throughout (maximum at slice 54) 
declining on progression through the biofilm down to slice 80. The red channel 
was extremely low in experiment 5 (96 h) compared to that of experiment 4 (ca. 
0% vs. up to ca. 15%). This may be as a result of analysing a randomly selected 
single specific biofilm column. 
 
Under peri-implant mucositis conditions:  
In experiment 4, CLSM analysis of a 246 h biofilm (peri-implant mucositis) was 
performed and the results are presented in figure 4.13, it can be seen that viable 
bacteria were dominant in the peripheral portion (slice 29) and declined on 
progression through the biofilm down to slice 51 (Ti surface). This can also be 
observed in a subjective manner in figure 4.17. CLSM analysis of a 246 h biofilm 
from experiment 5 is also presented in figure 4.17. Here, the viable bacteria were 
dominant throughout (maximum at slice 32) declining on progression through the 
biofilm down to slice 53. The red channel was low in experiment two (246 h) 
compared to that of experiment one (ca. 15% vs. up to ca. 20%). 
In experiment 4, CLSM analysis of a 366 h biofilm (peri-implant mucositis) was 
performed and is presented in figure 4.13. It can be seen that the viable bacteria 
were dominant in the peripheral portion (slice 75) and declined on progression 
through the biofilm to slice 97 (Ti surface). The same observation can be made 
in a subjective manner in figure 4.18. CLSM analysis of a 366 h biofilm from 
experiment 5 is also illustrated in figure 4.18. Here, the viable bacteria were 
dominant throughout (maximum at slice 24) declining on progression through the 
biofilm to slice 55. This again can also be seen in a subjective manner in figure 
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4.18. The red channel was low in experiment 5 (366 h) compared to that of 
experiment 4 (ca. 12% vs. up to ca. 19%). 
In experiment 5, only CLSM analysis of a 390 h biofilm (peri-implant mucositis) 
was performed and in figure 4.13. Viable bacteria were dominant in the 
peripheral portion (slice 25) and declined on progression through the biofilm 
down to slice 84 (Ti surface). This can also be seen in a subjective manner in 
figure 4.19. The red channel was low in (ca. 9%).  
CLSM analysis of a 438 h biofilm (peri-implant mucositis) is shown in figure 4.14 
for experiment 4, with viable bacteria being dominant in the peripheral portion 
(slice 62) and declining through the biofilm to slice 82 (Ti surface). This can also 
be observed in a subjective manner in figure 4.20. CLSM analysis of a 438 h 
biofilm from experiment 5 (Figure 4.14), shows that the viable bacteria were 
dominant throughout (maximum at slice 67) but declined on progression through 
the biofilm down to slice 96. The red channel was low in experiment two (438 h) 
compared to that of experiment one (ca. 1% vs. up to ca. 25%). 
 
Under peri-implantitis conditions: 
Analysis of CLSM fluorescence relative to biofilm depth for 540 h biofilms (peri-
implantitis) is presented for experiments 4 and 5 in figure 4.14 and 4.21. In both 
cases, viable bacteria were dominant in the peripheral portion (slice 83; 
experiment 4, slice 33; experiment 5). The amount of viable fluorescence then 
declines with increasing biofilm depth. Similar findings were evident for later time 
points (588 h, 612 h and 714 h), with viable cells again predominating, but 
declining as the depth of the biofilm increased (Figures 4.22 - 4.24).   
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Figure 4.13. Fluorescent image intensity, blue line represents the total biomass 
intensity while the green and red lines represent the viable and non-viable channels 
from the CLSM stacks images; under health condition at 96 h, under peri-implant 
mucositis at 246 h, 366 h and 390 h. 4 and 5 represent individual experiments. 
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Figure 4.14. Fluorescent image intensity, blue line represents the total biomass 
intensity while the green and red lines represent the viable and non-viable channels 
from the CLSM stacks images; under peri-implant mucositis at 438 h and under peri-
implantitis at 540 h, 588 h. 4 and 5 represent individual experiments. 
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Figure 4.15. Fluorescent image intensity, blue line represents the total biomass 
intensity while the green and red lines represent the viable and non-viable 
channels from the CLSM stacks images; under peri-implantitis at 612 h and 714 
h. 4 and 5 represent individual experiments. 
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Figure 4.16. Individual optical sections of biofilms sampled at 96 h from both 
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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Figure 4.17. Individual optical sections of biofilms sampled at 246 h for both 
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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Figure 4.18. Individual optical sections of biofilms sampled at 366 h for both   
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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Figure 4.19. Individual optical sections of biofilms sampled at 390 h from 
experiments 5. Numbering is from 1 at the apex in 1 µm increments until the 
titanium surface is reached. 
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Figure 4.20. Individual optical sections of biofilms sampled at 438 h from both 
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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Figure 4.21. Individual optical sections of biofilms sampled at 540 h from both 
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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Figure 4.22. Individual optical sections of biofilms sampled at 588 h from both 
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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Figure 4.23. Individual optical sections of biofilms sampled at 612 h from both 
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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Figure 4.24. Individual optical sections of biofilms sampled at 714 h from both 
experiments 4 and 5. Numbering is from 1 at the apex in 1 µm increments until 
the titanium surface is reached. 
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4.3.3 Biofilm thickness 
The thickness of the biofilm at each sampling point was calculated from the 
orthogonal view using Image J software (Figure 4.25). Under healthy conditions, 
experiment 4 at 6 h, the biofilm thickness was (ca. 1 µm) increasing at 96 h to ca. 
51 µm. Under peri-implant mucositis, the biofilm thickness seems to drop slightly 
to ca. 30 µm at 246 h when a change of atmosphere and increased peri-implant 
sulcular fluid flow occurs. At 366 h, the biofilm thickness increased to ca. 38 µm 
then remained constant to ca. 31 µm at 438 h. Under peri-implantitis conditions, 
the biofilm thickness fluctuated between ca. 41 µm and ca. 36 µm at 540 h and 
588 h, respectively. At 612 h, the biofilm thickness increased slightly to ca. 42 
µm and remained constant at 714 h. In experiment 5, the biofilm thickness under 
health conditions at 6 h, was ca. 1 µm and increased at 96 h to ca. 34 µm. Under 
peri-implant mucositis conditions, the biofilm thickness reduced slightly to ca. 29 
µm at 246 h. Under peri-implantitis conditions, the biofilm thickness was constant 
at 540 h (ca. 25 µm) and at 588 h, it reduced to ca. 21 µm. At 612 h, the biofilm 
thickness increased to ca. 31 µm then decreased slightly at 714 h to ca. 28 µm.  
 
 
Figure 4.25. Changes in biofilm thickness (µm) over time. First black dash line 
represents the switch over to microaerophilic gas mixture, second black dash 
line represents switch over anaerobic gas mixture. 
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4.3.4 Comparisons between experiment 4 and experiment 5 
The CFU per biofilm data for both runs is presented in Table 4.2 along with the 
means of these data.  
 
Comparison between health and peri-implant mucositis conditions  
There was a reduction difference in Candida spp. counts between health (96 h 
and 216 h) and peri-implant mucositis (390 h and 438 h) conditions. There was 
no difference observed in the counts of anaerobic spp., aerobic spp., Gram–
negative anaerobic spp., Actinomyces spp., Streptococcus spp. and 
Staphylococcus spp. between these above conditions at the same time points. 
Veillonella spp. was not present in experiment 5 therefore it could not be 
compared. 
 
Comparison between health and peri-implantitis conditions  
There was a reduction difference in Actinomyces spp. counts between health (96 
h and 216 h) and peri-implantitis (612 h and 714 h) conditions. There was also a 
difference of Candida spp. counts between health (96 h and 216 h) and peri-
implantitis (612 h and 714 h). There was no difference in the counts of anaerobic 
spp., aerobic spp., Gram–negative anaerobic spp., Streptococcus spp. and 
Staphylococcus spp. between these above conditions at the same time points.  
 
Comparison between peri-implant mucositis and peri-implantitis 
conditions there was no difference observed in the colony counts on selective 
and non-selective media for these two conditions at 390 h, 438 h and at 612 h, 
714 h. 
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Table 4.2. The mean CFU/ml data of biofilm generated in experiment 4 and experiment 5 under healthy, peri-implant 
mucositis and peri-implantitis conditions.  
 
 
 
  
 
 
 
 
 
 
 
 
 
Bacteria species 
Health 
96 h & 216 h 
Peri-implant mucositis 
390 h & 438 h 
Peri-implantitis 
612 h & 714 h 
Exp. 4 
Total 
Exp. 5 
Total 
Mean 
Exp. 4 
Total 
Exp. 5 
Total 
Mean 
Exp. 4 
Total 
Exp. 5 
Total 
Mean 
Aerobe spp. 8.25E+07 5.86E+07 7.06E+07  4.08E+07 4.41E+07 4.24E+07 2.08E+07 2.90E+07 2.49E+07  
Anaerobe spp. 1.04E+08 8.06E+07 9.25E+07 8.33E+07 9.63E+07 8.98E+07 4.76E+07 1.21E+08 8.44E+07 
Streptococcus spp. 2.98E+07 3.63E+07 3.30E+07  1.31E+07 4.05E+07 2.68E+07 1.59E+07 9.03E+06 1.25E+07  
Actinomyces spp. 6.89E+07 6.03E+07 6.46E+07  1.97E+07 3.70E+07 2.84E+07 1.98E+07 1.01E+07 1.49E+07   
Gram–ve anaerobe spp. 7.05E+07 6.06E+07 6.56E+07  5.78E+07 5.81E+07 4.54E+07 2.20E+07 4.73E+07 3.06E+07  
Candida spp. 5.21E+07 6.54E+07 5.88E+07   2.03E+07 1.84E+07 1.93E+07   2.47E+07 2.00E+07 2.24E+07   
Staphylococcus spp. 5.66E+07 4.40E+07 5.03E+07 2.28E+07 6.14E+06 1.45E+07 2.24E+07 3.04E+07 2.64E+07 
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4.3.5 16S rRNA gene PCR, gene cloning and sequencing 
Biofilms from 6 time points were analysed by 16S rRNA gene cloning and 
comparative sequencing. A total of 30 random clones from each transformation 
for each time point were sequenced and identified, the results are shown in 
Table 4.3.  
 
 Health conditions (6 h and 96 h) 
The artificial saliva and PISF medium with aerobic condition resulted in dominant 
populations mainly of Streptococcus mitis group (22/60) and Neisseria species 
(14/60), followed by the S. salivarius group (8/60). There was a 40:20 split with 
respect to Gram-positive and Gram-negative taxa. 
 
Peri-implant mucositis conditions (246 h to 438 h) 
The increased flow of PISF and microaerophilic gas mixture into the system 
resulting resulted in a predominance of Streptococcus spp. (15/60), Neisseria 
spp. (9/60) and Capnocytophaga spp. (7/60) with low numbers of Abiotrophia 
defectiva, Gemella haemolysans, Granulicatella para-adiacens, Eikenella 
corrodens, Fusobacterium nucleatum, and Fusobacterium periodonticum. 
Veillonella parvula and TM7 were also detected. The ratio of Gram-positive and 
Gram-negative taxa decreased to a 26:34 split.  
 
Peri-implantitis conditions (540 h to 714 h) 
Obligate and facultative anaerobic Gram-negative bacteria dominated (42/60) 
including Capnocytophaga spp. (16/60) and Veillonella spp. (14/60) together with 
a few examples of Parvimonas micra, Peptococcus sp. and Neisseria spp. The 
ratio of Gram-positive and Gram-negative taxa further decreased to an 18:42 
split. 
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Species (Health) 
6 h and 96 h 
No. of 
Clones 
Species (Peri-implant mucositis) 
246 h and 438 h 
No. of 
Clones 
Species (Peri-implantitis) 
540 h and 714 h 
No. of 
Clones 
Enterococcus hirae 1 Abiotrophia defectiva 1 Abiotrophia defectiva 1 
Gemella sanguinis 1 Gemella haemolysans 2 Gemella haemolysans 2 
Granulicatella paraadiacens 1 Granulicatella para-adiacens 1 Granulicatella para-adiacens 1 
Mycobacterium chelona 2 Parvimonas micra 6 Parvimonas micra 2 
Mycobacterium  sp. 1 Peptococcus sp. 1 Peptococcus sp. 2 
Rothia mucilagenosa 4 Streptococcus anginosus group 1 Streptococcus mitis group 9 
Streptococcus mitis group 22 Streptococcus mitis group 13 Uncultured Streptococcus group 1 
Streptococcus salivarius group 8 Streptococcus sineses 1 Total Gram-positive 18 
Total Gram- positive 40 
Total Gram-positive 26 Capnocytophaga ochracea 1 
Campylobacter showae 1 Capnocytophaga spp. 1 
Klebsellia pneumonia 4 Capnocytophaga leadbetteri 2 Capnocytophaga sputigena 14 
Moraxella oslonesis 1 Capnocytophaga ochracea 2 Klebseilla pneumoniae 1 
Neisseria sp. 10 
Capnocytophaga sputigena 3 Leptotrichia sp. 2 
Eikenella corrodens 1 Neisseria mucosa 1 
Neisseria perflava 3 Fusobacterium nucleatum 2 Neisseria subflava 1 
Neisseria mucosa 1 Fusobacterium periodonticum 1 Neisseria sp. 1 
Uncultured Enterobacterium 1 Klebseilla pneumoniae 2 Uncultured Neisseria sp. 3 
Total Gram- negative 20 Neisseria spp. 9 Escherichia coli 3 
  Leptotrichia sp. 5 Uncultured Veillonella 1 
  Veillonella parvula 3 Veillonella dispar 2 
  Veillonella sp. 1 Veillonella parvulla 10 
  Vibrio sp. 1 Veillonella sp. 1 
  TM7 1 Total Gram- negative 42 
  Total Gram- negative 34 
Table 4.3. Taxa detected by using 
16S rRNA gene cloning and 
sequencing from microcosm biofilms 
grown on titanium surfaces in a 
CDFF at different time points 6 h and 
96 h representing health, 246 h and 
438 h representing peri-implant 
mucositis and, 540 h and 714 h 
representing peri-implantitis. Green 
shading refers to organisms 
commonly classified from the 
literature as being associated with 
healthy dental implants. Yellow 
shading refers to organims 
associated with peri-implant 
mucositis and red shading refers to 
dominant organisms associated with 
peri-implantitis. Blue shading refers to 
organisms not normally associated 
with the resident oral microbiota.  
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4.4 Discussion 
Peri-implant infections (peri-implant mucositis and peri-implantitis) are caused by 
a biofilm covering the dental implant surface and crown (Ata-Ali et al., 2011). In 
the previous chapter, an in vitro method was developed to generate a dental 
plaque biofilm associated with healthy dental implants progressing to peri-
implant mucositis conditions in a manner similar to the in vivo situation. In this 
chapter, the model was further developed to include peri-implantitis conditions. 
From an ecological standpoint, this model was designed to reflect the changes in 
a community as a result of environmental changes (nutritionally and 
atmospherically). The microcosm biofilms were characterised by traditional 
culture and CLSM microscopy as well as molecular biology techniques. The 
gaseous environment mixtures in the CDFF were used to represent those 
conditions encountered when the lesion is above or below the gingival margin. 
The results presented in this chapter represent the analysis of biofilms generated 
within the CDFF for 29 days in two independent experiments.  
 
4.4.1 Culture analysis 
The microbiological characterisation of the saliva inoculum and the CDFF 
biofilms was based on the use of a variety of agar media. There was variation in 
the starting inoculum for experiments 4 and 5. Furthermore, it was a slight 
concern that higher numbers and Gram–negative anaerobe spp. was evident 
compared with total anaerobes (Experiment 4). The reason for this remains 
unclear but could relate to the effectiveness of the agars employed. However, 
the total microbial counts increased from 216 h and then reached a steady state 
with minor fluctuations. This growth profile appeared to be constant for each 
target group of microbes. This was also apparent using of the selective media 
which encourage the growth of specific genera or microbiota that may be part of 
the oral consortium.  
In terms of progression from healthy implant conditions to those of peri-implant 
mucositis conditions, significant changes in Candida species occurred. Changes 
were also evident in Actinomyces spp. levels as the transition from the healthy 
condition to peri-implantitis conditions occurred. No other changes in microbial 
groups were seen between peri-implant mucositis and peri-implantitis conditions. 
To ascertain the reproducibility the model the similarity between both 
experiments was confirmed by viable counts. The total counts of Actinomyces 
spp., Streptococcus spp., anaerobes spp. and aerobes spp. increased during the 
hours 96 h, 246 h, 438 h and 540 hours. There was slight decrease observed in 
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the prevalence of Candida spp. between health and peri-implant mucositis 
(Table 4.1). There was no difference observed in the counts of bacteria on other 
selective and non-selective media.  
There was reduction in the levels of Actinomyces spp. between health and peri-
implantitis conditions (Table 4.1). There were no differences encountered 
between peri-implant mucositis and peri-implantitis conditions. This small 
variation in both experiments could be attributed to the metabolic activity of some 
bacteria present in microcosm provides lifestyles suitable for the growth of 
oxygen intolerant bacteria (Bradshaw et al., 1996). Overall, few differences 
between the numbers of target bacteria and fungi across the disease conditions 
were seen. This may reflect the ability of the biofilm community to alter metabolic 
pathways with the changing conditions. However, more detailed characterisation 
using CLSM and molecular techniques, showed changes were occurring at the 
biofilm structure, genera and species level.  
 
4.4.2 Characterisation of biofilm architecture 
Several methods have been used to view the microstructure of biofilms including 
light microscopy, transmission electron microscopy, scanning electron 
microscopy (SEM) and confocal laser scanning microscopy (CLSM). Traditional 
light microscopy has been used only in the early stages of colonisation and 
plaque development, while electron microscopy usually requires dehydration of 
biofilm specimen, which may cause disruptive shrinkage and the loss of biofilm 
matrix (Pratten et al., 2000). However, by using CLSM, to optically section the 
biofilm without disruption, a different kind of analysis can be performed. For 
example the differences in intensity profiles can be used to profile the biofilm 
and, with detailed analysis, yield information about the viability in protruding 
surface structures. Image stack data can also be combined to give a projection 
through the biofilm showing all optical sections.  
In general, fluorescence microscopy approaches offer the opportunity to 
visualize bacteria directly on substrata and in the state of adherence (Hannig et 
al., 2007). The CLSM has been used with vital fluorescent stains to determine 
the structure of natural, heterogeneous nature of intact undisturbed microcosm 
biofilms (Wood et al., 2000). Under healthy conditions, after 96 h, the immature 
biofilm was found to be low in morphotypic diversity, as the cells all appeared to 
be coccoid in nature. However, the biofilms appeared to contain stacks and fluid-
filled spaces and were highly heterogeneous in their architecture. These findings 
agreed with previous in vitro electron microscopy studies of developing dental 
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plaque (Takeuchi and Yamamoto, 2001). In addition to the prevalence of coccoid 
cells that have been reported as the principal components of dental plaque, after 
6 h the titanium surface were covered by colonies of dividing bacteria that initially 
spread laterally along the increasing surface. Small numbers of rod-shaped and 
filamentous bacteria were also evident which has also been reported previously 
by Nyvad and Kilian (1987). Once the surface is fully covered, proliferating 
bacteria are reported to grow to form columnar microbial colonies that are closely 
packed and compete for space and nutrients with neighboring colonies in dental 
plaque (Listgarten, 1976). Under peri-implant mucositis, after approximately 1 
week the filamentous bacteria began to penetrate the coccoid bacteria from the 
surface, gradually replacing the coccoid microbiota and finally leading to a 
predominantly filamentous microbiota. This has also been reported previously on 
a covered surface by Listgarten (1994). Non-viable bacteria then became more 
widely distributed through out the biofilm, this process appeared to continue for 
approximately 2 - 3 weeks.  
In general, an increase in nutrient supply such as the provision of PISF and 
artificial saliva leads to the formation of a dense biofilm, mostly due to an 
increase in production of extracellular polysaccharide (EPS) by the oral 
microbiota (Pratten et al., 2000). The increased EPS provides another source of 
nutrients and plays an important key role in biofilm architecture by providing 
points of attachment for new species. The structure of the biofilms seemed to 
follow the progression reported by a previous study (Pratten et al., 2000) in 
which low nutrition biofilms had an open structure but in biofilms in a high 
nutrient environment like saliva/PISF might be expected to produce high-density 
biofilm.  
Columnar colonies subsequently disappeared and were replaced by a dense mat 
of filamentous bacteria under peri-implantitis conditions at 612 h and 714 h. 
These biofilms developed as a result of a higher flow rate of nutrients and an 
anaerobic atmosphere. The biofilm associated with the anaerobic atmosphere 
revealed dense embedded clusters of long filaments on titanium disc surfaces. 
The present study also showed that the cell viability increased from the upper 
surface of the biofilm and then decreased towards the titanium surface 
(substratum) at 96 h under health conditions. After the increased flow of peri-
implant sulcular fluid at 246 h, 366 h, 390 h (experiment two only) and 438 h, the 
fluorescence intensity of viable cells demonstrated maximum fluorescence 
intensity in the deeper layer. The non-viable bacteria appeared to form a more 
significant portion and were visible in the uppermost region. Such distribution of 
Chapter 4: Development of an in vitro microcosm model   
 
161 
 
viable and non-viable cells also been reported previously in laboratory grown 
biofilms (Dalwai et al., 2006, Hope and Wilson, 2002). At 540 h, 588 h, 612 h and 
714 h, the viable bacteria proportions decreased from the titanium surface and 
then increased towards the biofilm upper surface; the non-viable fluorescence 
demonstrated maximum intensity closer to the titanium surface under peri-
implantitis and anaerobic atmosphere.  
Biofilm thickness was not uniform. Hence, the structure of biofilm can range from 
the relatively featureless, flat type to one consisting of a more complex 
organisation involving tower like stacks consisting of microbes enclosed in an 
extracellular matrix separated by water channels (Dige et al., 2007). Under 
healthy conditions at 96 h in experiment 4, the biofilm thickness was greatest 
and then fluctuated slightly under peri-implant mucositis at 366 h (38 µm) and 
increased again in peri-implantitis (ca. 41 µm) at 540 h. In experiment 5, the 
biofilm thickness was 34 µm at 96 h. The biofilm thickness then fluctuated 
between ca. 29 µm at 246 h, to ca. 27 µm at 714 h. This variability in biofilm 
thickness between both experiments highlights the heterogeneity of (Figs 4.4 & 
4.6) (Dige et al., 2007). This study data is agreed with cultural technique viable 
counts represented with high viable counts at 96 h and fluctuated slightly until 
714 h. The results of CLSM images have useful in mapping the in vitro 
distribution of viable bacteria (Auschill et al., 2001) and revealing similar 
channels to those seen with in vivo plaque samples (Wood et al., 2000).  
However, the culture data and the CLSM data did not agree in terms of detecting 
community changes associated with environmental changes. The CLSM data 
highlighted difference in biofilm structure and cell morphology in the biofilms 
which was not apparent from the bacterial culture. These differences may be due 
to the possibility that a large proportion of the community was unculturable on 
the media that was used.  
 
4.4.3 Characterisation of biofilm using comparative 16S rRNA gene cloning 
and sequencing 
The limited shift of microbiota from health to mucositis to peri-implantitis was 
unexpected and the change of conditions was expected to alter the microbial 
population to a far greater extent. An explanation for this could be that some taxa 
increased in number and others decreased but these were not cultured, forming 
part of the unculturable proportion of the community.  
A large proportion of the bacterial community are unculturable either because of 
incorrect nutrition supplied in the growth media or as a result of living in a biofilm 
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in a stressful environment (viable but unculturable). To further understand this, it 
was decided to analyse the biofilms by molecular microbiological techniques to 
establish the diversity of the species in the biofilm communities.  
The molecular biology technique negates the bias involved with culturing 
bacteria and relies on detecting the bacterial DNA in the sample to identify the 
bacterial species. 16S rRNA gene cloning and comparative sequencing was 
carried out to see if the community changed with altered environment. Six 
biofilms were selected for analysis: at early health at 6 h and late health at 96 h 
sampling points, peri-implant mucositis (early at 246 h) and late at 438 h 
sampling points, and induction of peri-implantitis early at 540 h and late 714 h 
sampling points. The healthy biofilms were dominated by a range of oral 
streptococci such as Streptococcus mitis and Streptococcus salivarius groups. 
These species are frequently detected in healthy dental implant biofilms (Lee 
and Wang, 2010, Lee et al., 1999, Mombelli et al., 1988). These data, particularly 
with regards to Gram-positive facultative bacteria and Gram-negative bacteria 
which were recovered mainly by independent culture technique and data from 
other studies support our findings (Rams et al., 1984, Sanz et al., 1990).  
Other molecular biology techniques have been used to characterise peri-
implantitis e.g. Checkerboard DNA-DNA hybridization. This was previously 
employed to study the microbiota associated with dental implant infections and 
showed that Parvimonas micra were positively associated with peri-implantitis 
(Al-Radha et al., 2012). Máximo et al. (2009) detected S. sanguinis, S. gordonii, 
P. intermedia, V. parvula at elevated levels in peri-implant mucositis. In infected 
dental implants, Newman and Flemming (1988) reported an increased incidence 
of Capnocytophaga spp. A further study by Alcoforado et al. (1991) reported 
pathogenic bacteria such as P. micra, Fusobacterium spp. and P. intermedia 
associated with infected dental implant. The same author reported significant 
numbers of enteric rods and Capnocytophaga spp. Augthun and Conrads (1997) 
detected N. mucosa, C. ochracea and Fusobacterium spp. at elevated levels in 
peri-implantitis while E. corrodens was identified with less frequency. Other 
clinical studies found that the microbiota associated with peri-implantitis was 
more diverse than that of the healthy implants including F. nucleatum and 
Granulicatella adiacens (Koyanagi et al., 2010, Koyanagi et al., 2013, Kumar et 
al., 2012). The result of this present study showed that some Streptococcus spp., 
Neisseria, V. dispar, Capnocytophaga spp. and F. nucleatum were identified in 
peri-implantitis. Differences at species level were observed between the three 
states, and some as yet unreported bacteria from this environment were also 
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detected, such as TM7 and Vibrio spp. (Al-Radha et al., 2012).  Surprisingly little 
is thus far known about the microbiological differences between peri-implant 
mucositis and peri-implantitis which may signify that in most cases, the disease 
evolves gradually from mucositis to peri-implantitis. There is no evidence for the 
existence of one or a limited number of specific pathogens for peri-implantitis 
(Mombelli and Décaillet, 2011). The presence of these principal periodontal 
pathogens in the disease model was evidence that the model may be reflecting 
the clinical situation. These data support the CLSM data in that different 
morphologies taxa were present at these different time points. The data indicate 
that peri-implant communities differ in health, peri-implant mucositis and peri-
implantitis and several species; including previously unsuspected and unknown 
organisms are unique to these niches. Furthermore, peri-implantitis appears to 
be a heterogeneous infection, which is dominated by Gram-negative bacteria as 
identified by pyrosequencing techniques (Kumar et al., 2012). 
 
4.5 Conclusions 
The results of this investigation have shown that it is possible to produce an in 
vitro model of microcosm biofilms growing on titanium discs. The study has 
shown that using an in vitro model it is possible to create peri-implantitis biofilms 
grown under conditions similar to those which would exist in vivo. The data 
confirmed that the biofilms were reproducible between independent CDFF 
experiments and within the two experiments. Furthermore, the CDFF allowed the 
study of the events that cause the microbiota to progress from a “commensal” to 
a pathogenic community. 16S rRNA analysis was used successfully to explore 
the diversity of this biofilm community, avoiding the need for lengthy cultural 
procedures. The sequencing methodology provided a more representative 
picture than was previously possible by culture. The CLSM analysis supports the 
sequencing data in that high numbers of long rods that may be Capnocytophaga 
spp. were present in the biofilm. Furthermore, viability profiling including both 
viable and non-viable data, has also revealed more information, which could be 
used to quantify the penetration effects of antibacterial and oral disinfectant 
agents. The identification of the organisms causing the infectious process 
remains a goal both to understand the disease process and to provide effective 
antimicrobial and supportive treatment of infected dental implants. 
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Chapter 5 
Characterization of microcosm biofilm associated with healthy, peri-
implant mucositis and peri-implantitis conditions using multiplex qPCR 
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5.1 Introduction 
Numerous methods of microbial detection and quantification have been 
developed, mainly driven by the need to detect putative pathogens. These 
include, in the first instance, direct microscopy (van-Leeuwenhoek, 1674) and 
several hundred years later, bacterial culture. Indeed, cultural-based methods 
have until recently been the main method for detecting and enumerating 
pathogens and indeed microbial communities. However, there are some 
drawbacks to these, including the facts that they are:  
 time consuming 
 labour intensive 
 do not take account of fastidious taxa 
 do not take account of viable but non culturable taxa 
This approach may not therefore reflect the true composition of a mixed 
bacterial community and enumerating bacteria may also produce erroneous 
results (Dymock et al., 1996).  
Polymerase chain reaction (PCR) has become a powerful tool due to its 
speed, sensitivity, simplicity and specificity (Rodu, 1990). It has been used 
successfully in clinical microbiology to detect slow growing microorganisms or 
organisms that are difficult to culture (Nadkarni et al., 2002). However, it is 
difficult to accurately quantify the number of bacteria by conventional PCR 
because the reaction is evaluated after gene amplification is completed. In 
addition the quantification of PCR products can be affected by contamination, 
interfering substances and unequal amounts of collected samples. Also it is 
difficult to use for routine diagnosis because of the additionally required time 
for handling and post PCR analysis such as gel electrophoresis and 
radioactive hybridization (Nadkarni et al., 2002, Suzuki et al., 2004, Dewhirst 
et al., 2010). 
In recent years, quantitative PCR (qPCR) methods have revolutionised the 
investigation of bacterial communities and infections (Suzuki et al., 2004). The 
qPCR is a convenient technique that enables detection of absolute numbers 
of bacteria when used in combination with data derived from available 
accurate standards and sample size (Price et al., 2007). However, this method 
does not provide evidence of pathogen viability and bacterial activity since the 
probes, and or primers, detect DNA originating from living or dead bacteria. 
qPCR provides high sensitivity and specificity and it offers a faster detection 
time and increased accuracy compared with traditional methods. qPCR is 
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attractive because of its ease of use, relatively low cost in terms of laboratory 
manpower, rapid turnaround time, and potential to be fully automated. When 
used with species-specific primers, qPCR can also provide a precise and 
sensitive method for more accurate quantitation of individual species as well 
as quantification of total bacteria (using universal primers), and is therefore a 
useful tool for studies on the aetiology of peri-implantitis (D'Ercole et al., 
2008). Furthermore, a large number of samples can be accurately measured 
at one time (Morikawa et al., 2008, Rupf et al., 2011). These methods are now 
being employed in the study of microbial communities involved in both oral 
health and disease (Dalwai et al., 2007, Ledder et al., 2007, Keijser et al., 
2008, Ciric et al., 2010, Sakamoto et al., 2005).  
The early development of biofilms on implant surfaces has been found to be 
similar to that on natural teeth and on other restorative materials placed in the 
oral cavity (Subramani et al., 2009). Studies dealing with the microbiota 
associated with infected implants indicated that the presence of more 
complex, multiple species community existed and was analogous to those in 
periodontal lesion (Mombelli et al., 2011). A close association was 
demonstrated between peri-implantitis and several microorganisms 
associated with periodontitis including: Porphyromonas gingivalis, 
Fusobacterium spp., Parvimonas micra, Actinomyces israelii, Prevotella spp., 
Tannerella forsythia, Aggregatibacterium actinomycetemcomitans, Treponema 
denticola, Campylobacter rectus, Capnocytophaga sp. and Eikenella 
corrodens (Sanz et al., 1990, Becker et al., 1990, Rosenberg et al., 1991, 
Alcoforado et al., 1991, Mombelli et al., 1992, Kalykakis et al., 1996, Augthun 
and Conrads, 1997, Keller et al., 1998, Leonhardt et al., 1995, Persson et al., 
1996, Leonhardt et al., 1999, Barboza et al., 2002, Mombelli, 2002, 
Buchmann et al., 2003, Botero et al., 2005, Persson et al., 2006, Shibli et al., 
2008, Máximo et al., 2008, Máximo et al., 2009, Emrani et al., 2009, Tabanella 
et al., 2009, Persson et al., 2010). However, microorganisms not primarily 
associated with periodentitis such as Staphylococcus spp., Pseudomonas 
spp. and enterics such as Escherichia coli, Helicobacter pylori and yeast such 
as Candida spp. have also been isolated (Rams et al., 1991, Rams et al., 
1990, Leonhardt et al., 2003, Persson et al., 2010).  
In previous chapters, an in vitro peri-implantitis model was developed which 
allows modelling of three conditions health, peri-implant mucositis and peri-
implantitis.  
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The aim of the current study was to use three triplex qPCR assays designed 
and optimized previously by Ciric et al. (2010), to determine the numbers (and 
proportion) of eight orally important taxa including: Fusobacterium nucleatum, 
Lactobacillus casei, Veillonella dispar, Neisseria subflava, Actinomyces 
naeslundii, Prevotella intermedia, Streptococcus sanguinis and Streptococcus 
mutans. Some of these taxa are associated with gingivitis (Zee, 1996, Zee et 
al., 1996) and therefore, the aim was to determine their presence and amount 
in mucositis/peri-implantitis associated communities. Others are health 
associated and were used to report on health associated microbiota (Kumar et 
al., 2006). In addition to these, quantification of the total number of bacteria 
present was also evaluated. This would allow for the calculation of the 
proportion of each species within the community and allow comparison 
between the three conditions.  
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5.2 Materials & Methods 
5.2.1 Preparation of DNA for standard curve generation 
Depending on the specific target of the primers used for each PCR assay, a 
standard curve of bacterial genomic DNA from a known number of bacterial 
cells was created. One swab from a plate of each organism was suspended in 
1 ml of RTF. The colony forming units in this culture were than enumerated by 
serial dilution and plating on fastidious anaerobic agar. Total nucleic acids 
were extracted from all samples according to the protocol of (Griffiths et al., 
2000) (chapter 2, section 2.3.1.1.). In order to produce standard curves for the 
enumeration of microorganisms, purified DNA was used in the optimisation 
reactions from the following reference strains: Fusobacterium nucleatum 
(NCTC 10562), Lactobacillus casei (ATCC 334), Veillonella dispar (NCTC 
11831), Neisseria subflava (DSM 17610), Actinomyces naeslundii (DSM 
17233), Prevotella intermedia (DSM 20706), Streptococcus sanguinis (NCTC 
02863) and Streptococcus mutans (ATCC 700610).  
 
5.2.2 Quantitative PCR analysis of biofilm samples 
One disc containing a biofilm from two CDFF experiments described 
previously in chapter 4 was used; this resulted in 15 sampling points from 
each of the two experiments. The samples used were from 6 h, 48 h, 96 h, 
216h, 222 h, 246 h, 366 h, 390 h, 438 h, 510 h, 516 h, 540 h, 588 h, 612 h 
and 714 h biofilms.  
Three triplex qPCR assays were designed to enumerate three organisms 
associated with gingivitis (F. nucleatum, A. naeslundii, P. intermedia); three 
organisms associated with oral health (S. sanguinis, V. dispar, N. subflava); 
and two organisms strongly implicated in dental caries (S. mutans, L. casei). A 
universal primers and probe was used to quantify the total number of cells.  
5.2.3 Oligonucleotide primers and TaqMan probes 
The specific primers and specific probes used for detection and quantification 
of microorganisms listed (Ciric et al., 2010) are shown in table 5.1. The dual 
labeled fluorogenic probes were single stranded oligonucleotides labeled with 
two differen                                                          
                                                                        
Q         B Q™)                    3    end (Livak et al., 1995). The length of 
amplicon for all assays was approximately 100 bp except for the universal 
amplicon which was approximately 450 bp (Table 1.5). 
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Table 5.1. Primers and probes used in the three triplex qPCR arrays. The 
triplex were composed of F. nucleatum, L. casei and V. dispar (FLV); N. 
subflava, A. naeslundii and P. intermedia (NAP); and S. sanguinis, S. mutans 
and universal (SSU) with few modifications to the assays previously reported 
(Ciric et al., 2010). 
 
 
5.2.4 QPCR assay  
The universal primers and probe sets used were based on the original Lane 
sequences (Lane, 1991), as shown in Table 5.1.  
All reactions were run in triplicate in a final volume of 25 µl. Sensimix Probe 
(Bioline) qPCR mastermix was used, together with the Rotor-gene 6500 
(Qiagen) cycler using the green, yellow and red channels for data collection. 
Each reaction contained the concentration of the oligonucleotides as shown in 
Table 5.1.  
The reaction conditions were performed as specified by the manufacturer with 
the annealing/extension temperature ranging from 60°C to 64°C. Data 
collection took place during the annealing/extension step. Species-specific 
primers and dual-labelled fluorogenic probes were designed for all organisms 
using 16S rRNA gene sequences. In order to produce standard curves for the 
enumeration of organisms, DNA extractions were performed on organisms 
that had been enumerated using viable counts making it possible to relate 
numbers of cells to volumes of DNA. DNA used in the optimisation reactions 
and for the running of standards was obtained from the reference strains. A 
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mixture of DNA from different strains was used for the reference and standard 
DNA in the universal assay. Standard curves consisting of eight 10-fold 
dilutions of reference DNA were run in triplex assays. The detection limit for 
each of the single taxon was accepted as 20 cells, as determined by Ciric et 
al. (2011). 
 
5.2.5 Statistical analysis 
Bonferroni test analysis was used to test whether changes in the numbers of 
individual taxa under the three growth conditions were significant (significant 
level when P < 0.05 and P < 0.01).  
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5.3 Results  
5.3.1 Standard curve 
Analysis of the standard curve can provide important information about the 
assay. The assays were initially validated from a serial dilution of high quality 
template. Each concentration was amplified in triplicate to determine 
reproducibility. The standard curve was constructed from a measure of threshold 
cycle (Ct) against log template quantity as shown in figure 5.1. The efficiency of 
the reaction was shown as being close to 100%. Reproducibility of the replicate 
reactions reflected assay stability, with R2 values of 0.98 or above being 
indicative of a reliable or stable assay.  
An optimised assay resulted in a standard curve with a slope between -3.2 and -
3.5 as shown in figure 5.2. Reactions efficiencies were found to be 0.99 for F. 
nucleatum; L. casei 0.99; V. dispar 0.97; N. subflava 0.99; A. naeslundii 0.99; P. 
intermedia 0.96; S. sanguinis 0.99; S. mutans 0.94; and 0.92 for the universal. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. The standard curve of L. casei generated from a plot Ct against log 
concentration for eight 10-fold serial dilutions.  
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5.3.2 Quantification of bacteria by qPCR  
The total number of bacteria in each sample was quantified using universal 
probes and primers for the 16S rRNA gene. Following this, the number and 
proportion of each of the target species was investigated at each time point 
throughout the CDFF experiment (health, peri-implant mucositis and peri-
implantitis). The results of this are shown in figures 5.3 – 5.10. 
Figure 5.2. The linear slope of L. casei, with a slope of -3.337 and an R2 of 
0.99 for triplicate samples replicated three times.  
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5.3.2.1 Detection of Fusobacterium nucleatum 
 
Health Peri-implant mucositis Peri-implantitis 
Figure 5.3. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of F. nucleatum obtained by qPCR are represented by the black line. The 
proportion of F. nucleatum is represented by the yellow line with data points labelled. At 
222 h the environment was changed to a microaerophilic atmosphere with increased 
introduction of PISF.  At 516 h, the change of environment to anaerobic atmosphere. F. 
nucleatum error bars represent standard deviation (n = 6). Universal error bars 
represent standard deviation (n = 9). 
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5.3.2.2 Detection of Lactobacillus casei  
  
 
 
 
 
 
 
 
 
Health Peri-implant mucositis Peri-implantitis 
Figure 5.4. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of L. casei obtained by qPCR are represented by the black line. The 
proportions of L. casei are represented by the yellow line with data points labelled. 
At 222 h the environment was changed to a microaerophilic atmosphere with 
increased introduction of PISF. At 516 h, the change of environment to anaerobic 
atmosphere. L. casei error bars represent standard deviation (n = 6). Universal 
error bars represent standard deviation (n = 9). 
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5.3.2.3 Detection of Veillonella dispar 
 
 
 
Figure 5.5. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of V. dispar obtained by qPCR are represented by the black line. The 
proportions of V. dispar are represented by the yellow line with data points 
labelled. At 222 h the environment was changed to a microaerophilic atmosphere 
with increased introduction of PISF. At 516 h, the change of environment to 
anaerobic atmosphere. V. dispar error bars represent standard deviation (n = 6). 
Universal error bars represent standard deviation (n = 9). 
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5.3.2.4 Detection of Neisseria subflava 
 
 
 
Health Peri-implant mucositis Peri-implantitis 
Figure 5.6. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of N. subflava obtained by qPCR are represented by the black line. 
The proportions of N. subflava are represented by the yellow line with data 
points labelled. At 222 h the environment was changed to a microaerophilic 
atmosphere with increased introduction of PISF. At 516 h, the change of 
environment to anaerobic atmosphere. N. subflava error bars represent 
standard deviation (n = 6). Universal error bars represent standard deviation (n 
= 9). 
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5.3.2.5 Detection of Actinomyces naeslundii 
 
 
 
 
 
 
 
 
Health Peri-implant mucositis Peri-implantitis 
Figure 5.7. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of A. naeslundii obtained by qPCR are represented by the black line. 
The proportions of A. naeslundii are represented by the yellow line with data 
points labelled. At 222 h the environment was changed to a microaerophilic 
atmosphere with increased introduction of PISF. At 516 h, the change of 
environment to anaerobic atmosphere. A. naeslundii error bars represent 
standard deviation (n = 6). Universal error bars represent standard deviation (n = 
9).  
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5.3.2.6 Detection of Prevotella intermedia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health Peri-implant mucositis Peri-implantitis 
Figure 5.8. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of P. intermedia obtained by qPCR are represented by the black line. 
The proportions of P. intermedia are represented by the yellow line with data 
points labelled. At 222 h the environment was changed to a microaerophilic 
atmosphere with increased introduction of PISF. At 516 h, the change of 
environment to anaerobic atmosphere. P. intermedia error bars represent 
standard deviation (n = 6). Universal error bars represent standard deviation (n = 
9). 
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   5.3.2.7 Detection of Streptococcus sanguinis 
 
 
 
 
 
 
 
 
 
 
 
Health Peri-implant mucositis Peri-implantitis 
Figure 5.9. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of S. sanguinis obtained by qPCR are represented by the black line. The 
proportions of S. sanguinis are represented by the yellow line with data points 
labelled. At 222 h the environment was changed to a microaerophilic atmosphere 
with increased introduction of PISF. At 516 h, the change of environment to 
anaerobic atmosphere. S. sanguinis error bars represent standard deviation (n = 
9). Universal error bars represent standard deviation (n = 9). 
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5.3.2.8 Detection of Streptococcus mutans 
 
 
 
Health Peri-implant mucositis Peri-implantitis 
Figure 5.10. Total counts of bacteria obtained by qPCR represented by blue bars. 
Numbers of S. mutans obtained by qPCR are represented by the black line. The 
proportions of S. mutans are represented by the yellow line with data points 
labelled. At 222 h the environment was changed to a microaerophilic atmosphere 
with increased introduction of PISF. At 516 h, the change of environment to 
anaerobic atmosphere. S. mutans error bars represent standard deviation (n = 9). 
Universal error bars represent standard deviation (n = 9). 
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5.3.3 CDFF peri-implant biofilm communities 
The data regarding the numbers of individual taxa were analysed and the total 
number of organisms present over the experiment is shown in tables 5.2, 5.3 and 
5.4. Based on all the amplified taxa, the highest number of bacteria detected was 
4.09 x 107 at 438 h, and the lowest number was 5.35 x 103 at 6 h.   
Health communities: The most numerous bacteria were N. subflava (ca. 107 at 
96 h – ca. 107 at 216 h), followed by F. nucleatum (ca. 105 at 96 h – ca. 106 at 
216 h), S. sanguinis (ca. 105 at 96 h – ca. 105 at 216 h), V. dispar (ca. 102 at 96 h 
– ca. 104 at 216 h), P. intermedia (1.19 x 103 at 216 h), whilst L. casei, S. mutans 
and A. naeslundii were below the detection limit (< 20) as shown in table 5.2.  
 
Peri-implant mucositis communities:  
There was little change in total numbers of organisms present over time, the 
numbers increased from around 106 at the start of the experiment to around 107 
cells per disc up to 222 hours and remained at this level throughout the 
experiment. The numbers of L. casei, P. intermedia and A. naeslundii were very 
low throughout the experiments. Other taxa increased after changing the 
environment conditions between 246 h and 438 h. For example, N. subflava 
(from 1.8 to 2.5 x 107), F. nucleatum (from 1.26 x 106 - 1.02 x 106), V. dispar 
(from ca. 104 to ca. 105), and. S. sanguinis increased by 1 log10 (ca. 10
5). 
Streptococcus mutans was detected in low levels at all the time points as shown 
in table 5.3. 
 
Peri-implantitis communities:  
The total number of organisms remained broadly steady over the duration of the 
experiment. The numbers of L. casei and S. mutans were at similar levels 
throughout the experiments. However, the numbers of V. dispar only increased 
by 1 log10 throughout the experiment (from ca. 10
4 to ca. 105), numbers of F. 
nucleatum, N. subflava and S. sanguinis deceased by around 1 log10 (ca. 10
6, 
ca. 105, ca. 104, respectively). Prevotella intermedia and A. naeslundii were 
below the detection limit throughout, as shown in table 5.4. 
 
Comparison of taxa numbers between communities: Statistical analysis 
using Bonferroni test showed there was a significant difference in the levels of S. 
sanguins between health and peri-implant mucositis conditions (P < 0.01). There 
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was a significant difference in the numbers of F. nucleatum, V. dispar, N. 
Subflava between health and peri-implantitis conditions (P < 0.01). There was 
also a significant difference in the levels of F. nucleatum, V. dispar, N. subflava 
and S. sanguins between peri-implant mucositis and peri-implantitis conditions 
(P < 0.01). 
Table 5.2. Numbers of each of the taxa investigated in microcosm biofilms 
samples under health conditions. ± represents standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health 6 h 48 h 96 h 216 h 
F. nucleatum 
n = 6 
2.95 x 10
1
          
± 5.09 x 10 
2.95 x 10
1             
 
± 1.29 x 10
1
 
2.27 x 10
 5              
± 2.34 x 10
4
 
1.23 x 10
6
         
± 8.93 x 10
5
 
L. casei 
n = 6 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
6.65 x 10
1             
 
± 7 x 10
1
 
V. dispar 
n = 6 
Below the 
detection limit 
Below the 
detection limit 
7.06 x 10
2               
± 7.63 x 10
2
 
2.63 x 10
4               
± 2.16 x 10
3
 
N. subflava 
n = 6 
7.17 x 10
2             
 
± 3.17 x 10
2
 
1.94 x 10
6               
± 2.22 x 10
6
 
3.17 x 10
7
                 
± 1.46 x 10
7
 
1.57 x 10
7              
± 2.91 x 10
6
 
A. naeslundii 
n = 6 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
P. intermedia 
n = 6 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
1.19  x 10
3
               
± 1.27 x 10
3
 
S. sanguinis 
n = 9 
9.73 x 10
1               
± 1.52 x 10
2
 
1.83 x 10
4               
± 9.27 x 10
3 
1.60 x 10
5               
± 6.57 x 10
4
 
1.87 x 10
5              
± 7.64 x 10
4
 
S. mutans 
n = 9 
9.82 x 10
1
                
± 8.64 x 10
1
 
5.46 x 10
1
                
± 5.6 x 10
1
 
3.66 x 10
1 
               
± 5.15 x 10
1
 
3.77 x 10
1 
                
± 6.52 x 10
1
 
Universal 
n = 9 
5.35 x 10
3 
               
± 2.95 x 10
3
 
6.81 x 10
6 
                
± 2.62 x 10
6
 
3.75 x 10
7               
± 6.32 x 10
6
 
1.70  x 10
7             
± 4.56 x 10
6
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Table 5.3. Numbers of each of the taxa investigated in microcosm biofilms samples under peri-implant mucositis conditions. 
± represents standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peri-implant 
mucositis 
222 h 246 h 336 h 390 h 438 h 510 h 
F. nucleatum 
4.73 x 10
5               
± 4.33 x 10
5
 
1.26 x 10
6               
± 8.38 x 10
5
 
9.22 x 10
5              
± 9.85 x 10
5
 
2.69 x 10
5               
± 1.2 x 10
5
 
1.02 x 10
6
          
± 4.39 x 10
5
 
1.25 x 10
6
          
± 6.94 x 10
5
 
L. casei 
4.52  x 10
1
         
± 5.07 x 10
1
 
1.63 x 10
2
         
± 2.07 x 10
2
 
Below the 
detection limit 
1.04 x 10
2
          
± 1.32 x 10
2
 
2.92 x 10
2
          
± 3.86 x 10
2
 
9.3 x 10
1
            
± 1.23 x 10
2
 
V. dispar 
7.51  x 10
3              
± 4.72 x 10
3
 
5.53 x 10
4              
 
± 1.29  x 10
4
 
4.12   x 10
4              
± 4.13  x 10
4
 
3.18 x 10
4              
± 2.9 x 10
4
 
1.02 x 10
5                
± 5.79 x 10
4
 
1.01 x 10
5               
± 3.97 x 10
4
 
N. subflava 
8.97 x 10
6
              
± 1.13 x 10
7
 
1.8  x 10
7               
± 3.83 x 10
7
 
9.39 x 10
5                 
 
± 4.01 x 10
5
 
3.63 x 10
6
                   
 
± 2.02 x 10
6
 
2.51
 
 x 10
7
                       
± 1.34 x 10
7
 
5.99
  
x 10
6             
± 1.27 x 10
6
 
A. naeslundii 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
P. intermedia 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
2.33 x 10
1               
± 1.3 x 10
1
 
3.32 x 10
1              
± 9.22 x 10 
S. sanguinis 
7.37 x 10
4                     
± 1.07 x 10
5
 
1.95 x 10
5                      
± 8.26 x 10
4 
1.14 x 10
5                     
± 9.11 x 10
4
 
2.85 x 10
5 
                
± 2.3 x 10
5
 
5.72 x 10
5
          
± 4.09 x 10
5
 
1.88 x 10
5               
± 1.13 x 10
5
 
S. mutans 
3.68 x 10
1 
          
± 5.79 x 10
1
 
4.73 x 10
1 
         
± 7.08 x 10
1
 
4.64 x 10
1               
± 7.36 x 10
1
 
3.39 x 10
1               
± 5.32 x 10
1
 
3.66 x 10
1
                  
± 5.61 x 10
1
 
3.53 x 10
1                    
± 5.04 x 10
1
 
Universal 
4.31 x 10
6
                  
± 1.39 x 10
6
 
9.55 x 10
6                
± 2.5 x 10
6
 
2.2  x 10
7                         
± 1.16 x 10
6
 
1.04 x 10
7                     
± 3.16 x 10
6
 
4.09 x 10
7
                              
± 1.02 x 10
7
 
1.93 x 10
7                      
± 5.07 x 10
6
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Table 5.4. Numbers of each of the taxa investigated in microcosm biofilms samples under peri-implantitis 
conditions. ± represents standard deviation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peri-implantitis 516 h 540 h 588 h 612 h 714 h 
F. nucleatum 
2.81 x 10
5
     
±1.04 x 10
5
 
1.05 x 10
6                    
± 5.02 x 10
5
 
5.87 x 10
5
                 
± 5.49 x 10
4
 
5.65 x 10
5               
± 1.35 x 10
5
 
5.47 x 10
5              
± 4.28 x 10
5
 
L. casei 
3.1 x 10
1                           
± 3.21 x 10
1
 
1.83  x 10
2
                       
± 2.38 x 10
2
 
1.1  x 10
2
                  
± 1.41 x 10
2
 
1.95  x 10
2
                
± 2.57 x 10
2
 
1.62 x 10
1
                 
± 9.66 x 10
 
 
V. dispar 
3.5  x 10
4
                            
± 2.30 x 10
4
 
1.34 x 10
5                       
± 7.96 x 10
4
 
3.17 x 10
4
                   
± 7.3  x 10
3
 
1.79 x 10
5                      
± 4.65 x 10
4
 
1.51 x 10
5                       
± 3.39 x 10
4
 
N. subflava 
4.57 x 10
6
           
± 2.51 x 10
6
    
7.41 x 10
6
                     
± 4.82 x 10
6
 
1.04 x 10
6                          
± 7.37 x 10
5
 
2.83 x 10
6
                               
± 2.02 x 10
6
 
4.16
 
x 10
5                      
± 5.01 x 10
4
 
A. naeslundii 
Below the 
detection limit 
9.07 x 10
3                       
± 1..28  x 10
4 
 
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
P. intermedia 
2.99 x 10
2                       
± 2.52 x 10
2
 
3 x 10
4
               
± 3.29 x 10
4
  
Below the 
detection limit 
Below the 
detection limit 
Below the 
detection limit 
S. sanguinis 
1.03 x 10
5                         
± 8.3 x 10
4
 
2.23 x 10
5                     
± 1.46x 10
5 
3.21x 10
4 
                
± 1.57 x 10
4
 
6.76 x 10
4
                     
± 3.75 x 10
4 
                  
3.67x 10
4                           
± 2.5 x 10
4
 
S. mutans 
4.93 x 10
1 
                 
± 7.24 x 10
1
 
4.04 x 10
1 
                  
± 5.03 x 10
1
 
4.16 x 10
1 
                  
± 5.99 x 10
1
 
4.29 x 10
1 
                 
± 5.17 x 10
1
 
2.06 x 10
1 
                 
± 1.1 x 10
1
 
Universal 
9.81 x 10
6 
                  
± 2.85 x 10
6
 
1.04  x 10
7
                  
± 4.9  x 10
6
 
2.17 x 10
6                       
± 6.69 x 10
5
 
5.55 x 10
6                      
± 9.34 x 10
5
 
2.55  x 10
6                     
± 8.25 x 10
5
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5.4 Discussion 
Microcosm plaque biofilms grown in the CDFF on titanium (Ti) discs had 
previously been characterized by direct amplification and cloning of 16S rRNA 
genes (see chapter 4 section 4.3.6). The species detected by cloning, included 
Streptococcus spp. and Neisseria spp. under health conditions, but these 
changed to Neisseria spp., F. nucleatum, Veillonella spp. and Capnocytophaga 
spp. under peri-implant mucositis. Further changes occurred under peri-
implantitis conditions when Capnocytophaga spp. and Veillonella spp. were also 
detected. Although this provided insight into the community, there was no way of 
quantifying the numbers of these species. Therefore, to characterize these 
changes further, a quantitative PCR method for specific species was chosen.  
The triplex qPCR method was designed to enumerate eight microorganisms; 
whilst a universal probe served to enumerate all microorganisms and allow for 
the calculation of the proportions of each taxon within the total community (Ciric 
et al., 2010). To create higher specificity and efficiency in multiplex reactions, 
locked nucleic acid (LNA) was used. LNA is nucleic acid that              –     - 
C methylene bridge (Ciric et al., 2010). All assays contained locked nucleic acid 
except for the assay of A. naeslundii and the universal standard dual-labelled 
fluorogenic probes (see table 5.1). 
In this study, all reactions eff                           ≥ 97%, with the exception 
of the universal assays, where the efficiency was 92%. The reason for the lower 
efficiency of the universal assay could be due to the length of the amplicons 
(Ciric et al., 2010), which was approximately 450 bp in comparison to the other 
amplicons which were approximately 100 bp.  
The bacterial community found in saliva was dominated by V. dispar, N. 
subflava, F. nucleatum, A. naeslundii, and S. sanguinis. These taxa have been 
observed in previous culture independent studies and are associated with 
healthy dental plaque biofilms (Kumar et al., 2006). Two studies have shown that 
the dominant phyla in saliva were Firmicutes, Bacteriodetes, Proteobacteria, 
Actinobacteria, and Fusobacteria by culture independent methods (Price et al., 
2007, Keijser et al., 2008). The triplex qPCR method had previously shown 
similar a similar picture: the Firmicutes were the dominant organisms, followed 
by Proteobacteria, Fusobacteria, Actinobacteria, and Bacteriodetes (Ciric et al., 
2010).  
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Neisseria subflava is a bacterial species that is amongst one of the earliest 
colonisers, and are generally aerobic although their growth is stimulated by CO2 
and retarded under anaerobic conditions. In this present study, differences in the 
proportions of N. subflava were seen between health and peri-implantitis 
conditions and also between peri-implant mucositis and peri-implantitis 
conditions (P < 0.01). Numbers of N. subflava were significantly higher in 
numbers at 96 h under health conditions and reduced under peri-implant 
mucositis after 336 h, recovering slightly under peri-implantitis conditions.  
Streptococcus sanguinis counts were 1.57 x 107 (± 2.91 x 106) at 216 h, and 
these numbers remained similar under pei-implant mucositis (438 h) at 1.88 × 
105 (± 1.13 × 105). The streptococci possess adherence and metabolic capacities 
that enable them to colonize a wide structure of oral cavity sites (Nobbs et al., 
2009). It can be hypothesised that the growth of the pioneer community (such as 
S. sanguinis and others) altered the environment in a number of ways. These 
may include oxygen utilisation, the production of reducing compounds, and the 
excretion of metabolic end-products. 
Veillonella dispar is able to coaggregate with a variety of oral bacteria including 
species belonging to the genera Streptococcus, Fusobacterium, Neisseria and 
Actinomyces (Bradshaw et al., 1996). Veillonella dispar levels were shown to be 
significantly different between health and peri-implantitis and between peri-
implant mucositis and peri-implantitis (P < 0.01). 
Some of the taxa investigated were only detected at low levels, including P. 
intermedia, L. casei, S. mutans, and A. naeslundii. Actinomyces naeslundii is 
known to be one of the early colonizers in the formation of dental plaque 
(Mombelli, 1987). It is likely that the environmental conditions within the CDFF 
experiments were not optimal for these taxa. 
Streptococcus mutans was detected at very low levels from microcosm plaque 
samples (Tables 5.2-5.4), representing a very small proportion (less than ca 
0.1%) of the total bacteria detected. Heuer et al. (2012) reported the absence of 
S. mutans around the abutment of dental implants using culture independent 
methods. The lack of glucose or sucrose could be the cause for the low detection 
of rates of these organisms (Ciric et al., 2010). Prevotella intermedia are more 
commonly isolated from dental plaque after the development of peri-implant 
disease (Mombelli et al., 1995). Serum is a constituent of gingival crevicular fluid 
(PISF) and has been shown to enhance the growth of Prevotella spp. and P. 
gingivalis (ter Steeg et al., 1987). Prevotella intermedia is an oral pathogen and 
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that is not usually found in high proportions in healthy oral environments. The 
proportions of P. intermedia at all time points in this study were very low. This 
finding is not in agreement with others who found high levels of P. intermedia 
associated with failing implants (Becker et al., 1991, Rosenberg et al., 1991, 
Augthun and Conrads, 1997, Mombelli, 2002, Leonhardt et al., 1995).  
Fusobacterium nucleatum numbers increased slightly once environmental 
conditions mimicking peri-implant mucositis occured. The proportion of F. 
nucleatum increased at 336 h then reduced and recovered again at 714 h. There 
was a significant difference in the levels of F. nucleatum between health and 
peri-implantitis and between peri-implant mucositis and peri-implantitis 
conditions. This may be due to the introduction of the large proteinaceous 
nutrients (e.g., amino acids and oligonucleotide peptides) present in PISF which 
could be exploited by this species. For protein-derived nutrients, F. nucleatum is 
often associated with peri-implantitis and is frequently cultivated from the 
surfaces of dental implants which have lost osseointegration (Mombelli, 1987). 
Fusobacterium nucleatum is considered an important organism in the formation 
of dental plaque and acts as a bridging organism between primary and late 
colonisers (Bradshaw and Marsh, 1999).  
Lactobacillus casei was detected in low proportions, which was in agreement 
with the previous data of cloning and comparative sequencing (chapter 4). Also, 
dental implants associated with either with health or diseases do not usually 
harbour L. casei (Kumar et al., 2012, Al-Radha et al., 2012). Furthermore, whilst 
L. casei are commonly isolated from the oral cavity they usually only compromise 
less than 1% of the total cultivable microorganisms (Marsh, 2010).  
The species found in consistently high numbers from the beginning of all of the 
experiments were N. subflava, S. sanguinis, and V. dispar. All of these species 
have been shown to be early colonizers during the formation of dental plaque as 
well as being among the most abundant taxa in the oral microbiota (Marsh, 2003, 
Zaura et al., 2009, Keijser et al., 2008). The prevalence of Actinomyces spp., 
Lactobacillus spp., Prevotella spp., and F. nucleatum is known to increase during 
inflammation of gingiva at the expense of Streptococcus spp. (Syed and 
Loesche, 1978, Moore and Moore, 1994). In the current study, the numbers of F. 
nucleatum increased over time under peri-implant mucositis and peri-implantitis 
conditions and S. sanguinis numbers declined after an initial peak coinciding with 
the F. nucleatum increase (Tables 5.3, 5.4).  
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5.6 Conclusions 
The qPCR findings were in agreement with 16S rRNA gene cloning and 
sequence data generated in chapter 4. The multi-triplex qPCR method allowed 
for the quick and efficient targeted analysis of the microbial community structure 
present in health and disease conditions associated with dental implants. Indeed, 
using qPCR it was possible to differentiate between the taxa in health and peri-
implantitis and between peri-implant mucositis and peri-implantitis conditions. 
The use of qPCR to assess the species numbers of these populations allows 
particular organisms to be assessed more accurately than they can be by 
cultural analysis.  
As the most abundant microbiota determined using comparative 16S rRNA gene 
cloning and sequencing was Capnocytophaga species, it was deemed to be 
beneficial to develop a probe and specific primers for quantifying of 
Capnocytophaga from three dental implant conditions biofilms. This research will 
be discussed in the next chapter. 
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Chapter 6 
Design and evaluation of a quantitative PCR assay for the detection of 
Capnocytophaga spp. 
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6.1 Introduction 
Many facultative anaerobic species have been implicated in peri-implantitis 
(Mombelli, 1987, Bower, 1996). Of these, several studies have reported the 
isolation of Capnocytophaga spp. from peri-implantitis sites (Sanz et al., 1990, 
Mombelli, 1987, Apse et al., 1989, Augthun and Conrads, 1997, Fardal et al., 
1999, Renvert et al., 2007). The genus Capnocytophaga, first proposed by 
Leadbetter et al. (1979) consists of five species: C. gingivalis, C. ochracea, C. 
sputigena, C. granulosa, and C. haemolytica, all of which can be isolated from 
the human oral cavity (Ciantar et al., 2001a). Another species, Capnocytophaga 
cynodegmi, is also present in the normal flora. Both can cause wound infections 
in humans after animal bite, C canimorsus being associated with more severe 
infections (Brenner et al., 1989).  
They comprise a group of capnophilic/facultative anaerobic Gram–negative, 
fuisiform rods. Capnocytophaga spp. manifest various features particularly their 
ability to adhere and co-aggregate with other bacteria, an important feature in 
biofilm formation. As well as being associated with peri-implantitis. Salvi et al. 
(2008) also showed that Capnocytophaga sputigena could be isolated from 
healthy implants. As stated by Socransky and Haffajee (1992), it is vital for 
pathogens to be present at the inception of periodontal diseases, however, the 
development of disease will not take place as long as the species does not 
exceed the threshold for the host. Indeed, It has been established that the mean 
number of target bacteria and others were involved in infection is higher in 
infected implants compared with healthy areas (van Winkelhoff and Wolf, 2000). 
Importantly, most of the periodontal microbiota can be found in healthy 
individuals, although in smaller numbers and lower proportions (Ximénez-Fyvie 
et al., 2000).  
Recently, the TaqMan qPCR technique has been used as described in detail in 
Chapter 5 (Suzuki et al., 2004). This method allows the detection and 
quantification of specific nucleic acid sequences. It offers a sensitive, efficient, 
and reliable approach to quantitation. The specificity and sensitivity of qPCR 
allows it to be used to amplify and quantify targeted DNA from any DNA source. 
Using the TaqMan system, it is easy to establish the total number of bacterial 
cells present in samples directly, without culturing, and is useful for detecting 
species that are difficult to grow in culture (D'Ercole et al., 2008). Furthermore, 
qPCR results can be obtained in 6-8 hours from sampling compared with up to 
14 days by culture (Suzuki et al., 2004). qPCR has been used for the 
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identification of P. gingivalis (Boutaga et al., 2003, Sakamoto et al., 2002), A. 
actinomycetemcomitans (Sakamoto et al., 2001, Jervøe-Storm et al., 2005), T. 
denticola (Sakamoto et al., 2001, Asai et al., 2002, Yoshida et al., 2004) and T. 
forsythensis (Jervøe-Storm et al., 2005), P. intermedia, F. nucleatum, P. 
gingivalis and T. forsythensis (Jervøe-Storm et al., 2005). In previous chapters, 
the microbial components of the biofilm community have been observed by 
CLSM, cultured on nutrient agars and detected and identified by 16S rRNA gene 
cloning and sequencing. The 16S rRNA gene cloning presented in Chapter 4 
showed that Capnocytophaga spp. seemed to increase under peri-implantitis 
conditions. Therefore, the main goal of this chapter was to develop a specific 
TaqMan qPCR assay for detection, identification and quantification of 
Capnocytophaga spp. from microcosm biofilms on titanium surfaces at different 
ages representing health and disease conditions. This work is the first to 
develop, design and optimise a specific probe and primers for quantification of 
Capnocytophaga species. 
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6.2 Materials and Methods 
6.2.1 Evaluation of qPCR primers 
6.2.1.1 Bacterial strains and culture conditions  
Capnocytophaga ochracea ATCC 33596 (MLC 23/38) was used as the test 
microorganisms in this study. The bacterial strain was grown on fastidious 
anaerobic agar (Lab M) with 5% defibrinated horse blood (E and O Laboratories, 
Bonnybridge, UK) for 3 to 4 days at 37°C under anaerobic conditions. In addition, 
the following closely and more distantly related reference strains were used as 
negative controls: Fusobacterium nucleatum (NCTC 10562), Lactobacillus casei 
(ATCC 334), Veillonella dispar (NCTC 11831), Neisseria subflava (DSM 17610), 
Actinomyces naeslundii (DSM 17233), Prevotella intermedia (DSM 20706), 
Streptococcus sanguinis (NCTC 02863), Streptococcus mutans (ATCC 700610), 
Porphyromonas gingivalis (DSM 20709), Tannerella forsythia (ATCC 43037) and 
Aggregatibacterium actinomycetemcomitans (ATCC 33384).  
 
6.2.1.2 Design of oligonucleotide primers 
The 16S rRNA gene sequences of the oral Capnocytophaga species were 
retrieved from the Ribosomal data base (http://rdp.cme.msu.edu/). These 
sequences were aligned using Clustal w2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/program). Clustal format files were 
aligned using a portion of the 16S rRNA gene containing the amplicon for 
Capnocytophaga species. A 100% sequence identity was observed for all 8 
species. On the basis of the sequence alignments of specific regions from 
different strains, a conserved sequence region for each bacterium was selected 
for designing the PCR primers using primer 3 version 4.0 
(http://frodo.wi.mit.edu/primer3/). Confirmation of the primer specificity was 
performed by blast (www.ncbi.nlm.nih.gov/blast) while probe specificity to the 
region of interest was confirmed using probe check (http://131.130.66.200/cgi-
bin/probecheck/probecheck.pl; figures 6.1, 6.2 and table 6.1).  
The 6-caroxyflourescein (6-FAM)                                                
and the n              q     i g          (    k      Q       , BHQ™)     
located at the 3    end (Livak et al., 1995). The primers listed in table 6.1 were 
tested for their signalling specificity for their target using conventional PCR using 
SYBR Green I (section 6.2.1.4). The sequence for primers and probe was 
employed with locked nucleic acid with their final concentrations as shown in 
table 6.2. These primers were specific when assessed by conventional PCR and 
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with TaqMan probe using qPCR using TaqMan probe. Analysis of the melting 
curves showed no production of non-specific products which would interfere with 
obtaining accurate results (Tables 6.2; figures 6.1 to 6.4).  
 
Table 6.1. Lists of primers based on 16S rRNA gene sequence were 
designed in this study for detection and quantification of Capnocytophaga 
species.  
 
 
 
 
 
 
 
 
 
Table 6.2. Sequences of primers and probe were used with final concentration. 
 
 
 
 
Primer Length            -   bp Tm °C 
Forward 23 GGAATCATTGGGTTTAAAGGGTC 
143 
65.1 
Reverse 22 GCATTTCACCGCTACACTACAC 63.4 
Forward 21 GACTGCCTTATGGGTTGTAAA 
147 
59.2 
Reverse 18 GATAACGCTCGCATCCTC 59 
Forward 20 GCTGGAATCGCTAGTAATCG 
188 
61.3 
Reverse 18 ACGGCTAGGTTGTTACGA 58.3 
Forward 24 ATAGCGAAGGCATATTACTAACAA 
142 
59.7 
Reverse 21 TAGCCACTCAGATTACTCCAA 59 
Primers S          -    nM bp Tm °C 
Forward CTCCTACGGGAGGCAGCAG  300 nM 
224 
67.3 
Reverse ATCATTGGGTTTAAAGGG  900 nM 56.3 
Probe 6FAM AAGG[+G]AA[+G]AA[+T]AA[+G]GG[+C]TBHQ1 200 nM  
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Figure 6.1. Regions used as target for Capnocytophaga species. The primers 
and TaqMan probe based on alignment of the 16S rRNA gene sequence. The 
black forward primer position 357F (Lane, 1991) and red text is the reverse 
primer position. Blue text is the dual labelled probe position; [ ] represents locked 
nucleic acid bases; *** represents identical aligned sequences. 
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Figure 6.2. Signature sequences for the closely and more distantly related 
reference strains were aligned by Clustal W2 program. The black forward primer 
position 357F (Lane, 1991) and red text is the reverse primer position. Blue text 
is the dual labelled probe position; [ ] represents locked nucleic acid bases; *** 
represents identical aligned sequences. 
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6.2.1.3 Genomic DNA extraction 
Genomic DNA from pure cultures was extracted using the method described by 
Griffiths et al. (2000) Chapter 2.   
6.2.1.4 Optimization of qPCR amplification 
The specificity of potential primers for their desired target was assessed using 
conventional PCR against the oral species previously described (6.2.1.1). PCR 
amplification was carried out in a reaction volume of 50 l containing 5 l of 
buffer, 1 l each of 10 mM dATP, dCTP, dGTP and dTTP (all deoxynucleoside 
triphosphates from Bioline, London, UK), 2.5 l of 50 mM MgCl2, 1 l/100 µM 
each PCR primer (1:10 diluted) and 0.5 l of 2000 U/µl Taq polymerase (Bioline) 
and 34 l of sterilised water. The negative control was 45 µl of reaction mix with 
the template replaced by 5 µl of sterilised deionised water. PCR thermocycling 
was performed using a Biometra T3000 thermal cycler (Biometra) conditions for 
all samples were: (i) an initial denaturation for 5 min at 94C, (ii) 29 amplification 
cycles of denaturation at 94C for 1 min, annealing of primers at 60C for 1 min 
and primer extension at 72C for 1 min followed by (iii) a final extension step at 
72C for 5 min.  
The reaction products were assessed by loading 5 l of the PCR product into the 
wells of a 1% (w/v) agarose gel containing gel red (2 l/100 ml). A Five l of 
hyper ladder I marker was loaded into the first well. Five l of the PCR reaction 
mixture from each was mixed with 2 l of the loading buffer and loaded into the 
appropriate wells of the gel. The gel was immersed in Tris-acetate EDTA buffer 
(Oxoid) and subjected to 100 V that led to separation of the fragments. The gel 
was visualised after excitation under UV transillumination (Ringmer, UK) by 
placing it in a multiimage light cabinet, resulting image was captured by a 
computer software programme (AlphaEase™, AlphaInnotech, Ringmer, UK) to 
confirm that only one product of the appropriate length was obtained. 
Primers concentrations and annealing temperatures optimised by conventional 
PCR. The tested primer concentration was tested 100 nM, 300 nM and 900 nM. 
The primer annealing temperatures were tested were 54°C, 58°C and 60°C. The 
TaqMan probe concentration was assessed by qPCR at 100 nM, 200 nM, 300 
nM, and 900 nM. Subsequently the reactions were optimized for qPCR assays. 
The probe annealing temperature was tested at 60°C, 61°C, 62°C, 63°C and 
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64°C using Rotor-gene 6500 (Qiagen) cycler with green channel for data 
collection. The qPCR was performed in triplicate. Negative control reaction 
(NTC) mixtures contained molecular sterile-filter H2O instead of template DNA.  
 
6.2.1.5 Real time PCR assays and melting curve 
qPCR was performed in a final volume of 10 µl containing PCR SensiMix 
(SensiMix probe™, Bioline), for SYBR Green probe (Sigma, SYBR Green 
JumpStartTaq™ Ready Mix™)/or for TaqMan probe (Sigma), forward primer and 
reverse primer (Sigma), DNA template, and molecular H2O (Sigma). The 
composition of the reaction is shown in table 6.3. Quantitative PCR reactions 
were carried out using the Rotor-gene 6500 (Qiagen) cycler and using the green 
channel for data collection. 
Table 6.3. qPCR assays reactions for single tube and 5 tubes.  
 
 
 
 
 
 
 
6.2.1.6 Melting curve cycling conditions 
The contents of each reaction were labeled and replicate samples grouped 
together using the software. It was necessary to include the dissociation curve 
(melting curve) to check the production of non-specific products when using 
SYBR Green probe (Invitrogen). The melting curve was used to obtain the 
melting temperature (Tm) of the target nucleic acid sequence. The standard PCR 
conditions used for SYBR Green probe cycling were an initial cycle of activation 
at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 15 s, then 
annealing/extension at 60°C for 15 s, followed by a final cycle at 72°C for 15 s. 
Melting curves were plated between 50°C and 99°C.   
qPCR Mastermix 
Volume to add 
for single tube 
10 µl 
Volume to add 
for 5 qPCR tubes 
PCR SensiMix
™
 Probe 5 µl 25 µl 
Primer forward (300 nM) 0.3 µl 1.5 µl 
Reverse primer (900 nM) 0.9 µl 4.5 µl 
Water (H2O) 3.4 µl 17 µl 
DNA template 0.2 µl 1 µl 
TaqMan or SYBR Green (200 nM) 0.2 µl 1 µl 
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6.2.1.7 TaqMan probe assay for qPCR data collection 
The TaqMan probe (Sigma) sequence was designed to quantify 
Capnocytophaga species. The qPCR cycling conditions were an initial cycle of 
activation at 95°C for 10 min, followed by 40 cycles of denaturation at 95°C for 
15 s, then annealing/extension at 64°C for 60 s. 
6.2.1.8 Standard curve for Capnocytophaga species 
Colonies from an agar plate of C. ochracea was suspended in 1 ml of sterile 
RTF. Bacteria were enumerated by plating serial dilutions in phosphate buffer 
saline on fastidious anaerobic agar with 5% defibrinated horse blood and 
incubating for 5 days at 37°C under anaerobic conditions. In order to produce 
standard curves for the enumeration of organisms, DNA extraction was 
performed and by using viable count (CFU/ml), the numbers of cells were related 
to amounts of DNA. Standard curves consisting of six 10-fold dilutions of 
reference DNA were run in triplicate on a Rotor-gene 6500 cycler using the 
green channel for data collection.  
 
6.2.1.9 Reproducibility and Reliability 
To assess the reproducibility of the TaqMan PCR assay. Six ten fold serial 
dilutions of target bacteria were amplified in three separate runs under the same 
conditions. The reliability of the qPCR was evaluated by three amplifications of 
the same dilution range in a single run.  
6.2.1.10 Quantitative PCR analysis of biofilm samples 
One disc of each CDFF experiment (biofilms from two experimental runs used) 
from the previous chapter was used, resulting in 15 samples (6 h, 48 h, 96 h, 
216h, 222 h, 246 h, 366 h, 396 h, 438 h, 510 h, 516 h, 540 h, 588 h, 612 h and 
714 h). The biofilms were centrifuged for 1 min (14600 × g). These had 
previously been stored at -80°C. These were thawed and DNA extracted as 
previously (Chapter 2).  
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6.3 Results 
6.3.1 Agarose gel electrophoresis of PCR products 
The specificity of potential primers for their desired target was assessed using 
conventional PCR against the oral test species. The gel was visualised after 
excitation under UV transillumination by placing it in a multiimage light cabinet 
and the resulting image was captured by a computer software programme 
(AlphaEase™) to confirm that only one product (red arrow) of the appropriate 
length size was obtained as shown in figure 6.3. 
 
Figure 6.3. Gel electrophoresis image of C. ochracea PCR products. Expected 
size by: 224 bp, 1 by: C. ochracea (red arrow). 2 by: F. nucleatum, 3 by: L. casei, 
4 by: V. dispar, 5 by: N. subflava, 6 by: A. naeslundii, 7 by: P. intermedia, 8 by: 
S. sanguinis, 9 by: S. mutans, 10 by: P. gingivalis, 11 by: T. forsythia, and 12 by: 
A. actinomycetemcomitans and M by: Hyberladder I.   
6.3.2 Melting curve 
There was no production of primer dimers or non–specific products using SYBR 
Green assays (Figure 6.4). The data showed the lowest Ct value with the highest 
fluorescent signal (red colour) triplicate samples and negative control samples 
(blue colour) at 60°C annealing temperature.  
The specific TaqMan probe with the primers for Capnocytophaga ochracea were 
found to be specific for their desired target, efficient and amplification specific 
cleavage resulted in a bright, clean and reliable amplification plots (Figure 6.5).  
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Figure 6.5. C. ochracea amplification plot determined by qPCR using primers set 
and TaqMan probe shows the optimal probe concentration given the lowest Ct 
value with the highest fluorescent signal (red colour) triplicate samples and 
negative control samples (blue colour) at 60°C annealing temperature. 
 
Figure 6.4. A SYBR Green melt curve demonstrating the target amplicons have a 
Tm           84˚C. T   y axis represents the derivative of fluorescence changes 
and the x axis represents the temperature (°C). 
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6.3.3 Specificity of primers and TaqMan probe 
The primers (Table 6.2) were tested and optimised for their specificity with the 
other reference strains and the analysis was carried out by qPCR. 
Figure 6.6, shows there is some cross reactivity with V. dispar, F. nucleatum and 
P. gingivalis at 60°C. When the melting temperature was raised to 63°C the 
cross reactivity was reduced and only F. nucleatum was amplified (Figure 6.7). 
No cross reactivity was apparent when the temperature was further increase to 
64°C (Figure 6.8). 
 
 
Figure 6.6. The amplicon of C. ochracea (red colour) is specific at 60°C against 
all strains mentioned in section 6.2.1.1 except V. dispar (blue colour), F. 
nucleatum (yellow colour) and P. gingivalis (black colour).  
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Figure 6.7. The amplicon of C. ochracea is specific at 63°C against all strains 
except F. nucleatum (green colour). 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  
Figure 6.8. The Amplicon is specific for C. ochracea at 64°C against all strains.   
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6.3.4 Standard curve 
In order to measure assay efficiency the relative Ct value for subsequent 
dilutions of Capnocytophaga DNA was plotted and the R2 and slope calculated. 
A measure of whether the standard curve was accurate or not was a distance of 
approximately 3.3 cycles for the cycle threshold between each ten folds dilution 
and an R2 value above 0.98. Each point represents an amount of 
Capnocytophaga DNA corresponding to the Ct value. The relation coefficient of 
straight line was R2 = 0.99139 which is indicated a reliable or stable assay with a 
slope equal -3.649 and Assay efficiency equal 88% (Figure 6.9).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9. The standard curve is linear from 101 to 106 copies of C. ochracea.  
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6.3.5 Quantification of Capnocytophaga species   
Total bacterial were quantified using universal probes and primers for the 16S 
rRNA region as mentioned previously in chapter 5. The Capnocytophaga spp. 
numbers were quantified in biofilm samples from a number of time points from 
the in vitro peri-implantitis model section 6.2.1.10. At 222 h, the change of 
environment to microaerophilic atmosphere with increased introduction of PISF. 
At 516 h, the change of environment to anaerobic atmosphere (Figure 6.10).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Health Peri-implant mucositis Peri-implantitis 
Figure 6.10. Total numbers of bacteria determined by qPCR represented by blue 
bars. Numbers of Capnocytophaga spp. obtained by qPCR are represented by 
the black line. The proportions of Capnocytophaga spp. are represented by the 
yellow line with data labelled. Capnocytophaga spp. error bars represents 
standard deviation (n = 6). Universal error bars represent standard deviation (n = 
9). 
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6.3.6 CDFF peri-implant biofilm communities 
The number of Capnocytophaga were analysed by qPCR over the course of a 
CDFF experiment. The detection limit was reported to be 20 cells (Ciric et al., 
2011). The number of organisms detected by qPCR was lower under conditions 
emulating health. Indeed, Capnocytophaga spp. were not detected until 216 h, at 
which point they represented ca 7.06% of total bacteria. When the conditions 
were altered to emulate peri-implant mucositis, Capnocytophaga spp. 
                     %     10%  i     “  ik ”    366      90.6% (Figure 
6.10).  
The number of Capnocytophaga were found to be higher in condition of peri-
implant mucositis at 390 h and 438 h than under health conditions (Table 6.4). 
When the conditions were altered again to emulate peri-implantitis and indeed 
steady state was attained, the proportion of Capnocytophaga spp. represented 
ca. 83.9% a high proportion of the species present.  
 
Table 6.4. The mean value of Capnocytophaga species investigated by qPCR of 
microcosm biofilms grown in the CDFF under health, peri-implant mucositis and 
peri-implantitis conditions, ± standard deviation (n = 6).   
 
 
 
 
 
 
 
 
Health Peri-implant mucositis Peri-implantitis 
Time Mean ± SD Time Mean ± SD Time Mean ± SD 
6 h 0 222 h 
3.09 × 10
5 
± 3.37 × 10
5
 
516 h 
1.86 × 10
6 
± 2.21 × 10
6
 
48 h 2.37 × 10 
± 5.31× 10
1
 
246 h 
8.97 × 10
5 
± 1.08 × 10
6
 
540 h 
7.15 × 10
5 
± 7.69 × 10
5
 
96 h 3.21 × 10
1
 
± 1.52 × 10
1
 
336 h 
1.99 × 10
6 
± 2.56 × 10
6
 
588 h 
2.62× 10
6 
± 2.91 × 10
6
 
216 h 1.20 × 10
6 
± 1.30 × 10
6
 
390 h 
5.32 × 10
6 
± 5.82 × 10
6
 
612 h 
3.41 × 10
6 
± 3.69 × 10
6
 
  438 h 
2.05 × 10
6 
± 2.28 × 10
6
 
714 h 
2.14 × 10
6 
± 2.89 × 10
6
 
  510 h 
1.27 × 10
6 
± 1.54 × 10
6
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6.4 Discussion 
Per-implantitis is clinically observed as an inflammatory condition of the 
supporting structures of dental implants that leads to progressive degradation of 
bone tissue and subsequent loss of implants (Mombelli and Décaillet, 2011). The 
microbiota associated with peri-implantitis is varied (Augthun and Conrads, 1997, 
Koyanagi et al., 2010, Koyanagi et al., 2013) and include Capnocytophaga spp., 
which play an important role in the onset of periodontal disease (Ciantar et al., 
2001b). Recently, qPCR techniques have been developed for providing better 
detection for oral pathogens (Boutaga et al., 2007) and qPCR assays are 
powerful and convenient tools that allow quantification and identification in a 
single assay (Suzuki et al., 2004).  
One of the most abundant groups of bacteria identified by 16S rRNA gene 
cloning and sequencing in biofilms grown under peri-implantitis conditions were 
Capnocytophaga species (Chapter 4). Therefore, due to the interest in this 
species, primers were developed for use in Taqman qPCR assays. A crucial 
aspect of qPCR is the design and testing of primers and probes based on the 
nucleotide sequence of the target organism. To be successful, qPCR assays 
depend on the relative concentration of primers, the probe concentration, PCR 
buffer concentration, probe design (with locked nucleic acids bases), cycling 
temperatures and amounts of DNA template.  
Chapter 5 utilised existing primer sets developed at the Eastman Dental Institute 
(Ciric et al., 2011) for a wide variety of organisms. These allowed the study of 
absolute numbers and changes in proportions of specific species in oral biofilms 
in an in vitro model before and after their exposure to the anti-plaque agent, 
chlorhexidine (Zaura et al., 2011, Ciric et al., 2011). 
In this part of study two strategies were employed. Firstly, to design specific 
primers for Capnocytophaga spp. that did not cross-react with sequences from 
non-target organisms. It is difficult to identify specific nucleotide sequences or to 
distinguish the 16S rRNA genes of closely related species. In fact, the 
microorganisms in dental plaque are characterised by a number of closely 
related species (Spratt, 2004). Furthermore, identification of these organisms by 
culture and by PCR is difficult due to a high degree of genetic and phylogenetic 
similarity with other species (Pratten et al., 2003). For example, F. nucleatum is 
genetically very closely related to C. ochracea, which show cross reactivity with 
other taxa including: V. dispar and P. gingivalis 
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16S rDNA of bacterial sequences were aligned and regions of homogeneity 
within the genus were identified. Once these were identified oligonucleotide 
primers and the probe set targeting 16S signature sequences were designed 
using primer software v.4.0. These were then tested in silica by comparing 
against the sequences within 16S rDNA databases using a similarity search 
program to see if they cross-reacted with other taxa. The primers listed, on Table 
6.1, were designed for the target microorganisms. The specifity of the primers for 
the target sequence was determined against target strains and with other 
references showed that some of primers pairs had cross reactivity. Therefore, an 
alternative forward (357 F Lane, 1991) primer and reverse primer was suggested 
by Dr David Spratt (data not published, previously designed for endpoint PCR 
detection of Capnocytophaga species). These primers were specific when 
assessed by conventional PCR and with a probe for qPCR. Analysis of the 
melting curve showed no production of non-specific products which would 
interfere with the results. The standard curve efficiency was found to be < 90%. 
The reason for the low efficiency of the assay could be due to the length of the 
amplicons (Ciric et al., 2010); this was approximately 224 bp, based on the 16S 
rRNA gene.  
At each cycle, the accumulation of PCR products was detected by monitoring the 
increase in fluorescence of the reporter dye, and double stranded DNA binding 
SYBR green. After the PCR, melting curve results showed no production of 
primer dimers or non–specific products and the specific probe showed no cross 
reaction at 64°C. All the reactions were analysed using the Rotor-gene 6500 
cycler (Qiagen). Furthermore, their specificity was thoroughly tested by both 
conventional PCR (Figure 6.4) and qPCR, demonstrating the suitability for 
detection of target microorganism (Figures 6.5 - 6.8).  
Capnocytophaga spp. were detected in the samples at a number of time points 
and became a significant part of the microbiota at later time points under peri-
implantitis conditions. The most significant observation from this study was that 
the results of the qPCR confirmed the trend observed by 16S ribosome RNA 
gene cloning and sequencing at same sampling points (Chapter 4). A greater 
proportion of Capnocytophaga spp. were identified under peri-implant mucositis 
conditions at 246 h and 438 h, where Capnocytophaga spp. accounted for ca. 
12%. Under peri-implantitis conditions, Capnocytophaga spp. accounted for ca. 
27% at 450 h and 714 h using cloning and sequencing (Chapter 4). The 
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proportion of these species was very low at 6 h, 48 h and 96 h under health 
condition and this would be expected, as Capnocytophagae spp. are generally 
undetectable in the health community with streptococci etc. dominating early oral 
biofilms (Marsh, 2010). It can be postulated that under health conditions the 
numbers of Capnocytophaga spp. were below the detection limit i.e. less than 
20. Once disease conditions were implemented, the numbers increased, 
probably as a result of the altered environmental conditions at 246 h and 438 h. 
In terms of the changes in the communities associated with environmental 
conditions emulating health and disease, the proportion of Capnocytophaga 
species was shown to be different between peri-implant mucositis and peri-
implantitis, This present study confirmed the trend observed by 16S ribosome 
RNA gene cloning and sequencing and results were also supported by CLSM 
data which showed large numbers of Capnocytophaga like rods in biofilms grown 
under peri-implantitis conditions (Chapter 4).   
6.5 Conclusion 
A primary aim of the CDFF for assessing the dental plaque associated with peri-
implantitis was to test antimicrobial agents for their efficacies against the buildup 
of plaque. The use of qPCR to assess the Capnocytophaga spp. and other taxa 
in communities perturbed by in antimicrobials will allow the fast and accurate 
assessment of the effects of these compounds on the population. It was shown 
that qPCR primer design for specific taxa is achievable in the context of a project 
such as this and has allowed analysis of complex communities. It also allows the 
primer set to be used in any in vitro or indeed ex-vivo samples for detection and 
quantification of Capnocytophaga species. Furthermore, these data give 
credibility to the ecological plaque hypothesis. It has been shown that the 
number of bacteria of a specific species is able to increase from below 
detectable levels (reported here to be less than 20) to become predominant 
species under disease conditions in a closed environmental situation.   
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Chapter 7 
An in vitro assessment of antibacterial treatment strategies, which are 
currently available against peri-implantitis biofilms 
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7.1 Introduction 
In previous chapters, an array of methods was employed for targeted 
identification of microorganisms associated with healthy peri-implants, peri-
implant mucositis and peri-implant disease using an in vitro model. These 
techniques showed that the in vitro model of peri-implantitis which has been 
developed appears to be a valid simulation of the dynamic bacterial biofilm which 
exists on dental implant surfaces. The ultimate aim of developing such a 
reproducible and realistic model of these conditions was to utilise the model to 
determine the efficiency of current and novel decontamination therapies.  
The accumulation of bacterial biofilms has been defined as a primary etiological 
factor for the development and progression of peri-implant infections (Mombelli 
et al., 2012). Changes in the microbial composition of plaque such as an 
increase in Gram-negative anaerobic bacteria can lead to peri-implantitis 
(Mombelli and Décaillet, 2011). The imbalance between microbial load and host 
defence may then lead to implant infection, which in turn results in the loss of the 
supporting bone and ultimately, lost of dental implants (Heitz-Mayfield, 2008, 
Scarano et al., 2004). In addition to streptococci, the fusobacteria and especially 
Fusobacterium nucleatum are known to play a significant role in plaque 
development as they are able to co-adhere to many oral microorganisms. 
Renvert et al. (2007) reported that Neisseria mucosa, F. nucleatum and 
Capnocytophaga spp. predominantly occurred within implant submucosal sites.  
In the development of peri-implantitis infections, the roughness of the implant 
surface plays an important role in the formation of biofilms. Albrektsson and 
Wennerberg (2004), defined smooth surfaces as having an average roughness 
(Sa) value of < 0.5 µm, minimally rough surfaces having an of Sa 0.5 -1 µm, 
moderately rough surfaces having an Sa 1 - 2 µm and rough surfaces having an 
Sa > 2 µm.  
Rough surfaces of crowns, implant abutments, or prostheses bases accumulate 
and harbour significantly more plaque biofilms than smooth surfaces. Polished 
implant surfaces have shown less plaque accumulation than sand-blasted and 
acid–etched implant surfaces (Schwarz et al., 2006). A review by Renvert et al. 
(2011) confirmed this finding and they concluded that implants with rough 
surfaces were more likely to lead to peri-implantitis. It has been reported by 
Quirynen and Bollen (1995) that up to 25 times more bacteria adhere to rough 
surfaces than smooth ones. This is because rough surfaces provide niches that 
protect bacteria from host defences and routine oral hygiene treatments 
(Quirynen et al., 2002). 
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The removal of biological contamination from structured implant surfaces is 
difficult to achieve. As with periodontal diseases, various therapies have been 
proposed to reduce the number of pathogenic species and improve clinical 
parameters of peri-implant diseases (Klinge et al., 2002, Roos-Jansåker et al., 
2003, Mombelli et al., 2001). Indeed, several methods have been applied to 
remove supra and subgingival plaque biofilm for implant disinfection (Schwarz et 
al., 2005). These methods include use of polishing brushers, rubber polishers, 
teflon, plastic, carbon or titanium curettes, special modified tips for ultrasonic 
systems, and air powder flows (Augthun et al., 1998, Fox et al., 1990), 
burnishing with cotton pellet soaked in water, citric acid, or using air powdered 
abrasives. A potential disadvantage of conventional ultrasonic systems might be 
related to the working tip which may cause loss of osseointegration at advanced 
defect sites (Braun et al., 2005). Furthermore, all surfaces treated with ultrasonic 
systems showed conspicuous surface damage (Schwarz et al., 2004).  
Air powder flow can be associated with an increased risk of emphysema on 
clinical application and damage to the implant micro-topography (Schwarz et al., 
2009). Persson et al. (2001) reported a lack of re-osseointegration at implants 
sites receiving surface decontamination using either abrasive pumice with a 
rotating tooth brush or cotton pellets soaked in sterile saline in an animal model. 
Instrumentation with metal curettes can remove the edge of irregularities but 
often damage machined titanium surfaces resulting in scratches and modification 
of the surfaces (Rühling et al., 1994).  
Citric acid can be effective in inhibiting multispecies biofilms. However, acid 
chemotherapeutic agents have an irritating effect if applied in contact with 
gingival tissues for prolonged periods. Valenza et al. (1987) have shown that 
application of citric acid to the gingiva with periodontal disease for 5 and 10 min 
caused diffuse edema with cytologic alterations. Other in vitro studies 
determined that bacterial lipopolysaccharides can be removed from structured 
implant surfaces following application of citric acid, tetracycline HCL, CHX, 
hydrogen peroxide, chloramines-T, sterile sodium solution, modified ultrasonic 
systems or air powder flows (Kreisler et al., 2005). In this context, there is the 
potential risk of damage to the implant micro-topography following application of 
these chemicals (Kreisler et al., 2005). Other agents such as hydrogen peroxide 
are also harmful to the cell membrane integrity and cause irreparable biological 
damage (Braun et al., 2005). Using an animal model, Kim et al. (2012) found that 
contaminated implants swabbed with saline showed increased bone 
regeneration on fresh sockets compared to contaminated implants swabbed with 
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10% of H2O2 where inflammation who observed around the implants and less 
osseointegration. 
Besides the mechanical removal of biofilms, lasers have been introduced as a 
potential alternative in reducing pathogen levels on implant surfaces. For 
example, solid state lasers such as Er:YAG lasers have been considered 
promising therapies for peri-implant disinfection (Kreisler et al., 2002). However, 
a different approach again is the use of lasers as a potential therapeutic method 
for decontamination of implants (photodynamic therapy; PDT). PDT employs a 
non toxic dye, termed a photosensitizer, and low intensity visible light (660-905 
nm). PDT has the potential to be important in several clinical applications such 
as disinfection of root canals, periodontal pockets, and carious lesions. In the 
periodontal field, PDT has shown efficiency in the treatment of periodontitis and 
peri-implantitis in animal models and clinical trials (Dörtbudak et al., 2001). PDT 
offers the advantages in that the photosensitizer can be targeted to its cell or 
tissue and illumination can be spatially directed to the lesion. It has been 
reported that bacterial killing by the photochemical reaction is mainly caused by 
damage to the bacterial cytoplasmic membrane, leading to DNA damage 
(Konopka and Goslinski, 2007). The results of a number of in vitro studies have 
demonstrated the effective and efficient use of PDT for periodontal and peri-
implant diseases (Takasaki et al., 2009). However, sufficient clinical and 
microbiological data that support the effect of PDT for non-surgical periodontal 
treatment has not been demonstrated.  
Finally, antimicrobial substances, as well as local or systemic antibiotics can be 
applied as adjunctive measures the treatment of peri-implant infections. CHX is 
still considered a “gold standard” among oral antimicrobial agents. Chlorhexidine 
is a broad spectrum antimicrobial that is active against a wide range of Gram-
positive and Gram-negative supragingival and subgingival plaque bacteria and 
fungi (Lee et al., 2005). The mode of action of CHX is by causing damage to the 
microbial cell membrane, leading to cytoplasmic leakage. The agent is frequently 
employed as a rinsing solution (0.1 - 0.2%). Nevertheless, several studies have 
demonstrated that this compound may have an adverse effect on oral tissues. 
For example, direct application of CHX during regenerative treatment of peri-
implantitis leads to toxic effects on gingival fibroblasts, osteoblasts and 
endothelial cells; thus inhibiting the early healing phase of peri-implantitis 
(Giannelli et al., 2008).  
Different treatments of titanium surface can modify the implant microstructural 
properties that in turn are able to affect bone formation processes. According to 
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Renvert et al. (2009), re-osseointegration is defined as the formation of new 
bone on to a previously biofilm contaminated implant surfaces, and this is the 
aim of treating peri-implantitis. Cooper et al. (1999), concluded that an increase 
in surface roughness of titanium implants improved bone integration, and surface 
roughness is known to have positive impact on the bone to implant contact 
(Shalabi et al., 2006). In contrast to the surface of natural teeth, surfaces of 
modern implants are highly micro-structured and macro-structured to improve 
osseointegration. However, as previously discussed rough surfaces facilitate 
initial microbial adhesion and formation of complex biofilms, and make sufficient 
debridement of implant surfaces very difficult. Furthermore, effective periodontal 
debridement of pathogenic biofilms on rough titanium implant surfaces is nearly 
impossible to achieve in daily practice because of the textured surface and the 
screw-shaped design of the implants. All the previously described therapies have 
shown efficiency in decontamination, but have failed in their ability to also restore 
biocompatibility (Schwarz et al., 2012). This work is the first to assess the effects 
of specific treatments on in vitro biofilms cultured under conditions of peri-implant 
mucositis and peri-implantitis. 
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7.1.1 Objectives 
This study evaluated the efficiency of current and novel treatment modalities for 
the elimination of biofilms on different titanium surfaces using an in vitro model of 
peri-implantitis.  
 
The CDFF in vitro model of peri-implant infection was used to investigate: 
a. The viable numbers of facultative anaerobes, Gram-negative anaerobes, 
Staphylococcus spp. and Candida spp., remaining on three different titanium 
surfaces (polished, SLA and SLActive) following a range of decontamination 
regimes. 
b. The remaining biofilm on titanium discs post-treatment. This was analysed 
using CLSM and Baclight™ viability staining and the biofilm thickness was also 
determined. 
c. The surface biocompatibility, which was analysed by culture of MG-63 cells 
(osteosarcoma cell line) on three different titanium surfaces; polished SLA and 
SLActive following a range of decontamination regimes. 
d. Cell morphology following a range of decontamination regimes was analysed 
by scanning electron microscopy (SEM). 
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7.2 Materials and Methods 
7.2.1 Commercial titanium (Ti) discs 
Standard Ti discs were provided by the Straumann Company (Basel, 
Switzerland). These discs were 5 mm in diameter and 0.1 mm thick, and 
exhibited three different surface characteristics polished, Sand blasting acid 
etching (SLA) and Sand blasting acid etching active (SLActive). For the polished 
surface, discs with surface roughness of 0.2 µm were used with an arithmetic 
mean surface roughness Ra value of < 0.5 µm, this polished surface was 
considered smooth. SLA (sand blasted, large grit, acid etched) has a moderately 
rough surface, with an Ra equal to 1.75 µm. The SLA surface is produced by a 
large grit sand-blasting process with corundum particles that leads to a 
macrorughness on the titanium surface. This is followed by treating with a strong 
acid-etching bath with a mixture of HCl/H2SO4 at elevated temperature for 
several minutes.  
This process produces fine micropits superimposed on the rough blasted 
surface; the chemical composition of SLA surface structure is titanium oxide. 
SLActive (a surface modification of SLA with the same surface roughness) is 
manufactured by rinsing the titanium surface after the etching procedure under 
nitrogen (N2) protection and continuous storage in an isotonic sodium chloride 
(NaCl) solution. This modification results in a hydroxylted/hydrated and highly 
hydrophilic surface (Rupp et al., 2002). 
 
7.2.2 Microcosm biofilms 
Aliquots of 1 ml of pooled saliva were dispensed into 1.5 ml cryotubes and stored 
at -80°C for subsequent use (Chapter 2). The CDFF microcosm biofilms were 
grown and evaluated at two time points: 
366 h representing a peri-implant mucositis associated biofilm. 
612 h representing a peri-implantitis associated biofilm.  
 
7.2.3 Medium and Inoculum 
The medium used in the CDFF was artificial saliva with a composition identical to 
that previously described (Chapter 2, Section 2.1). This consisted of mucin 
containing artificial saliva and peri-implant sulcular fluids (used to provide 
nutrients present in tissue exudates, which are major component of peri-implant 
sulcular fluid)  
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7.2.4 CDFF set up 
A CDFF was used as described previously in Chapter 2, Section 2.2.1. The 
CDFF containing its pans was autoclaved at 121°C for 15 min and discs were 
then added aseptically to the pans through the sampling port (Figure 7.1). 
Sample discs were carefully placed on to five plugs with a pair of sterile titanium 
tweezers without touching the surfaces. During all experiments, the CDFF was 
maintained at a constant temperature of 37°C. A vial of 900 µl of stored pooled 
saliva was thawed and used to inoculate 500 ml of artificial saliva. This was 
mixed and pumped into the CDFF for 6 h at a flow rate of 1.38 ml/min. The 
inoculation flask was then disconnected and the CDFF was fed from a medium 
reservoir of sterile artificial saliva. The artificial saliva was circulated via a 
peristaltic pump at a flow rate of 0.72 l day-1 which was representative of the 
daily salivary flow rate (Pratten et al., 1998). 
 
  
 
  
Figure 7.1. The CDFF containing pans were autoclaved at 121°C for 15 min. A. 
The Ti discs were added aseptically to the pans through the sampling port with a 
flat-ended tool inside a flow cabinet. B. The pan was tapped down to the level of 
the turntable with a flat-ended tool. 
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7.2.5 In vitro model parameters 
The titanium discs were placed on PTFE plugs and held in place using vacuum 
silicone grease. The discs were recessed to a depth of 600 µm using sterile 
titanium tweezer without touching the top of the disc surfaces. The pan was 
tapped down to the level of the turntable with a flat-ended tool. Biofilms were 
removed during experiments via a port in the top plate using a flat-ended tool 
inserted into a tapped hole in the centre of the film pan. Extracted biofilms were 
subjected to various analyses (Figure 7.1). 
 
7.2.6 Conditions used for running the CDFF 
Conditions associated with healthy dental implants, peri-implant mucositis and 
peri-implantitis were generated as previously described (Chapter 2, section 
2.2.5). 
 
7.2.7 Titanium surface decontamination 
Each of the discs removed from the CDFF was allocated to a specific treatment 
including an untreated control group. In the treatment group, discs were 
subjected to non-mechanical, mechanical or both non-mechanical and 
mechanical decontamination measures. The non-mechanical decontamination 
therapy was the application of reduced transport fluid, 0.2% chlorhexidine 
mouthwash or photodynamic therapy (PDT). The mechanical decontamination 
group consisted of titanium brush (TiBrush) supplied by Straumann® and 
combined use of titanium brush and photodynamic therapy (TB + PDT). 
 
7.2.7.1 Non-mechanical cleaning 
7.2.7.1.1 Reduced transport fluid (control untreated biofilms) 
In the control group, the disc was left completely immersed in reduced transport 
fluid for 60 s. Once removed, the disc was then immersed in post treatment 
reduced transport fluid for serial dilution. 
 
7.2.7.1.2 Chlorhexidine 
For this study, the chlorhexidine used was Corsodyl (Chlorhexidine Digluconate 
0.2% w/v; GlaxoSmithKline, Brentford, UK). The discs were completely 
submerged for 60 s in 1 ml of chlorhexidine. Following treatment, the discs were 
dipped into post-treatment in RTF to remove excess chlorhexidine. The 
chlorhexidine concentration was chosen as this was the concentration employed 
Chapter 7: An in vitro assessment of antibacterial treatment strategies 
 
218 
 
in the standard clinical procedure to manage peri-implantitis patient’s protocol for 
management of patients with peri-implantitis (Salvi et al, 2007; Bürgers, 2012). 
 
7.2.7.1.3 Photodynamic therapy (PDT) 
The photosensitiser used was 3, 7-Bis (dimethyl-amino) phenazathionium 
chloride trihydrate (methylene blue) (Sigma) at a concentration of 0.005% (w/v). 
This was prepared in sterile water and kept in the dark at room temperature. 
Methylene blue (0.5 ml – 1.0 ml) was then added to the disc and left in situ for 60 
s prior to irradiation.  
7.2.7.1.3.1 Light Source 
A pulsed diode soft laser (Periowave™, Figure 7.2) with a wavelength of 660 - 
675 nm and a power output of 13.68 J/cm2 for 60 s, was used for all the 
irradiation experiments. The power output was measured using a TPM-300 
thermopile power meter (Genetic-eo, Québec, Canada). A uniform light 
distribution was emitted from the tip of the laser at a fixed distance of 1 cm from 
the disc. Static irradiation for the entire disc was completed in 60 s. The 
methylene blue was then removed. 
 
 
 
 
 
 
 
Figure 7.2. Periowave photodisinfection system. 
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7.2.7.2 Mechanical cleaning 
7.2.7.2.1 Titanium brush (TB) 
The titanium coated brush (Figure 7.3) manufactured by Struamann, has a shank 
of approximately 10 mm in length and the end bristle was fitted to a slow speed 
NSK Contra angle handpiece (ERI 6i 16:1).  
The hand piece was attached to the portable NSK Mio Coreless Micromotor 
System (120V). Mechanical decontamination was carried out at the selected 
speed at 300 rpm for 60 s. To avoid contact on the surface of interest, the disc 
was placed into a sterile petri dish and held with sterilize titanium tweezer from 
their edges to prevent movement during decontamination process. During 
brushing, the plate was filled with approximately 5 ml of RTF, to allow the surface 
of the disc to be irrigated continuously to emulate the irrigation with clinical 
conditions. (Note: one TiBrush was used to decontaminate two discs and then 
discarded). 
 
 
 
 
  
 
  
 
 
 
  
A 
D 
C B 
Figure 7.3. A. The Straumann TiBrush; B. The titanium brush (manufactured by 
Straumann); C. Slow speed NSK Contra angle handpiece (ERI 6i 16:1); D. 
Portable NSK Mio Coreless Micromotor System (120V). 
 
Chapter 7: An in vitro assessment of antibacterial treatment strategies 
 
220 
 
7.2.7.2.2 Combination of titanium brush followed by photodynamic therapy 
(TiBrush + PDT) 
Similar to the methods described above, a combination technique was applied, 
which first used the Straumman titanium brush for 60 s to disrupt and remove the 
biofilm, followed by PDT for 60 s. The methylene blue was removed by 
repeatedly dipping into RTF to ensure removal of the photosensitiser. 
 
7.2.8 Biofilm sampling 
Biofilms sampling have been described previously (chapter 2 section 2.2.4) and 
these were employed with minor modification. The titanium discs were 
aseptically removed and subjected to the appropriate decontamination method 
(or placed in 1 ml RTF in the case of the control). The biofilm was then removed 
from the discs by vortex mixing with glass beads (5 beads of 3 mm diameter per 
disc) for 1 min. The recovered biofilm suspension was then serially diluted up to 
107 fold and 20 aliquots were spread in duplicate onto appropriate media to give 
viable counts. The biofilm microorganisms were cultured on fastidious anaerobic 
agar culture media, Gram-negative anaerobe culture media, mannitol salt culture 
media for isolation of Staphylococcus spp. and Sabourauds dextrose culture 
media for isolation of Candida species. All plates were incubated aerobically for 
48 h with 5% CO2, except fastidious anaerobic agar and Gram-negative 
anaerobic agar which were incubated for 4 to 5 days under anaerobic conditions. 
Following appropriate incubation, the colonies were counted (CFU/biofilm) and 
used to calculate the viable counts (CFU/biofilm) of different species.  
 
7.2.9 Confocal laser scanning microscope 
The structure of CDFF biofilm has previously been studied using confocal laser 
scanning microscopy (CLSM). The current research used CLSM to analyse 
those biofilms grown under peri-implantitis conditions. The aim of this study was 
to contribute to the limited knowledge of biofilm structures following treatment 
therapies. For microscopy observations, discs harbouring biofilms were carefully 
held with sterilize forceps and processed. Each biofilm was subsequently 
immersed in 5 ml solution of RTF with Baclight™ viability staining and stored in a 
dark place, covered with foil for 15 min. Each biofilm was analysed by Image J in 
combination with Image analysis software for investigation of microbial biofilms. 
The cell counting function was used to measure total bacterial biomass and the 
distribution of the green (live) channel and red (dead) channel in one image. 
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Other colours such as cream colour were considered as dead or dying (Chávez 
de Paz, 2009). 
 
7.2.10 Biocompatibility test 
An Alamar blue assay was used to assess metabolic activity of the MG-63 cells. 
Alamar blue is a dye that is used to assess the metabolic activity of MG-63 cells 
by functioning as an oxidation–reduction indicator. Alamar Blue dye is reduced 
from blue to a pink fluorescence by live cells. The oxidation-reduction process is 
based on the detection of the level of oxidation. The level of fluorescence was 
monitored at 530 nm excitation and 590 nm emission wavelength.  
 
7.2.10.1 Standard curve of MG-63 cells 
The cell media were first removed and 900 µl of fresh culture media was added 
to each well of a 24-well plate containing MG-63 cells. One well devoid of MG-63 
cells served as a control. Subsequently, a 100 µl of Alamar blue was added to 
each well and incubated for exactly 4 h in incubator at 37°C. After 4 h incubation, 
2×100 µl were taken from each well and transferred to a black 96 h well plate. 
The fluorescence was measured immediately (Luminoskan Ascent Microplates 
Reader, Labsystems, UK) at 530 nm excitation wavelength and 590 nm emission 
wavelength using software Ascent version 2.4.   
 
7.2.10.2 MG-63 cells on decontamination surfaces 
Once the surface decontamination had been performed, discs from both test and 
control groups were irradiated with UV (254 nm wavelength; 230 V, 50 Hz) for 30 
min per side prior to cell culture. MG-63 cells were cultured and maintained in 75 
cm² flask in 500 ml of Dulbecco’s modified Eagle medium (DMEM; Gibco, 
Paisley, UK) containing 10% fetal bovine serum (FBS; Gibco), 1% penicillin-
streptomycin, at 37°C in 5% CO2 incubator. The medium was changed every 48 
h – 72 h. The cells were washed with phosphate-buffered saline (PBS; Gibco) 
and detached with trypsin-EDTA solution (0.25% trypsin-EDTA; Gibco) at 37°C 
for 2 min. Once trypsinised, the cells were counted using a coulter-counter via 
haemocytometer using trypan blue. The MG-63 cells were then seeded onto the 
discs in a 48-wells plate, at a concentration of 2500 cells/disc and incubated for 4 
h at 37 °C. The culture medium was added to ensure that the final volume of 
each well was 200 µl and the preparation was incubated at 37°C. The MG-63 
cells were incubated and aliquots harvested at different time periods (day 1, 4 
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and 7) for the Alamar blue assay as shown in figure 7.4 and figure 7.5. All 
subsequent experiments were performed in duplicate. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4. A. MG-63 cells were placed onto a disc; B. 200 µl of culture 
medium was added after 4 h of incubation of MG-63 cells. 
 
Figure 7.5. 20 µl of Alamar blue was added into the medium and 
incubated for 4 h prior to fluoroscan assay. 
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7.2.10.3 Fluoroscan assay 
After 24 h, the 48 well plates were removed from the incubator. To each well, 20 
µl of Alamar blue was added to the medium giving a final concentration of 10% 
v/v). After incubation for 4 h at 37°C, 100 µl of medium was removed and the 
optical densities of each sample were read at 530 nm (excitation wavelength) 
and 590 nm (emission wavelength) on a micro-plate reader (Flouroscan II). 
Fluorescence was measured in arbitrary fluorescent units. A control using just 
MG-63 cells and Alamar blue was also prepared. The same steps were repeated 
for data collection on day 4 and day 7. Once the samples for the reading were 
collected, the medium in each experimental well (containing the disc) and control 
well was changed. The existing medium was removed and replaced with 200 µl 
of medium. The plate was then returned to the incubator until the next sampling 
point. For the control group, the same protocol was applied, except that the 
surfaces had not previously been inoculated with biofilm. Sterile discs were 
placed in the well plate, exposed under the UV radiation as described previously 
prior to cell culture (Figure 7.6). 
 
 
 
 
 
  
 
 
 
 
 
 
 
7.2.10.4 Scanning electron microscopy (SEM) 
SEM was used to investigate osteoblast morphology in the presence of biofilm 
(control), sterilised discs and those 'decontaminated' by the three specific 
approaches. Analysis by field emission scanning electron microscopy (FE-SEM) 
for the discs cultured under conditions of peri-implantitis was performed. 
These discs were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 
7.4) and stored at - 4°C for 1 week. They were dehydrated for 10 mins in a 
graded series 50%, 70%, 90% and twice in 100 % of ethanol, treated with 
A B 
Figure 7.6. A. 100 µl of sample (medium and Alamar blue) was 
removed and placed into each well of 96 wells. B. The optical 
densities of each sample were read at 530 nm (excitation) and 590 nm 
(emission) on a micro-plate reader (Fluoroscan II). 
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isoamyl acetate for 1 min, and then sputter-coated with gold and the surface and 
cellular morphology was observed. Images of the discs with and without biofilm 
following the various decontamination regimes were obtained both without biofilm 
and with biofilm and following decontamination regimes. 
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7.3 Results 
7.3.1 Cultural analysis 
Culture-based analysis of the inoculum showed the total number of 
microorganisms for the targeted groups were ca. 107 CFU/ml (Gram-negative 
anaerobic bacteria), ca. 106 CFU/ml (Candida) and ca. 102 CFU/ml 
(staphylococci) (Table 7.1). 
 
Table 7.1. The mean ± standard deviation of CFU/ml (n = 4) of the salivary 
inoculum. 
 
 
 
 
 
 
 
 
 
 
 
7.3.2 Substratum  
7.3.2.1 Peri-implant mucositis conditions 
The biofilm CFU/ml data revealed some differences between treatments and 
between biofilms when grown on the three different surfaces. The culture data 
for the various decontamination regimes with error bars representing the 
standard deviation for 366 h peri-implant mucositis microcosm are shown in 
figures 7.7, 7.8 and 7.9. 
 
Polished Surface (Fig 7.7) 
Compared with the control, reduced numbers of anaerobic bacteria and Candida 
were evident when the combined technique, PDT or CHX treatments were used. 
There was reduction of anaerobe spp., Candida spp. between control and 
TiBrush. There was reduction of Gram-negative anaerobe spp. between control 
and combined techniques, and CHX. There was reduction of Staphylococcus 
spp. between control and all decontamination regimes. From these data it is 
shown that CHX and combined technique (TiBrush and PDT) were the most 
efficient decontamination regimes. 
Bacteria species Mean (CFU/ml) ± SD 
Anaerobe spp. 1.85 × 10
7
 ± 3.19 × 10
6
 
Gram-negative anaerobe spp. 8 × 10
6 
± 7.60 × 10
6
 
Candida spp. 3.31× 10
6
 ± 9.90 × 10
5
 
Staphylococcus spp. 3.75 × 10
2
 ± 2.50 × 10
2
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SLA Surface (Fig 7.8) 
Compared with control surfaces, there was a reduction in the total number of 
anaerobic bacteria, Gram-negative anaerobic bacteria, and Candida on surfaces 
treated with the combined technique, Tibrush and PDT. There was reduction of 
Staphylococcus spp. between control and TiBrush, PDT. Compared with the 
control, there was a reduction in the number of staphylococci when surfaces 
were treated with CHX. From these data it was shown that the TiBrush was the 
most efficient decontamination regime. 
 
SLActive Surface (Fig 7.9) 
Compared with control surfaces, reduction in the numbers of anaerobic bacteria, 
Gram-negative anaerobic bacteria, Candida and staphylococci occurred 
following application of the combined technique, TiBrush and PDT. A reduction in 
the number of staphylococci, Candida, anaerobic bacteria and Gram-negative 
anaerobic bacteria was also evident when surfaces were treated with CHX. From 
these data it was shown that a combined technique (TiBrush and PDT), TiBrush 
and PDT were the most efficient decontamination regimes. 
 
Significant differences were found between biofilms when grown on the 
three different surfaces under peri-implant mucositis at 336 h.  
On all surfaces, a reduction in the number of CFU/ml of anaerobe bacteria was 
observed between the polished surface and both the SLA surface and SLActive 
surface. Lower numbers of Gram-negative anaerobic bacteria were evident on 
polished surfaces compared with both SLA and SLActive surfaces. There were 
no differences between Candida spp. and Staphylococcus spp. numbers on all 
three surfaces.  
Overall, these data show that the lowest number of microorganisms in mature 
biofilms (366 h) occurred on polished surfaces, with comparably higher numbers 
present on the SLA and SLActive surfaces.  
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Figure 7.7. The composition of the biofilm microorganisms (CFU/ml) after 
decontamination techniques on polished titanium surfaces under peri-implant 
mucositis conditions. Error bars represent standard deviation (n = 4). 
  
 
Figure 7.8. The composition of the biofilm microorganisms (CFU/ml) after 
decontamination techniques on SLA titanium surfaces under peri-implant 
mucositis conditions. Error bars represent standard deviation (n = 4). 
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Figure 7.9. The composition of the biofilm microorganisms (CFU/ml) after 
decontamination techniques on SLActive titanium surfaces under peri-implant 
mucositis conditions. Error bars represent standard deviation (n = 4). 
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7.3.2.2 Peri-implantitis conditions 
Analysis of the biofilm CFU data revealed some significant differences between 
treatments and between biofilms between biofilms cultured on the three different 
surfaces. The culture data (CFU/biofilm) for the various decontamination regimes 
with error bars representing the standard deviation for 612 h peri-implantitis 
microcosm (Figures 7.10, 7.11 and 7.12). 
 
Polished Surface (Fig 7.10) 
Compared with the control surfaces, treatment with the TiBrush, combined 
technique or PDT resulted in reduced numbers of anaerobic bacteria, Gram-
negative anaerobic bacteria, Candida and staphylococci. In addition, compared 
with the control, a reduction in the number of these same groups of 
microorganisms was evident following CHX treatment. From these data, the 
TiBrush was deemed as the most efficient decontamination regime. 
 
SLA Surface (Fig 7.11) 
There was reduction in the number of anaerobe spp., Gram-negative anaerobe 
spp., Candida spp., Staphylococcus spp. between control and combined 
techniques, PDT, TiBrush and CHX. From these data, the combined technique 
(TiBrush and PDT) was the most efficient decontamination regime. 
 
SLActive Surface (Fig 7.12) 
Lower numbers of anaerobic bacteria, Gram-negative anaerobic bacteria, 
Candida and staphylococci were evident on the SLActive surfaces after use of 
the combined technique (TiBrush and PDT) or TiBrush compared with the 
control. 
The difference in microbial numbers was found between biofilms cultured on the three 
different surfaces under peri-implantitis conditions at 612 h. comparing the levels 
of microorganisms for the untreated control surfaces, it was apparent that the 
numbers of anaerobic bacteria were lower on the polished surface compared 
with the SLActive surface. No other differences were evident between surfaces. 
 
Overall, these data show that polished surfaces were different from SLActive 
surfaces, whilst no difference was evident between SLA and SLActive surfaces. 
Also, polished surfaces were not different from SLA surfaces.  
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Figure 7.10. The total counts of biofilm microorganisms (CFU/ml) after 
decontamination techniques on polished titanium surfaces under peri-implantitis 
conditions. Error bars represent standard deviation (n = 4).  
 
Figure 7.11. The total counts of biofilm microorganisms (CFU/ml) after 
decontamination techniques on SLA surfaces under peri-implantitis conditions. 
Error bars represent standard deviation (n = 4).   
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Figure 7.12. The total counts of biofilm microorganisms (CFU/ml) after 
decontamination techniques on SLActive surfaces under peri-implantitis 
conditions. Error bars represent standard deviation (n = 4). 
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7.3.3 Biofilm analysis using CLSM 
Biofilms grown on polished, SLA and SLActive surfaces were analysed by Image 
J in combination with an investigation of total biomass (a volume/area of 
fluorescence) were analysed using the Bioimage-L software package. The cell 
counting function was used for measuring live (Green), dead (Red) or cream 
coloured (cells were assumed to be dying).  
 
The CLSM imaging results for the control untreated biofilms (RTF) are 
shown in figure 7.13: The total biomass of the 3 surfaces ranged between ca. 
22,000 µm3 for the polished surface and was higher for the other two surfaces 
(ca. 27,000 µm3). The CLSM images of the biofilm were characterised by the 
presence of large amounts of viable bacteria with an open void like biofilm 
structure. Dead cells were a small proportion of the cells on polished (4%) and 
SLActive surfaces (2%), but increased in proportion, to 10% on the SLA surface.  
 
The CLSM imaging results for the PDT treatments are shown in figure 7.14: 
The total biomass of the 3 surfaces ranged between ca 23,000 µm3 for the 
polished surface to ca. 26,000 cm3 and ca. 28,000 µm3 for the other two 
surfaces. These values were similar to those on the control surfaces. Compared 
to the control, the proportion of dead or dying cells was greater in the biofilms on 
polished (29% vs. 4%) and SLActive (21% vs. 2%) surfaces. Only a small 
increase in the proportion of dead cells (12% vs. 10%) was evident on the SLA 
surfaces compared with the control. The CLSM imaging of biofilm reflects the 
data generated from the Bioimage-L software package and was characterised by 
the presence of greater quantities of non-viable bacteria on polished and 
SLActive surfaces.  
 
The CLSM imaging results for the combined (TB+PDT) are shown in Figure 
7.15: The total biomass of the 3 surfaces ranged between ca. 1,000 µm3 and ca. 
7,000 µm3. These values were greatly reduced for all surfaces compared to the 
control biomass. The non-viable cells were in higher proportions on polished (8% 
vs. 4%), on SLA (52% vs. 2%) and SLActive surfaces (31% vs. 10%) compared 
to the control. The CLSM imaging of biofilm was characterised by the presence 
of a small amount of viable/non-viable bacteria on all surfaces. 
 
The CLSM imaging results for the (Ti Brush) are shown in figure 7.16: The 
total biomass of the 3 surfaces varied greatly between the surfaces and ranged 
Chapter 7: An in vitro assessment of antibacterial treatment strategies 
 
233 
 
between ca. 1,000 µm3 and ca. 16,000 µm3. These values were greatly reduced 
for all surfaces compared to the biomass on the control. The proportion of non 
viable cells was small and did not exceed 5% on any of the three surfaces. The 
CLSM imaging of biofilms has characterised by the presence of a small amount 
of viable/non-viable bacteria on all surfaces.  
 
The CLSM imaging results for the (CHX) are shown in figure 7.17: The total 
biomass of the 3 surfaces ranged between ca. 25,000 µm3 and ca. 27,000 µm3 
and was similar to control surfaces. The proportion of dead or dying cells was 
higher on the SLA (8% vs. 3%) and SLActive (11% vs. 2%) surfaces compared 
to the control. CLSM imaging of the biofilms was characterised by the presence 
of a greater amount of viable/non-viable bacteria on all surfaces. 
 
Overall, the Ti + PDT combination treatment was most effective at reducing total 
biofilm mass at reducing total biofilm biomass, with reductions of 93%, 80% and 
74% evident with polished, SLA and SLActive surfaces, respectively. The Ti + 
PDT combination treatment also showed good antimicrobial efficacy. Compared 
to the control, the viable biomass was reduced by over 80% for all surfaces 
(93%, 90% and 81% for polished, SLA and SLActive surfaces, respectively). 
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Figure 7.13. CLSM images showing viability 
of 612 h microcosm on control untreated 
biofilms (RTF) biofilms. Vertical view 
represents yz and sagittal view represents xz 
taken through layers of z axis. Scale bar 
represents 20 µm. 
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Figure 7.14. CLSM images showing 
viability of 612 h microcosm (PDT) 
biofilms. Green represents viable bacteria. 
Red represents non-viable bacteria. 
Vertical view represents yz and sagittal 
view represents xz taken through layers of 
z axis. Scale bar represents 20 µm.   
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Figure 7.15. CLSM images showing viability 
of 612 h microcosm (TB+PDT) biofilms. Red 
represents non-viable bacteria. Vertical view 
represents yz and sagittal view represents 
xz taken through layers of z axis. Scale bar 
represents 20 µm. 
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Figure 7.16. CLSM images showing viability 
of 612 h microcosm (TiBrush) biofilm on 
three surfaces. Red represents non-viable 
bacteria. Vertical view represents yz and 
sagittal view represents xz taken through 
layers of z axis. Scale bar represents 20 µm. 
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Figure 7.17. CLSM images showing viability 
of 612 h microcosm (CHX) biofilms. Green 
represents viable bacteria. Red represents 
non viable bacteria. Vertical view 
represents yz and sagittal represents xz 
taken through layers of z axis. Scale bar 
represents 20 µm.  
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7.3.3.1 Biofilm thickness 
CLSM was used to analyse the biofilms of the different titanium surfaces, with 
two discs of each surface type being examined. The CLSM images were 
obtained from four sites per disc. In 3D section analysis, the z step size was 1 
µm and the image stacks were converted into JPEG format and processed 
through the image J software analysis with orthogonal views, which calculated 
the biofilm thickness (Figure 7.18).  
Biofilm thickness on the different titanium surfaces was investigated after 612 h 
of biofilm growth. The thickness of the biofilm was similar on all untreated 
surfaces (49 µm – 55 µm). When the surfaces were treated using the four test 
regimes, the mechanical approach using TiBrush therapy was the most effective 
at reducing the mean biofilm thickness (8.5 µm, ca. 16.25 µm, ca. 16.5 µm for 
polished, SLA and SLActive surfaces, respectively). The next most effective was 
combined technique treatment (TiBrush + PDT) which reduced the biofilm 
thickness to 8 µm, ca. 21.5 µm, 18 µm for polished, SLA, SLActive surfaces, 
respectively. When using mechanical regimes, the reduction in biofilm thickness 
was greatest with the polished followed by SLActive and SLA surfaces. On the 
whole, there were observable differences between the biofilm thicknesses on 
different titanium surfaces. 
 
Figure 7.18. Thickness of biofilm µm grown on the three titanium surfaces 
after treatment regimes. Biofilms were 612 h old and grown under peri-
implantitis conditions. Error bars represent standard deviation (n = 4). 
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7.3.4 Cell morphology 
The results of decontamination and MG-63 cell culture were accompanied by 
imaging of both test and control discs by SEM. All Ti surfaces were examined 
after 7 days. The surface topography for the polished surface was moderately 
smooth (Ra > 0.5 µm) in appearance; SLA and SLActive surfaces were moderate 
rough (Ra = 1.75 µm) with the micro-pits, peaks and channels across the entire 
surface observed under 200 µm magnification were examined by the Straumann 
Company (Basel, Switzerland) (Figure 7.19).  
 
Sterile discs– Figure 7.20: the MG-63 cells were grown on the three Ti 
surfaces. The cells grew well and assumed the appearance of (i) elongated cells 
scattered across the surface on polished surfaces, (ii) spindle shaped or 
polygonal cells on SLA surfaces and (iii) circular cells on SLActive surfaces.   
 
Reduced transport fluid (RTF; control untreated biofilms) – Figure 7.21: the 
SEM of the polished surface revealed biofilm. The SLA was partially covered 
with an organic layer and the SLActive was completely covered with bacteria and 
MG-63 cells. 
 
Photodynamic therapy (PDT) - Figure 7.22: the micrograph, at day 7 showed 
that the pits and troughs were entirely covered with an organic layer. The MG-63 
cells were shown to be attached to the surface and dividing on polished and SLA 
surfaces. On SLActive surfaces, the presence of an organic layer with residual 
bacteria was observed. 
 
Titanium brush and PDT (Ti + PDT) – Figure 7.23: no bacteria were observed 
on the polished Ti surfaces, but there was attachment of MG-63 cells (red 
arrow). The MG-63 cells were observed attached to the surface showing 
possible cell division. On SLA surfaces, the MG-63 cells were shown attached to 
other MG-63 cells. On SLActive surfaces the presence of an organic layer with 
residual bacteria was observed. Complete elimination of biofilm was not seen. 
There was no evidence of any surfaces changes brought about by the use of the 
Ti Brush.  
 
Titanium brush (TiBrush) – Figure 7.24:  from the SEM analysis, MG-63 cells 
were attached to all three surfaces. On all surfaces there were areas of 
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multilayered MG-63 cells. There was no evidence of any surface alteration 
brought about by the use of the Ti Brush. 
 
Chlorhexidine (CHX) – Figure 7.25: SEM analysis of the polished surface 
showed an absence of MG-63 cells, and these surfaces were completely 
covered by layers of biofilm and organic material. SLA surfaces showed MG-63 
cells covered with bacteria. The SLActive surface showed an absence of MG-63 
cells and complete coverage with bacteria. 
 
Overall, the SLA and SLActive surfaces were demonstrated most 
biocompatibility following treatment modalities. The Ti + PDT combination 
treatment and TiBrush treatment indicated good biocompatibility efficacy 
compared to the other therapies. 
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Polished 
SLA 
SLActive 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.19. Sterile discs examined under SEM revealed that 
polished surfaces were relatively moderately smooth, whilst SLA and 
SLActive surfaces exhibited micropits, grooves and troughs (deemed 
moderately rough). Samples were viewed at ×200 (Bar 200 µm).   
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Figure 7.20. MG-63 cells (red arrows) attaching on three different 
sterile structural surfaces. Samples were viewed at ×1500, ×500, and 
×150 (Bar 40 µm, 100 µm, 400 µm, respectively). 
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Figure 7.21. MG-63 cells grown on three untreated control biofilms 
surfaces (RTF) after 7 days in culture. Green arrow indicates residual 
biofilm, yellow arrow indicates organic layer made solid lamp, and red 
arrow indicates MG-63 cells. Samples were viewed at ×1500, ×500, 
and ×150 (Bar 40 µm, 100 µm, 400 µm, respectively). 
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Figure 7.22. SEM images of MG-63 cell on three different titanium 
surfaces following PDT decontamination regimes after 7 days in 
culture. Red arrow indicates MG-63, yellow arrow indicates residual 
bacteria and biofilm, and green arrow indicates organic layer. Samples 
were viewed at ×1500, ×500, and ×150 (Bar 40 µm, 100 µm, 400 µm, 
respectively). 
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Figure 7.23. SEM images of MG-63 cells grown on three different 
titanium surfaces following TiBrush and PDT decontamination regimes 
after 7 days in culture.  Red arrows indicates MG-63 cells division on 
polished surface, MG-63 attaching to the surface on SLA, and MG-63 
split from the surface due to SEM sample processing. Samples were 
viewed at ×1500, ×500, and ×150 (Bar 40 µm, 100 µm, 400 µm, 
respectively). 
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SLActive SLActive 
Polished Polished 
SLActive 
SLA SLA 
SLActive 
Figure 7.24. MG-63 cells (red arrows) attaching to three different 
titanium surfaces following TiBrush decontamination regime. Samples 
were viewed at ×1500, ×500, and ×150 (Bar 40 µm, 100 µm, 400 µm, 
respectively). 
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Figure 7.25. SEM images of MG-63 cells on three different titanium 
surfaces following CHX decontamination regimes after 7 days in 
culture. Red arrow indicates MG-63 attaching and splitting due to SEM 
process on SLA surface, yellow arrow indicate residual bacteria or 
biofilm, and green arrow indicates organic materials. Samples were 
viewed at ×1500, ×500, and ×150 (Bar 40 µm, 100 µm, 400 µm, 
respectively). 
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7.3.5 Surface biocompatibility 
The standard curve of fluorescence and number of MG-63 cells after 4 h 
incubation with Alamar blue was performed and the fluorescence measured 
(Figure 7.26).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After sterilizing the discs for 30 min on each side by UV light (254 nm) exposure, 
MG-63 cells were then cultured on triplicate titanium discs with biofilm (control 
untreated) or devoid (sterile) of biofilm. All experiments were repeated twice 
under each of the two conditions (peri-implant mucositis and peri-implantitis). 
The MG-63 cells were further incubated and samples were harvested at different 
time periods (Day 1, 4 and 7), the harvested samples were subjected to the 
Alamar blue assay and analysed by fluoroscan. The data are shown in Table 7.2. 
 
Under peri-implant mucositis conditions  
The total numbers of MG-63 cell were determined for all three different titanium 
surfaces at day 1, 4 and 7 (Table 7.2).  
 
On day 1: the cells count was highest on the control biofilms (6516 cells) grown 
on the polished surfaces, and lowest after PDT (2028 cells). The cells count on 
SLA surface was highest in the sterile control (8140 cells) and lowest (3114 
cells) after PDT treatment. The highest cell count on SLActive surface was 
12241 cells on control biofilms without treatment and lowest after (1780 cells) 
CHX treatment.  
Figure 7.26. The standard curve of fluorescence and number of MG-63 cells 
after 4 h incubation with Alamar blue. The MG-63 cell number represents the 
mean ± standard deviation (n = 4). 
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On day 4: the cells count was highest on polished (13202 cells) surfaces after 
CHX treatment and lowest (3461 cells) after PDT. The cell count on SLA surface 
was highest (19167 cells) on the sterile disc and lowest (5902 cells) following 
PDT. The cell count on SLActive surface was highest (21002 cells) on the sterile 
disc and less than 2847 cells following PDT.   
 
On day 7: the cell count on polished surface was highest (82079 cells) on the 
sterile disc and lowest (19891 cells) following combined treatments (Ti + PDT). 
The cell count on SLA surface was highest (89629 cells) on the sterile disc and 
lowest (21303 cells) following PDT. The cell count on SLActive surface was 
highest (88508 cells) on sterile disc and lowest (3620 cells) following CHX 
treatment. 
 
Under peri-implantitis conditions: 
The total numbers of MG-63 cell were determined for all three different surfaces 
at day 1, 4 and 7 (Table 7.3).   
 
On day 1: The highest cell count was on the polished surfaces was on the sterile 
disc (14552 cells) and was lowest (4893 cells) after CHX treatment. The cell 
count on the SLA surface was highest (18782 cells) for the untreated surface 
and lowest (7130 cells) following PDT. The cell count on the SLActive surface 
was highest (10666 cells) for the untreated surface and lowest (3524 cells) after 
combined treatment with the TiBrush and PDT. 
 
On day 4:  the cell count on the polished surface was highest (35634 cells) on 
the sterile discs and lowest (14326 cells) on untreated controls. The cell count on 
SLA surfaces was highest (41233 cells) on the sterile discs and lowest (31217 
cells) following PDT. The cell count on SLActive surfaces was highest (31217 
cells) following Tibrush treatment and lowest (4451 cells) after combined 
(TiBrush and PDT) treatments. 
 
On day 7: the cell count on polished surface was 52920 cells on sterile surfaces 
and 14326 cells on untreated controls. The cell count on SLA surfaces was 
70046 cells on untreated controls and 12272 cells after PDT. The cell count on 
SLActive surfaces was 45030 cells after TiBrush treatment and 7745 cells 
following the combined technique of TiBrush and PDT. 
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Overall, the sterile control (no biofilm ever grown on it) was shown to be as 
biocompatible as the biofilm control (original CFU ca.108). There was no 
measurable difference between any of the decontamination regimes and controls 
for either of the sampling time points (366 h or 612 h) used. 
 
Table 7.2. The number of cultured MG-63 cells on days 1, 4 and 7 on the three 
Ti surfaces. Biofilms were grown under peri-implant mucositis conditions prior to 
treatment. Control disc with untreated biofilm and sterile disc without biofilm; ± 
standard deviation (n = 2). 
 
 
 
 
Peri-implant mucositis conditions 
1st day biocompatibility test 
Treatment  
Polished SLA SLActive 
Mean ± SD Mean ± SD Mean ± SD 
Control 6516 ± 7790 4164 ± 4271 12241±16245 
PDT 2028 ± 1831 3115 ± 3629 3551 ± 3448 
TB + PDT 4268 ± 4493 3698 ± 4324 2677 ± 2754 
TB  6223 ± 7801 4220 ± 4910 3777 ± 4701 
CHX 4001 ± 4664 4959 ± 6340 1781 ± 2499 
Sterile 6298 8140 7624 
4th day biocompatibility test 
Treatment 
Polished SLA SLActive 
Mean ± SD Mean ± SD Mean ± SD 
Control 8010 ± 7527 10079 ± 9637 6383 ± 3503 
PDT 3462 ± 1309 5902 ± 3839 2848 ± 385 
TB + PDT 4353 ± 2501 13271 ± 14540 7107 ± 6380 
TB  10507± 11440 11030 ± 12938 13783 ± 14717 
CHX 13203 ± 11015 17284 ± 21577 3341 ± 1047 
Sterile 11860 19168 21003 
7th day biocompatibility test 
Treatment 
Polished SLA SLActive 
Mean ± SD Mean ± SD Mean ± SD 
Control 48459 ± 68387 39477 ± 51267 69199 ± 93931 
PDT 28866 ± 40506 21304 ± 27159 45954 ± 59792 
TB + PDT 19891 ± 27292 35234 ± 47260 46347 ± 61257 
TB 34525 ± 48153 45476 ± 60469 38164 ± 49207 
CHX 49141 ± 67935 46614 ± 62356 3620 ± 915 
Sterile 82080 89629 88508 
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Table 7.3. The number of cultured MG-63 cells on day 1, day 4, day 7 on the 
three Ti surfaces. Biofilms were grown under peri-implantitis conditions prior to 
treatment. Control untreated biofilm surfaces and sterile without biofilm surfaces; 
± standard deviation (n = 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peri-implantitis conditions 
1
st
 day biocompatibility test 
Treatment  
Polished SLA SLActive 
Mean ± SD Mean ± SD Mean ± SD 
Control 6207 ± 3674 4164 ± 10257 10666 ±7438 
PDT 6630 ± 928 7130 ± 5943 6695 ± 6341 
TB + PDT 8730 ± 6944 11997 ± 1795 3524 ± 3987 
TB  13113 ± 8035 17162 ± 5975 8991 ± 731 
CHX 4893 ± 3340 8040 ± 7391 6223 ± 5983 
Sterile 14552 ± 2393 12847 ± 8596 6933 ± 8833 
4
th
 day biocompatibility test 
Treatment 
Polished SLA SLActive 
Mean ± SD Mean ± SD Mean ± SD 
Control 8935 ± 7867 24481 ± 29162 28970 ± 13847 
PDT 24141 ± 22432 13650 ± 16071 15654 ± 19499 
TB + PDT 24580 ± 19605 21701 ± 10078 4451 ± 2120 
TB  24794 ± 9542 20459 ± 16372 31217 ± 21485 
CHX 28314 ± 37169 19384 ± 22679 11060 ± 10564 
Sterile 35635 ± 785 41234 ± 34081 22871 ± 26978 
7
th
 day biocompatibility test 
Treatment 
Polished SLA SLActive 
Mean ± SD Mean ± SD Mean ± SD 
Control 14327 ± 6877 70047 ± 8579 34327 ± 13388 
PDT 49574 ± 26342 12271 ± 12846 29145 ± 34439 
TB + PDT 24766 ± 5400 27975 ± 34665 7745 ± 3177 
TB 45030 ± 2914 25694 ± 29995 40558 ± 19216 
CHX 24265 ± 32171 28431 ± 36630 29108 ± 36418 
Sterile 52920 ± 19107 33102 ± 31859 33701 ± 33110 
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7.4 Discussion 
 In this Chapter, microcosm biofilms were grown for 29 days and harvested. The 
biofilm covered discs were then treated using one of four treatment protocols 
(PDT, TiBrush + PDT, TiBrush, CHX) or left untreated (control; RTF). Ti discs 
(Polished, SLA or SLActive) were then subjected to microbiological analysis 
(selective and non- selective media), CLSM analysis and assessment of human 
fibroblast cell biocompatibility (SEM and Alamar blue assay). An in vitro study 
such as this is essential in the development of treatment modalities, as these are 
the basic steps with which to reveal the efficacy of different cleaning regimes on 
infected titanium surfaces. 
  
7.4.1 Microbial culture data 
The treatment of peri-implant infection is challenging because of the specific 
anatomical characteristics of the dental implants. Peri-implantitis is a common 
complication in dental implant therapy, and management of peri-implantitis is, at 
present, often difficult (Charalampakis et al., 2011).  
In a single study, peri-implantitis was diagnosed in 16% of patients treated with 
turned (machined) Branemark implants 9 to 14 years after loading (Esposito et 
al., 2007). Surface roughness modifications have been made to implants for 
increased biocompatibility between the titanium surface and bone tissue in order 
to decrease the healing period (Shibli et al., 2008). The problem with these 
rougher surfaces is that they can favour bacterial colonisation (Esposito et al., 
2012). Different treatment strategies for peri-implantitis have been suggested 
(Esposito et al., 2012) and include:  
1. Mechanical debridement.  
2. Pharmaceutical therapy (chlorhexidine irrigation, local or systemic 
antibiotics). 
3. Surgical procedures. 
4. Use of soft lasers. 
5. Smoothing the implant surface (to decrease surface roughness). 
6. ‘Decontamination’ or ‘detoxification’ of the implant surface using 
various chemical agents or laser. 
The present study attempted to evaluate whether a range of decontamination 
regimes were effective in reducing the levels of bacterial biofilm formed on three 
different characteristic surfaces. In this study, it was shown that the combined 
treatment (TiBrush and PDT) was equal to, or better than the other treatments 
for removing peri-implant mucositis biofilms from all three implant surfaces.  
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Combined treatment (TiBrush and PDT) was also the most effective approach on 
polished and SLActive surfaces. Furthermore, the combined technique was the 
most effective of the four treatments for removing peri-implantitis biofilms from all 
implant surfaces. These results were perhaps expected because the combined 
technique included mechanical and chemical aspects. The rotating titanium 
brush with stiff titanium bristles allowed for effective biofilm clearance from the 
surfaces prior to chemical cleaning. The reduction in biofilm thickness may allow 
for better penetration and diffusion of the photosensitiser into the remaining 
biofilm, however complete elimination was not achieved.  
The biofilms used in this study were multispecies, complex microbial 
communities embedded in a matrix of polymers of bacterial and salivary origin. In 
the case of biofilms, it is possible that the presence of extracellular matrix acts as 
a barrier to the diffusion of the photosensitiser through the biofilm (Wilson et al., 
1996). There is also evidence that the bacterial phenotype changes once cells 
move from the planktonic growth state to the biofilm state making them more 
resistant to killing (Wilson et al., 1996, Zanin et al., 2005, Wood et al., 1999). A 
further contributing to microbial resilience on a surface is the influence of a high 
surface energy leading to higher binding force between bacterial cells and the 
surface thus leading to difficulties in removing of bacteria from the surface 
(Claffey et al., 2008).  
The present results were in agreement with other in vitro PDT studies that clearly 
demonstrated that PDT alone was able to kill oral bacterial species (Takasaki et 
al., 2009). Marotti et al. (2013) had investigated sixty implants by means of PDT 
to analyse implant surface decontamination in vitro; the implants were irradiated 
with a low-level laser (660 nm, 30 mW) for 3 or 5 min (7.2 and 12 J). After 5 min 
in contact with methylene blue dye, the authors suggested that PDT can be 
considered an efficient method for reducing anaerobic bacteria on implant 
surfaces. 
Al-Ahmed et al. (2013) had investigated the effectiveness of antimicrobial 
photodynamic therapy (APDT) using visible light together with water-filtered 
infrared-A (VIS+wIRA) to eradicate single species of planktonic bacteria and 
microorganisms during initial oral bacterial colonization in situ. Toluidine blue 
(TB) was utilised as a photosensitizer at concentrations of 5, 10, 25 and 50 µg/ml 
and applied for 1 min on planktonic cultures of Streptococcus mutans and 
Enterococcus faecalis. The authors found that up to 2 log10 of S. mutans and E. 
faecalis were killed by APDT. This study had shown that APDT in combination 
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with TB and VIS+wIRA is a promising method for killing bacteria during initial oral 
colonization.  
The nature of the pellicle formed on a substratum has been shown to depend on 
its hydrophobicity (van der Mei et al., 1993). Few in vitro studies of the binding of 
antiplaque agents to substrata have been reported. However, Freitas et al. 
(1993) showed that CHX binds to both hydrophobic and hydrophilic surfaces by 
hydrophobic and electrostatic interactions respectively via polar and non-polar 
regions of the molecule. The susceptibility of biofilm to an agent is dependent, 
amongst other factors, on a number of attributes of the agents including its rate 
of penetration into the biofilm which will depend on its charge, its size and its 
affinity for the biofilm matrix and its ability to exert an anticlerical effect in the 
microenvironment (pH, redox potential etc.). This may be attributable to specific 
agent/substrata and bacteria/substrata interactions. 
Chlorhexidine (CHX) treatment resulted in bacterial reduction under peri-implant 
mucositis conditions on polished surfaces, when compared to the control. The 
limited ability of CHX to remove the whole biofilm from the SLA and SLActive 
surfaces could be attributed to the more mature biofilms which are known to be 
complex, diverse and less susceptible to antimicrobial agents due to several 
physical and biological factors that protect the complex bacteria communities. 
Bacteria living within biofilms are more resistant to antimicrobial treatments than 
bacteria suspended in solution. Furthermore, the biofilm-EPS matrix has 
repeatedly been cited as a barrier which may protect cells from the influence of a 
range of stress factors including antimicrobial agents. It has been stated that in 
order to kill microorganisms in a mature and well organised biofilm community, a 
higher concentration of the antimicrobial agent together with longer exposure 
times is required (Gera, 2008).  
Oosterwaal et al. (1989) reported that CHX had a bacteriostatic effect when used 
at low concentrations and a bactericidal effect when used at very high 
concentrations (0.5 - 2% for 10 min) against periodontal pathogens. The results 
of a study by Henderson et al. (2012) support the current findings. These authors 
reported that 0.2% CHX had significant effects on biofilms when applied for 2 
min on contaminated mirror polished surface covered with multilayers of 
Staphylococcus epidermidis. However, complete removal of the biofilm was not 
achieved. Also, studies by Zablotsky et al. (1992) and Wennström et al. (1987) 
provided similar supportive evidence.  
The findings of this present study were in agreement with Zaura-Arite et al. 
(2001), who reported that CHX 0.2% treatment for 1 min had a significant effect 
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on 6 h biofilms and only in the outer layer of 48 h old in situ – grown biofilm. 
Limited diffusion of CHX into the biofilm may have been an issue as it has been 
shown that it can take up to 5 minutes to diffuse to the deeper layers of biofilm. 
Therefore, increasing the contact time of the CHX may increase its efficacy in the 
treatment of peri-implant pathologies in a way similar to periodontal treatment 
(Salvi et al., 2002). The only study on CHX diffusion into plaque was performed 
on in vitro condensed intra-orally grown plaque (Melsen et al., 1983), where it 
was reported that 0.2% CHX was able to penetrate rapidly (within 1 min) the 
outer 2 mm of a 5-mm-thick biofilm. However, in the present study, on 
undisturbed dental biofilm, with a thickness approximately 55 µm, CHX had only 
a superficial bactericidal effect, especially in heavy-plaque-formers, where there 
might have been larger amounts of EPS. 
Initial microbial colonisation of a surface readily occurs within surface 
irregularities, and it is difficult to completely remove plaque from these grooves 
(Quirynen et al., 1993). Furthermore, implant surfaces with greater roughness 
can promote the attachment of bacteria and hamper mechanical and chemical 
cleaning (Esposito et al., 1999).  
In this study, the evaluation of the surfaces to determine the most effective 
treatment showed that the polished surface was easier to decontaminate than 
the SLA or SLActive surfaces. This was perhaps expected as the polished 
surfaces were smooth (Ra < 0.5) and therefore provided better access for the Ti 
brush. The moderate roughness of the SLA and SLActive surfaces (Ra =1.75 
µm) possibly provided enough habitats in the forms of pits and troughs, to 
protect adherent bacterial cells from shear forces of the titanium brush and 
resisting photosensitizer exposure. 
 
7.4.2 CLSM analysis 
After treatment, the microbial biofilms were evaluated by CLSM and Baclight 
viability staining. The changes in bacterial viability and bacterial non-viability 
were monitored. The viability of untreated control biofilms was similar for all 
surfaces (Figure 7.13). The CLSM images of polished surfaces showed dense 
viable biofilm (green channel) with few dead bacteria and the other 2 surfaces 
followed this trend. Following PDT therapy, the lowest total biomass was on 
polished, followed by SLActive and SLA surfaces (Figure 7.14). CLSM imaging 
revealed dense biofilms with higher amounts of non-viable cells, particularly on 
polished surfaces, followed by SLA and SLActive surfaces. After exposure to 
TiBrush for 1 min, followed by PDT for 1 min, a greater reduction of total biomass 
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was observed for all surfaces compared to untreated control biofilms. CLSM 
imaging showed few residual bacteria and clusters (live and dead) remained on 
all surfaces. This was perhaps expected because preliminary mechanical 
removal of biofilm followed by a chemical treatment served to disturb the 
protective structures within the biofilm and allowed better access to the 
remaining bacterial cells (Figure 7.15). After TiBrush therapy for 1 min, an 
increased reduction of total biomass was observed for all surfaces (94% on 
polished, 57% on SLA and 39% on SLActive) compared to untreated control 
biofilms. CLSM analysis showed few residual bacteria and clusters (live and 
dead) were remained on all surfaces (Figure 7.16).  
After CHX treatment, the total biomass proportion was 88% on polished, 92% on 
SLA and 89% on SLActive surfaces compared to untreated control biofilms. 
CLSM images revealed dense biofilm with residual bacteria of non-viable 
bacteria (red channel) on polished and few numbers on SLActive surfaces 
(Figure 7.17). The above data showed that the combined technique (Ti + PDT) 
was the better treatment. CLSM and total biomass proportions findings were in 
agreement with culture analysis.  
One mechanism that is used to increase bone to implant contact and promote 
rapid osseointegration is to increase the implant surface roughness (Rasmusson 
et al., 2001). The effects of titanium surface roughness on biofilm thickness were 
assessed. One of the surfaces had a Ra value < 0.5 µm (Figure 7.19, section 
7.3.4) and therefore was classified as smooth (Albrektsson and Wennerberg, 
2004). The biofilm thickness (obtained by measuring xz optical sections) was 
monitored after the different treatments regimes. The thickness of the biofilms 
ranged between 49 µm – 55 µm on all surfaces and control untreated biofilms 
(Figure 7.18). The average surface roughness is defined by the number and 
height of peaks on the surface. Based on this defined measurement, rough 
surfaces such as SLA and SLActive would potentially provide a greater surface 
area for potential bacterial interactions than the smooth surfaces (polished). 
However, developed surface area alone cannot wholly account for the observed 
difference in biofilm thickness, a one explanation of this was that topography 
(peaks and troughs) on the rougher surfaces provides the bacteria with 
protection from removal by shear forces (Bürgers et al., 2010).  
The polished surface yielded the biofilm of lowest thickness (8 µm) following 
combined (TiBrush and PDT) treatment. The next lowest (41 µm) was after CHX 
treatment. The other two surfaces also followed this trend (Table 7.18). The 
differences between the three surfaces was supported by the fact that on the 
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moderately rough surfaces, much of the biofilm thickness (17 µm on SLA, 17 µm 
on SLActive surfaces) remained after mechanical removal with a titanium brush, 
whereas almost all the biofilm was removed from the polished surface (9 µm). 
Also, the results of the difference in biofilm thickness were supported by biomass 
levels (Figures 7.15 & 7.16) which showed an increased reduction of total 
biomass (94% on polished, 57% on SLA and 39% on SLActive) compared to 
untreated control biofilms. Results from a previous in vivo study also showed that 
rough titanium surface had significantly more bacteria remaining than smooth 
titanium surface (Amarante et al., 2008).  
 
7.4.3 SEM  
Surface biocompatibility was assessed on treated Ti discs for both communities 
(366 h peri-implant mucositis and 612 h peri-implantitis) by visualising MG-63 
cells using SEM. Use of the human osteoblast-like cell line MG-63, had 
previously shown that an increased surface roughness of titanium discs led to 
reduced cell proliferation, whilst inducing cellular differentiation and matrix 
production (Martin et al., 1995, Herrero-Climent et al., 2013). 
Overall, the MG-63 cells grew well on all three sterile titanium surfaces (Figure 
7.20). On untreated control biofilms, polished surfaces, covered partially with 
biofilm there was no visible MG-63 presence. The SLA surface also 
demonstrated this observation. The SLActive discs (control untreated biofilm; 
RTF) were shown to be completely covered with bacteria and MG-63 cells 
(Figure 7.21). When the biofilm surfaces were exposed to PDT (Figure 7.22), 
fewer numbers of MG-63 cells were observed with signs of division on the 
polished surface. The MG-63 cells were found attached to the SLA surface, 
whilst on SLActive surfaces, only an organic layer was present. After application 
of combined technique (TiBrush + PDT), the MG-63 cells were observed on all 
three surfaces with no sign of surface alteration (Figure 7.23). After use of 
TiBrush (Figure 7.24), the same observation as seen with the combined 
technique was observed on all surfaces. Following CHX treatment, there were no 
MG-63 cells on polished and SLActive surfaces with the presence of organic 
matter and residual biofilm. On SLA surfaces, the MG-63 cells appeared to be 
separated from the surface, possibly due to the SEM processing method (Figure 
7.25).   
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7.4.4 Cell culture 
Surface biocompatibility was assessed on decontaminated Ti discs for both 
communities (366 h peri-implant mucositis and 612 h peri-implantitis) by 
assessing the viability of MG-63 cells and use of Alamar blue assay with 
reference to a standard curve. Cell culture experiments have become more 
attractive in recent years in an attempt to understand, control and direct 
interfacial interactions at biomaterial surfaces. In particular, cultures of 
osetoblasts, either primary or from tumor cell lines are frequently used to 
evaluate the effect of surface modifications on cell behaviour. Cell line, which is a 
human osteoblast–like cell lines was selected for this study. Originally isolated 
from a human osteosarcoma, the cell line is widely used for testing biomaterials 
(Billiau et al., 1975) and in this study they mimic osetoblasts during re-
ossointegration following the clinical therapy of peri-implantitis. Following 
application of a decontamination regime, the discs were placed under a UV light 
(30 min per side) to kill the cells prior to use in cell assay. This was to stop the 
bacteria infecting the human cell culture. Their viability of MG-63 cells was 
assessed using an Alamar blue assay. The aim of this was to MG-63 presence 
on decontaminated titanium surfaces. Despite the high numbers of bacteria (up 
to 108) that were present on the titanium disc surfaces, there appeared to be a 
high biocompatibility between the surfaces and the MG-63 based on the Alamar 
blue assay. This finding was unexpected and difficult to explain. Perhaps the 
most likely reason for these apparent high MG-63 biocompatibility levels was the 
continued existence of viable bacteria on the UV treated surfaces which 
subsequently contributed to the Alamar blue readings. After evaluating normal 
cellular growth by flouroscan analysis, scanning electron microscopy evaluation 
was carried out for all surfaces. It is unknown what affect this had on the MG-63 
cells or indeed the assay. Bacterial presence in the assay will contribute to the 
“cell number” measurement as they both possess resazurin, cell permeable 
compound that is blue in colour and virtually nonfluorescent. Upon entering cells, 
resazurin is reduced to resorufin, which produces a very bright red fluorescence. 
Viable cells continuously convert resazurin to resorufin.  
This therefore means that the figures for the number of cells in the tables (7.2 
and 7.3) are a sum of MG-63 cell line activity plus bacterial biofilm activity. 
Whenever fluorescence/absorbance is used as an end point measurement, as in 
the Alamar blue assay, awareness of contribution to such readings from other 
sources should be considered. Hence, the interpretation of the results following 
the Alamar Blue assay has to be done with caution. In addition, the results from 
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the SEM study revealed the presence of residual biofilm in the Alamar blue 
assay (Figs 7.22-7.25). It must emphasized that there are many factors that 
could have influenced the results, such as the small number of samples used, 
and the inadequate killing effect of UV radiation for half an hour per side. The 
duration of UV exposure may not have been sufficient for the total elimination of 
microbial viability within the mature and complex biofilm (Renier et al., 2011). 
Indeed increased duration of irradiation doses has previously been shown to be 
needed to increase mortality within biofilms (Nandakumar et al., 2006).  
 
7.5 Conclusions 
From these data (culture and CLSM) it was shown that a combined (TiBrush and 
PDT) technique was the most efficient treatment regime for decontaminating all 
three surfaces. This might be expected, as the treatment was a combination of 
mechanical plus chemical techniques. Biofilm removal includes biomass 
reduction and disruption of protective structures (EPS etc.) that may be present 
in the community and may promote more efficient killing. Once the biomass of 
the biofilm had been reduced, there would conceivably be enhanced access to 
the remaining cells for the PDT. In evaluating the surfaces, polished surfaces 
showed the largest reduction of bacterial biofilm better than SLA and SLActive 
surfaces. The CLSM evaluation of biofilm biomass was supported with cultural 
data on all treated surfaces.  
The results from this study have shown that it is possible to assess the efficacy 
of current treatment modalities in vitro. The treatments could be ranked in order 
of effectiveness, however further work would need to be carried out to assess 
whether this could be compared to clinical findings.  
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Chapter 8 
Assessment of novel nanotechnology surface implant coatings to reduce 
biofilm formation. 
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8.1 Introduction 
Pure titanium is commonly used for artificial joints and implants in both dental 
and orthopaedic clinics because of its biocompatibility and mechanical properties 
(Allaker and Ren, 2008). The initial attachment and the colonisation of bacteria to 
an implant surface play an important role in the pathogenesis of infections 
related to biomaterials (Grössner-schreiber et al., 2001). Once formed, the 
complex structure of a biofilm, containing a polymicrobial community and 
extracellular matrix, makes it extremely resistant to host-defense mechanisms or 
to antibiotic treatment. Furthermore, the lower susceptibility of biofilms to 
antimicrobial agents adds to the increasing burden of multiple-drug resistance in 
bacteria (Costerton et al., 2005). 
There is therefore a need to investigate novel alternatives to traditional 
antimicrobial agents. One such method could be to use antimicrobial metal 
nanoparticles (NPs) to control biofilm formation. Bacteria are less likely to 
acquire resistance against metal NPs than other conventional antibiotics (Allaker, 
2013). Recent advances in the field of nanotechnology, particularly the ability to 
prepare highly ordered nanoparticulates of any size and shape, have led to the 
development of new biocidal agents (Jones et al., 2008). Indeed, studies have 
indicated that nanoparticulates can be used as effective bactericidal materials 
(Allaker, 2010). In order to achieve better disinfection with biocompatibility, one 
method could be to modify the surface material of the titanium-base implant. 
Modification of implant surfaces resulting in antibacterial properties is a 
promising approach in the development of new biomaterials (Allaker and Ren, 
2008, Allaker, 2010). Surface coatings with antibacterial properties have 
previously been shown to be very effective in preventing bacterial adhesion 
(Allaker and Douglas, 2009, Ahearn et al., 1995). Examples of surface 
modification of titanium by active antibiotics are outlined below:  
1. Use of aminopropysilane to immobilize vancomycin on titanium surfaces 
(Jose et al., 2005). 
2.  Use of dry processes (Yoshinari et al., 2010) such as ion implantation, ion 
plating oxidation, and ion beam mixing to fabricate various surfaces on titanium 
modified with calcium, titanium oxide, alumina, silver, zinc, and fluorine have 
shown to be of benefit in clinical treatment by reducing bacterial numbers.  
Metallic nanoparticles (metal oxides) have so far proven to have a long lasting 
biocidal activity with high thermal stability and relatively low toxicity to human 
cells. There are various coating techniques used, such as plasma spraying 
(Kobayashi et al., 2012), dip coating (Kobayashi et al., 2012), sputtering and 
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pulsed laser deposition (Ozeki et al., 2002, Zabetakis et al., 1994) and more 
recently, electrohydrodynamic spraying (Ozeki et al., 2002, Zabetakis et al., 
1994). Plasma spraying is the most widely used commercially for producing 
hydroxylapatite coatings, but it requires high processing temperatures. The dip 
coating technique is cheap and fast, and also able to produce coatings on 
substrates of complex shape; but it also requires higher temperatures 
(Kobayashi et al., 2012).  
Sputter coatings and pulsed laser deposition techniques are able to produce a 
uniform coating thickness on flat substrates, but both techniques are incapable of 
producing coatings on substrates of complex geometries (Ozeki et al., 2002, 
Zabetakis et al., 1994). Electrohydrodynamic spraying is simple and economical 
with the ability to produce a uniform coating at room temperature while easily 
covering a large area. Additionally, a wide variety of materials from metal, 
polymer, ceramic to composite can be processed (Huang et al., 2011).  
There are at least three mechanisms by which nanoparticles can inhibit the 
formation of microbial plaque (Vargas-Reus et al., 2012):  
1. Nanoparticles larger than 10 nm accumulate on the cell membrane and 
lead to leakage of the intracellular components which eventually causes 
cell death.  
2. Nanoparticles smaller than 10 nm may penetrate membranes and 
accumulate intracellulary and lead to damaging effects on nucleic acids.  
3. Through disruption of normal cellular function, nanoparticles trigger the 
production of reactive oxygen species such as O2 and H2O2 which 
contribute to bacterial killing.  
Recent advances in the field of nanotechnology, particularly the ability to prepare 
highly ordered nanoparticulates of any size and shape, have led to the 
development of new biocidal agents. Many studies have found that TiN (Titanium 
nitride) and ZrN (Zirconium nitride) coatings possess antibacterial activity against 
members of the oral microbiota, for example Streptococcus spp. (Grössner-
Schreiber et al., 2001). Ag and Cu are known to be efficient antibacterial agents 
however, they have also been reported to be highly toxic to eukaryotic cells 
(Karlsson et al., 2008). Ren et al. (2009) reported that copper oxide (CuO) 
nanoparticles in suspension showed activity against a range of bacterial 
pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and E. 
coli, with minimum bactericidal concentrations (MBCs) ranging from 100 µg/ml to 
5000 µg/ml.  
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Hydroxyapatite (HA) has shown a great deal of promise in the field of 
orthopaedics as it provides a very stable interface between bone and the 
implant. Hence, nano-scale HA simulates more closely the size and properties of 
HA crystals in natural bone (Li et al., 2007). HA has chemical similarities to the 
inorganic components of bone and teeth (Li et al., 2010). Indeed, Huang et al. 
(2011) concluded that nanoTiHA had the ability to inhibit growth of both Gram-
negative and Gram–positive bacteria, including S. aureus and S. epidermidis.  
Colon et al. (2006) developed zinc oxide (ZnO) nanostructures and compared 
their ability to inhibit bacterial growth to that of titanium oxide (TiO) 
nanostructures. Both surfaces reduced the adhesion of S. epidermidis by 69%. 
ZnO in the form of nanoparticles has shown promise as an antimicrobial agent 
against E. coli and S. aureus (Premanathan et al., 2011). The preliminary studies 
of (Brayner et al., 2006) showed that ZnO nanoparticles at a concentration of 
between 3 and 10 mM cause 100% inhibition of bacterial growth. It has been 
reported that antibacterial activity of ZnO increases with a reduction of particle 
size (Nair et al., 2009). Smaller ZnO nanoparticles have been found to be more 
effective than larger particles against both Gram-negative and Gram-positive 
bacteria (Nair et al., 2009). Nevertheless, the effect of metal nanoparticles on 
oral cavity is still under exploration.   
In light of the above findings, it was hypothesized that a titanium surface coated 
with ZnO, HA, or 50% ZnO + 50% HA nanoparticles may exhibit antibacterial 
properties. To test this hypothesis, nanoparticle coatings were prepared on 
titanium surfaces using an electrodynamic deposition spraying method. The 
distribution of the nanoparticles was investigated with scanning electron 
microscopy (SEM). Furthermore, the antibacterial properties were evaluated 
using the in vitro peri-implantitis model developed in the previous chapters 
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8.2 Material and Methods 
8.2.1 Nanoparticles  
The nanoparticles were produced by collaboration between Queen Mary 
University of London, Barts & The London School of Medicine and Dentistry and 
the Departments of Mechanical Engineering, and Microbial Diseases, Eastman 
Dental Institute, UCL. The metal oxide particles had a size range of 20-100 nm. 
Handling and storage of these nanoparticles was carried out under industrial 
safe-working practices to avoid biological and environmental safety issues. The 
nanoparticles (NPs) tested included: ZnO, HA and combined 50% ZnO + 50% 
HA. 
Coating of Ti discs with nanoparticles: The samples were coated using 
Electrohydrodynamic Deposition (EHD) at the Department of Mechanical 
Engineering, UCL. This is illustrated in Figure 8.1.  
 
8.2.2 Electrohydrodynamic (EHD) spraying  
HA nanoparticles (nanoHA), ZnO nanoparticles (nanoZnO) or combination of 
equal proportion of these (ZnO + HA) nanoparticles were used. In EHD the 
suspension is jetted from a needle under an electric field. The needle (stainless 
steel) had a diameter of approximately 300 μm and is used to spray the content 
of the syringe onto the surface of the sample. Spraying was achieved as a result 
of the electrical field between the substrate (silicon) and the needle; this caused 
a cone shaped (8 mm) spray at the tip of the needle, which showed to be an 
optimal coating method in EHD (Figure 8.1). The distance between the substrate 
and the needle was maintained at 30 mm. Ten milligrams of the nanoparticles 
(NPs) were suspended in 10 ml of ethanol and sonicated for 10 min then 
pumped 1 ml using a syringe pump at the rate of 5 μl/min. All the experiments 
were performed from a freshly prepared suspension. The voltage used for 
spraying was between 4.5 – 5 kV. Pure titanium discs of (5 mm diameter and 2 
mm height) were coated for 60 s. Following coating, the nanoparticles were 
subjected to heat treatment in an oven at 600°C for 1 h followed by a cooling rate 
of 1°C/min as shown in Figure 8.2. 
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Figure 8.1. Electrohydrodynamic Deposition (EHD). A, the coating setup shows 
the nanoparticles were placed into a syringe and needle arrangement on a 
syringe pump to allow a controlled flow rate. B, Ti discs were arranged within the 
nanoparticle spray. The yellow conical line illustrates the spray coverage. 
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Figure 8.2. A & B, nano coated Ti discs prior to heat treatment (600°C for 1 
h). C. cooling at a rate of 1°C/min. 
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8.2.3 CDFF set up 
Various discs of titanium were prepared 
 Pure titanium (control) (n = 4) 
 Nano ZnO coated (n = 4) 
 Nano HA (n = 4) 
 50% Nano ZnO plus 50% Nano HA coated (n = 4) 
The three novel titanium discs coatings were prepared in addition to polished Ti 
(as control). The CDFF, described previously in Chapter 2 sections 2.2.1, was 
used to grow microcosm biofilms on these discs. The experiments were 
performed in two separate CDF runs. The discs were positioned on PTFE plugs 
and were held in place using vacuum silicone grease (Dow Corning) and 
recessed to a depth of 600 µm. Whole human saliva was used as an inoculum to 
provide microcosm biofilms. The nutrient source used for the experiments was 
mucin containing artificial saliva and 40 µl/ min of PISF used to mimic the healthy 
conditions associated with a dental implant under aerobic conditions for 5 days 
at 37 °C.  
8.2.4 Biofilm sampling 
CDFF pans were removed and placed in sterile universal tubes and discs from 
each pan were used for determining the bacterial composition of the biofilms 
(section 2.2.4). The titanium discs were aseptically removed and placed into 1 ml 
of RTF containing five sterile glass beads and then vortexed for 1 min to disrupt 
the biofilm. This suspension was then serially diluted up to 107 and spread in 
duplicate onto FAA, blood and mitis salivarius culture media. All plates were 
incubated aerobically for 48 h with 5% CO2 except fastidious anaerobic agar 
which was incubated for 4 to 5 days under anaerobic conditions. Following 
appropriate incubation the colonies on the agar plates were counted and 
CFU/biofilm calculated.  
 
8.2.5 Characterisation of nanocoatings surfaces 
The morphology of nano coatings was examined using scanning electron 
microscopy (SEM). The nanocoatings discs were mounted on carbon plugs. The 
coated discs were sputter-coated with gold and the surface morphology was 
observed.   
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8.2.6 Confocal laser scanning microscopy (CLSM) 
The bacterial biofilm structures were studied by means CLSM (section 5.2.1.1 
and 5.2.1.2). Each biofilm was analysed by Image J (http://rsb.info.nih.gov/ij) in 
combination with Image analysis software for Investigation of microbial biofilms 
(Chávez de Paz, 2009). A cell counting function was used to enumerate the total 
bacterial biomass and the distribution of the green (live) channel and red (dead) 
channel in one image. Other colours such as cream color were considered to be 
dying cells (Chávez de Paz, 2009).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 8: Novel nanocoatings surface implant 
 
270 
 
8.3 Results 
8.3.1 Culture analysis 
The composition of inocula for two independent CDFF experiments was 
determined using fastidious anaerobe agar, blood agar and mitis salivarius agar.  
Following appropriate incubation, the colonies were counted and the CFU/ml 
was calculated to give viable counts as shown in table 8.1. The inoculum data 
showed that the numbers of anaerobe spp. was ca. 106, aerobe spp. ca. 105 and 
Streptococcus spp. was ca. 105. 
Table 8.1. The mean ± standard deviation (n = 4) (CFU/ml) of the salivary 
inoculum. 
 
 
 
 
 
 
 
8.3.2 Culture analysis of substratum 
Samples were taken at 6 h, 24 h and 96 h and processed. Total anaerobes, total 
aerobes and total streptococci were enumerated. The differences between 
nanocoatings surfaces and control were revealed for 6 h, 24 h and 96 h peri-
implant health microcosm are shown in Figures 8.3, 8.4 and 8.5. Analysis of 
biofilms sampled at 6 h showed a reduction of Streptococcus spp. on ZnO 
compared with control as shown in figure 8.5. Older biofilms, (24 h) showed a 
reduced number of anaerobes spp., aerobes spp. and streptococci on the discs 
coated with ZnO. At 96 h, there was a reduction of the aerobes on ZnO, 
combined ZnO + HA surfaces compared with control.  
There was a reduction of anaerobes on ZnO, combined ZnO + HA surfaces 
compared with control. There was also a reduction of anaerobes on HA surfaces 
compared with control at 96 h. In terms of proportions, analysis of the data was 
performed: 
1. At 6 h, the Streptococcus spp. were reduced on coated surfaces (74% on 
ZnO, 29% on HA and 33% on ZnO + HA surfaces) compared with control.  
Bacteria species Mean CFU/ml  ± SD 
Anaerobe spp. 6.88×10
6 
± 2.17×10
6
 
Aerobe spp. 1.30×10
6 
± 9.56 × 10
5
 
Streptococcus spp. 6.50×10
5
 ± 1.73×10
5
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2. At 24 h on ZnO surfaces, the anaerobic bacteria counts were reduced by 
76%; aerobic bacteria were reduced by 89% and Streptococcus spp. were 
reduced by 96% compared with control.  
3. At 96 h, the number of anaerobes had reduced on coated surfaces (91% 
ZnO, 91% on HA and 95% on combined ZnO + HA surfaces); number of 
aerobes had also reduced (64% on ZnO, 50% on HA and 90% on ZnO +HA 
surfaces) and Streptococcus spp. were also reduced (92% on ZnO, 92% on HA, 
95% on ZnO +HA surfaces) compared to the control. 
  
Figure 8.3. Total anaerobic bacteria counts on fastidious anaerobic agar under 
conditions simulating health for biofilm grown on control (uncoated polished 
titanium surfaces); ZnO surfaces, HA surfaces and combined ZnO + HA 
surfaces. Sampling points were 6, 24, 96 hours. Two separate experimental runs 
comprised of 4 replicates. Error bars represent the standard deviations (n = 4).   
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Figure 8.4. Total aerobic bacteria counts on blood agar under conditions 
simulating health for biofilm grown on control (uncoated polished titanium 
surfaces); ZnO surfaces, HA surfaces and combined ZnO + HA surfaces. 
Sampling points were 6, 24, 96 hours. Two separate experimental runs 
comprised of 4 replicates of each were used. Error bars represent the 
standard deviations (n = 4).  
 
Figure 8.5. Total Streptococcus spp. counts on mitis salivarius agar under 
conditions simulating health for biofilm grown on control (uncoated 
polished titanium surfaces); ZnO surfaces, HA surfaces and combined 
ZnO + HA surfaces. Sampling points were 6, 24, 96 hours. Two separate 
experimental runs comprised of 4 replicates. Error bars represent the 
standard deviations (n = 4).  
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8.3.3 Characterisation of nanoparticles 
The SEM micrographs showed nanoparticles deposited on the titanium surface, 
with a diameter of approximately 20-100 nm. Some nanoparticles formed 
aggregates as shown in figure 8.6 on both ZnO and HA nanoparticles surfaces. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZnO 
HA ZnO + HA 
Control 
Control ZnO HA ZnO + HA 
Figure 8.6. Scanning electron micrograph showing the microstructure of the nano 
surfaces on the Ti substrate prepared using the electrosprayed technique. Nano 
spray surfaces are shown at magnification of ×120 (scale bar 100 µm). Inserts are 
higher magnification (×10,000 with scale bar 1 µm). Pure Ti (control) disc is 
shown a higher magnification, scale bar 200 µm. 
 
Figure 8.7. The surface colour of the Ti coated discs after 600°C treatment. ZnO 
coating become purple, HA become dark blue and combined ZnO + HA become 
blue/grey colour). 
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8.3.4 Biofilm structure analysis using CLSM 
The biofilms (all surfaces and at each time point) were removed and prepared for 
visualization using CLSM. All biofilms were stained with live/dead stain. The 
confocal micrographs revealed that very few cells were present at 6 h (data not 
shown) and that far more were present at 24 h and 96 h. Initially cells were 
seemingly randomly distributed over the control surface while on other coated 
surfaces the cells were more likely to form as chains. The major community 
changes in the biofilms were of one initially dominated by rods (24 h) to one 
dominated with fusiform bacteria (96 h) are shown in Figures 8.8 - 8.11. 
The cell counting function (section 8.2.6) was used for enumerating live (Green), 
dead (Red) or cream coloured cells (cream cells were assumed to be dying). The 
CLSM imaging results for the 24 h sampling point are shown in Figures 8.8 and 
8.9.  
The biomass volume of the 4 surfaces was highest on the control surface (ca. 
15,000 µm3) and lowest on the ZnO surface (ca. 5,000 µm3). The dead and dying 
cells were highest on the control surface (39%) and lowest on the combined ZnO 
+ HA surfaces (1%). The CLSM imaging results for the 96 h sampling point are 
shown in figures 8.10 and 8.11. The total biomass volume of the 4 surfaces was 
highest on the control surface (ca. 30,000 µm3) and lowest on the HA surface 
(ca. 6,000 µm3). The dead and dying cells were highest on the combined ZnO + 
HA surface (80%) and lowest on the HA coated discs (3%). Compared with 24 h 
samples, the dead or dying cells in the 96 h samples made up a greater 
proportion of the biofilm on the combined ZnO + HA surfaces (80% vs. 1%) and 
ZnO surfaces (56% vs. 37%). The proportion of dead and dying cells decreased 
for controls (39% vs. 13%) and HA coated discs (16% vs. 3%). 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 8: Novel nanocoatings surface implant 
 
275 
 
Control 24 h:  
Total biomass: 15326 (µm
3
) 
Green: 9460 (µm
2
) - (62 %) 
Red: 2691 (µm
2
) - (18 %) 
Cream: 3176 (µm
2
) - (21 %) 
Control 
ZnO 24 h:  
Total biomass: 5148 (µm
3
) 
Green: 3244 (µm
2
) - (63 %) 
Red: 673 (µm
2
) - (13 %) 
Cream: 1231 (µm
2
) - (24 %) 
ZnO 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.8. Live/dead staining of 24 h biofilm on control and ZnO 
nanoparticles. The lowest total viable biomass volume was on ZnO 
followed by HA nanoparticles surfaces. The highest total viable biomass 
volume was on combined ZNO + HA nanoparticles followed by control 
(pure titanium) surfaces. Scale bars 20 µm. 
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ZnO + HA 24 h: 
 Total biomass: 12700 (µm
3
) 
Green: 12641 (µm
2
) - (100 %) 
Red: 17 (µm
2
) - (1 %) 
Cream: 41 (µm
2
) - (0 %) 
ZnO + HA 
HA 
HA 24 h:  
Total biomass: 9107 (µm
3
) 
Green: 7659 (µm
2
) - (84 %) 
Red: 1299 (µm
2
) - (14 %) 
Cream: 149 (µm
2
) - (2 %) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 8.9. Live/dead staining of 24 h biofilm on HA and combined 
ZnO + HA nanoparticles. The lowest total viable biomass volume was 
on ZnO followed by HA nanoparticles surfaces. The highest total 
viable biomass volume was on combined ZNO + HA nanoparticles 
followed by control (pure titanium) surfaces. Scale bars 20 µm. 
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ZnO 
ZnO 96 h:  
Total biomass: 9886 (µm
3
) 
Green: 4294 (µm
2
) - (43 %) 
Red: 5345 (µm
2
) - (54 %) 
Cream: 247 (µm
2
) - (2 %) 
Control 96 h:  
Total biomass: 30856 (µm
3
) 
Green: 26923 (µm
2
) - (87 %) 
Red: 1432 (µm
2
) - (5 %) 
Cream: 2500 (µm
2
) - (8 %) 
Control  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 8.10. Live/dead staining of 96 h biofilm on control, ZnO nanoparticles.  
The lowest total viable biomass volume was on combined ZnO + HA followed 
by ZnO and HA nanoparticles surfaces compared with total viable biomass 
volume was on control (pure titanium) surfaces. Scale bars 20 µm. 
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ZnO + HA 
ZnO+ HA 96 h:   
Total biomass: 7466 (µm
3
) 
Green: 1478 (µm
2
) - (20 %) 
Red: 5777 (µm
2
) - (77 %) 
Cream: 210 (µm
2
) - (3 %) 
HA 96 h:  
Total biomass: 6112 (µm
3
) 
Green: 5890 (µm
2
) - (96 %) 
Red: 80 (µm
2
) - (1 %) 
Cream: 140 (µm
2
) - (2 %) 
HA  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 8.11. Live/dead staining of 96 h biofilm on HA and combined 
ZnO + HA nanoparticles. The lowest total viable biomass volume was 
on combined ZnO + HA followed by ZnO and HA nanoparticles 
surfaces compared with total viable biomass volume was on control 
(pure titanium) surfaces. Scale bars 20 µm. 
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8.3.5 Biofilm thickness analysis 
The four titanium discs were examined by CLSM. Ten stocks of each 
nanocoatings surface were analysed. The image stacks were converted into 
JPEG format and processed through the image J software analysis with 
orthogonal views, which calculated the biofilm thickness as shown in Figure 8.12. 
At 24 h, biofilm depth was measured at around 35 µm for control, 13 µm for HA, 
14 µm for ZnO and 7 µm for combined ZnO + HA. At 96 h biofilms depth was 
around 41 µm for control, 35 µm for HA, 24 µm for ZnO and 32 µm for combined 
ZnO + HA surfaces. Overall, the thickest biofilm was on control at 96 h (ca. 41 
µm) and the thinner biofilm was on ZnO surfaces at the same sampling points 
(24 µm). There was a difference in depth of biofilm between the nanocoatings 
and control surfaces.  
 
 
 
 
 
 
 
 
 
 
Figure 8.12. Thickness in µm of biofilms over time. Error bars represents 
the standard deviation (n = 10). 
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8.4 Discussion 
8.4.1 Characterization of nanoparticles modified titanium surface 
Electrohydrodynamic deposition techniques have been applied to deposit 
calcium phosphate coatings on metallic substrates (Leeuwenburgh et al., 2005), 
nano-metallic-oxides on silicone discs (Memarzadeh et al., 2012) and nano 
hydroxyapatite coatings on glass slides and TEM copper grids (Li et al., 2007, Li 
et al., 2008, Munir et al., 2011). The optimization of the conditions for spraying of 
nanoparticles suspensions, including the effects of needle size, the distance 
between the needle and substrate, the suspension flow rate and the voltage 
applied, have been systemically investigated and calibrated (Huang et al., 2011, 
Li et al., 2008 and 2007).  
Overall, the coating surfaces exhibited uniform topography and no cracks were 
observed by SEM (Figure 8.6). The uniformity still prevailed on all surfaces, 
although aggregation of nanoparticles was found in particular on ZnO and HA 
discs. During the process of preparing the surfaces one noticeable change was 
the color of the Ti disc which became purple on ZnO and blue on HA and dark 
blue on combined ZnO + HA  coatings (Figure 8.7). 
 
8.4.2 Culture data 
Saliva was used as an inoculum to provide a multispecies biofilm containing 
organisms found in the oral cavity. The nutrient source in both experiments was 
artificial saliva and PISF. The atmospheric parameters on both experiments were 
performed under aerobic conditions. The biofilms were grown on four titanium 
surfaces. The microcosm biofilms were treated in a similar manner, but were 
placed on to a various selective and non-selective media.  
There are at least two mechanisms of inhibiting the formation of microbial 
plaque. The first is to inhibit the initial adhesion of bacteria, and the second is to 
inhibit the colonization of bacteria. Streptococcus spp. have been reported to be 
the most common initial biofilm coloniser of human enamel surfaces in vivo 
(Nyvad and Kilian, 1987). Indeed, the earlier study in Chapter 4 corroborated 
these findings and showed that Streptococcus spp. dominated biofilms in healthy 
dental implant conditions in vitro. Therefore, this model was deemed appropriate 
for testing the antibacterial properties of the novel Ti nanoparticles coating 
surfaces. Culture analysis at early time points 6, 24, 96 hours (health associated 
conditions) was performed to determine the antibacterial activity of three 
nanoparticles tested. The minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration of ZnO nanoparticles was previously determined 
Chapter 8: Novel nanocoatings surface implant 
 
281 
 
(Memarzadeh et al., 2012). These previous studies tested ZnO against the E. 
coli, P. aeruginosa, S. aureus, and S. epidermidis and concluded that ZnO 
nanoparticles at a concentration of 10 mg/ml were bactericidal against S. aureus 
in suspension for 24 hours. 
A biofilm analogous to other similar biofilms (Chapters 3 and 4) was produced on 
the control Ti surfaces. Biofims grown on coated surfaces showed some 
differences compared to the controls. Broadly, the number of anaerobes and 
aerobes was similar for all discs and there was a significantly lower count of 
streptococci on the ZnO coated discs. This was unexpected as one might have 
expected the initial adherence and colonisation events to have had a greater 
effect as the bacteria would be in close proximity to the nano coatings and 
therefore perhaps more susceptible to their influence. There were no differences 
between any of the biofilms on coated surfaces and controls and the marginal 
significance of the ZnO disappeared even though there was a big difference 
(arguably larger than the 6 h biofilm) between this and control. After 96 h of 
biofilm growth a number of significant changes occurred and all three coatings 
had reduced numbers of anaerobes and 2 of them (ZnO and ZnO + HA) had 
fewer aerobes.  
At 96 h the biofilm was expected to be in quasi steady state and it seems that in 
this case, the coatings were reducing the numbers by about a log. It could be 
argued that they were inhibiting the growth of the community and stopping the 
biofilm reaching a steady state. This was unexpected as in all previous studies, it 
was the early points 6 h - 24 h where effects was observed and was often lost in 
later time points. The experiment was designed to capture early community 
changes as a result of the coatings not, later, steady state changes. This was an 
interesting finding as it hints at a different mode of action driving the changes. 
Further experiments with extended sampling times would need to be performed 
to start to answer this question. This variation may be attributed to the greater 
surface area, which may have effect in enabling bacteria to contact with the 
surface of nanoparticles. Furthermore, it may be attributed to the selectivity of 
nanoparticles towards Gram-positive species rather than Gram negative spp. in 
particular ZnO nanoparticles (Premanathan et al., 2011). These data are also 
supported by CLSM findings. 
It was also demonstrated a reduction of anaerobes occurred on combined 
ZnO+HA and ZnO surfaces at 96 h. At 24 h on ZnO surfaces, the proportion of 
anaerobe, aerobe and Streptococcus spp. had reduced (76%, 89%, 96%) 
compared with the control. This observation is consistent with the study of 
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Ahearn et al. (1995), who showed that following 24 h incubation of S. aureus and 
E. coli on Ti-nAg surface, 94% S. aureus and more than 95% E. coli in the 
bacteria suspension were killed.  
 
8.4.3 CLSM data 
The biofilms almost covered the entire discs at 24 h and 96 h as shown in 
Figures 8.8 - 8.11. An increase in time would be expected to promote an 
increase in bacterial extracellular polymers. Indeed, the total biomass of the 
biofilms on control surfaces at 24 h and 96 h time points was higher than the 
other surfaces. At 24 h, the total biomass of biofilm on ZnO was lower than that 
biofilm at 96 h. The proportion of dead or dying bacteria on ZnO surfaces was 
higher at 96 h compared with 24 h (56% vs. 37%). On HA surfaces, the 
proportion of dead or dying bacteria was lowest at 96 h compared with 24 h (3% 
vs. 16%). On combined ZnO+HA surfaces, the proportion of dead or dying 
bacteria was highest at 96 h compared with 24 h (80% vs. 1%). Overall the 
combined ZnO + HA surfaces was more bactericidal than other nanocoatings 
surfaces at 96 h. These data were supported by the culture data; it was observed 
that the proportion of killings CFU/ml of anaerobes spp., aerobes, and 
streptococci (95%, 95%, and 90%, respectively) on combined ZnO + HA 
surfaces compared with control. It was also observed that the control (pure 
titanium) biofilms at 96 h were thicker than all nanoparticles biofilms (ca. 41 µm). 
The exceptions were biofilms grown on ZnO coatings at 96 h were thinner than 
all nanoparticles surfaces (24 µm) as shown in Figure 8.12.  
8.5 Conclusions  
In the present study, novel nanoparticles-modified titanium surfaces were 
prepared using an electrodynamic deposition method. The microbial culture data 
indicated little antibacterial efficacy of either ZnO or combined nanoparticles 
against bacteria that initially attached. However, there was a significant reduction 
in the number of anaerobes at 96 h of which was also supported CLSM data. 
The data suggested that combined ZnO + HA and ZnO nanoparticles had some 
antibacterial properties and that they may have some clinical impact if used as 
implantable biomaterials in implant therapy.   
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9.1 General discussion 
Bacterial colonization and biofilm formation on dental hard tissues play a key role 
in the pathogenesis of caries, gingivitis, periodontitis (Marsh, 2005) and peri-
implantitis (Heitz-Mayfield and Lang, 2010). In modern dentistry, titanium 
implants are one of the most common treatment options used for tooth 
replacement (Esposito et al., 2012). During the past two and a half decades, 
extensive clinical and laboratory research has been performed in the field of peri-
implantitis microbiology. This has resulted in a significantly better understanding 
of the etiology and pathology of peri-implantitis (Koyanagi et al., 2013). 
The biofilm that forms on these (and all other) oral surfaces is extremely complex 
and involves representatives of the entire oral microbial community, which is 
thought to be anything up to 1000 bacterial species (Wade, 2012). The bacterial 
community of the mouth is dominated by the phyla Firmicutes, Bacteroidetes, 
Proteobacteria, Actinobacteria, Spirochaetes and Fusobacteria, which account 
for 96% of species detected (Dewhirst et al., 2010). All of these organisms could 
have interactions with implant surfaces and are responsible for short or long term 
success and/or failure of osseointegration (Abrahamsson et al., 1998). The 
microbial load and host defense are extremely important and any perturbation to 
these may lead to infection of the implant (Mombelli, 1993, Heitz-Mayfield and 
Lang, 2010).  
There are several limitations when analyzing the natural extent of inflammation 
around dental implants, as the implants themselves may reduce access for 
adequate clinical examination (Smith and Zarb, 1989). Since most peri-implant 
infections result in irreversible destruction of gingival tissue and resorption of 
alveolar bone, it is unethical to induce experimental peri-implantitis in humans 
and/or animals. There are numerous limitations when analysing the association 
of the microbiota at specific times and clinical conditions around implants at 
different time points and conditions around implants. Recent studies have shown 
that peri-implantitis includes a complex microbiota albeit less complex than that 
of periodontitis (Koyanagi et al., 2013). To overcome this, a laboratory model of 
peri-implantitis is required to help in the fundamental understanding of the 
microbiology associated with this condition. This could allow the testing of 
current and future treatments modalities and to test novel coating implants 
materials. Furthermore, a biofilm model system is essential to gain a better 
understanding of the mechanisms involved in biofilm formation and resistance to 
treatment regimes. 
Chapter 9: General discussion and conclusions 
 
285 
 
A number of biofilm-generating devices have been extensively used such as the 
Multiple Sorbarod Device (MSD) (McBain et al., 2005), various flow cells 
systems (Busscher and van der Mei, 1995), and the constant depth film 
fermentor (Peters and Wimpenny, 1988). The advantages of the CDFF system is 
that it provides many replicates in a single run, allows sampling of the biofilm at 
various intervals during the course of an experiment and inoculation can be of a 
single species; mixed species or microcosm (saliva or homogenous plaque). 
Given appropriate environmental conditions and substratum,  the CDFF can be 
used to model numerous oral biofilm communities (Wilson, 1999). In the CDFF 
system, the development of a biofilm on a surface is limited to a predetermined 
depth by mechanically removing excess biofilm. This situation is regarded by 
some to reflect the movement of tongue over the teeth (Pratten, 2007).  
The CDFF has been used comprehensively to study the ability of various 
antibacterial agents, to prevent biofilm formation (Pratten et al., 1998b), to kill 
bacteria in biofilms (Pratten et al., 1998a), to evaluate the erosion potential of 
oral biofilm (Wilson et al., 1997), to study the influence of surface characteristics 
(e.g. roughness) on biofilm formation (Morgan and Wilson, 2001), and  to model 
shifts in microbial population associated with health or disease (Dalwai et al., 
2006).  
An important aspect of any study involving cultural-based microbiology is the 
assumption that all of the community is represented by the culture. Cultivation 
methods, traditionally considered as being the golden standard approaches, are 
limited as they do not detect viable non-culturable bacteria due to the inability of 
some species to grow reliably on selective media. Additionally, it has been 
reported that less than half of bacterial species in biological samples seem to be 
culturable (Rappé and Giovannoni, 2003, Flynn et al., 2012). In this present 
study, efforts have been made to identify the oral microbiota and assess their 
biofilm-related growth dynamics as well as their association with peri-implant 
disease conditions.  
To overcome unculturable issues, culture independent microbiological 
characterisation methods were used. The comparative 16S rRNA gene cloning 
and sequencing approach has been used extensively in the study of the normal 
oral microbiota, oral infections, and the relationship of oral bacteria to systemic 
diseases. Molecular methods have been used to identify changes in the oral 
microbiota during growth and development (Aas et al., 2005). These methods 
have been used to study the microbiota of periodontal diseases (Spratt et al., 
1999, Paster et al., 2001, Paster et al., 2006) and comparing between the 
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subgingival microbiota associated with moderate to severe chronic periodontitis 
with healthy controls (Kumar et al., 2005). These methods have been used for 
the detection of almost every species in a given sample and are able to indicate 
the presence of uncultivated and unknown bacteria (Aas et al., 2005), to 
determine the bacterial richness within the human subgingival crevice (Kroes et 
al., 1999), dentoalveolar abscesses (Dymock et al., 1996) and analysis of 
microbiota associated with peri-implantitis (Koyanagi et al., 2010, Koyanagi et 
al., 2013). 
In the present investigation, biofilms were also imaged by confocal laser 
scanning microscopy (CLSM) to obtain structural analysis of natural, hydrated, 
and intact undisturbed microcosm biofilms formed on the titanium discs. CLSM 
offers several advantages over conventional light microscopy, including the 
ability to control depth of field, to eliminate or reduce background distortion, to 
collect serial optical images and generate 3D reconstructions from thick sections 
of specimens (Wood et al., 2000). CLSM is widely used in many scientific fields, 
especially in biology and medicine. CLSM has been used to determine the 
viability of biofilms (Hope and Wilson, 2003), to determine the structure of 
biofilms (Pratten et al., 2000) and in modeling shifts in microbial populations 
associated with health or disease (Dalwai et al., 2006). 
In the present study, two software packages; Image J and Bioimage-L developed 
by Chávez de Paz (2009) were employed to were employed to image biofilms 
and analyse specific features. The features examined included mean biofilm 
thickness, viable and non-viable bacteria and total biomass. CLSM has also 
been used in the analysis of multispecies biofilm formation on customised 
titanium surfaces (Fröjd et al., 2011).  
Multiplex qPCR has previously been used to assess the proportion and number 
of bacterial species present in communities associated with dental implants (Ciric 
et al., 2010). Similar methodology was used in the present study to analyse in 
vitro biofilms at 15 separate time points over 29 days of culture. These 
experiments were conducted on two separate occasions (Ciric et al., 2010). For 
generation of bacterial standard curves, the number of colony forming units 
(CFU/ml) was determined by plating serial dilutions of bacteria on agar media. 
Species-specific primers and probes homologous to regions in the 16S RNA 
gene portion and specific for F. nucleatum, L. casei, V. dispar, N. subflava, P. 
intermedia and total bacteria (universal) were determined. The exception to 
these were S. sanguinis, S. mutans where sod(A) gene was used and for A. 
naeslundii where ure(C) gene was used. To quantify Capnocytophaga spp., the 
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novel primers and dual labelled TaqMan probes were designed using the 16S 
rRNA gene sequence. Locked nucleic acid probes were employed in all assays 
except those for A. naeslundii and total bacteria. The advantage of using locked 
nucleic acid is that higher specificity and efficiency can be achieved (Ciric et al., 
2010).  
As in periodontal diseases, various therapies have been proposed to reduce the 
number of pathogenic species (Mombelli et al., 2011). Several methods for 
implant disinfection, such as chemical conditioning, air-powered abrasive, plastic 
curettes and laser therapies, have been used in combination with regenerative 
techniques and/or antimicrobials. To assess the bacterial population after certain 
treatments of commercial titanium surfaces associated with the onset of peri-
implant mucositis and peri-implantitis, the model was used to test the viable 
numbers of bacteria and fungi, remaining on three different titanium surfaces 
(polished, SLA and SLActive) following a range of decontamination regimes.  
The biocompatibility of the three different titanium surfaces (following 
decontamination regimes) was analysed by assessing culture and proliferation of 
MG-63 cells. Standard curves of MG-63 cell numbers were used with all 
experiments to determine cell proliferation on the titanium surfaces. In addition, 
SEM was used to evaluate cell morphology following use of the decontamination 
regimes. 
Bacterial attachment plays a significant role in determining the outcome and 
success of dental implants. Bacteria attached to a surface are able to replicate, 
move and form colonies beyond the biofilm. Therefore, surface modification of 
titanium to reduce the number of bacteria and microbial adhesion seems an 
efficient way to increase the benefit of clinical treatment. Generally, it is accepted 
that the most effective method to prevent biofilm buildup on dental implant 
surfaces is to inhibit initial bacterial adhesion, due to the fact that mature biofilms 
are more difficult to remove. Metal oxide particles (size range of 20-100 nm) 
were coated onto Ti discs using Electrohydrodynamic Deposition (EHD). The 
CDFF was then used to grow appropriate microcosm biofilms on these discs.  
 
To fulfil the above aims a number of objectives needed to be achieved:  
1. To grow appropriate microcosm biofilms on titanium discs.  
2. To develop the model to allow progression from a health-associated 
community to a peri-implant mucositis-associated community and then to a peri-
implantitis-associated community. 
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3. To develop microscopic and molecular biology methods to characterise these 
three communities. 
 
4. To use the model to test both commercially available and novel antimicrobial 
nanotechnology surfaces. 
 
9.1.1 Development of an in vitro model of peri-implantitis 
To provide conditions associated with healthy dental implants, only modified 
artificial saliva was initially introduced into the CDFF. To model a healthy dental 
implant progressing to peri-implant mucositis, the nutrition provided was changed 
to also include peri-implant sulcular fluid. An increased flow of artificial tissue 
fluid with microaerophilc gas mixture was supplied to simulate peri-implant 
mucositis conditions.  
The study showed that the number of anaerobes increased in the populations 
and that the number of aerobic bacteria and streptococci initially reduced; the 
anaerobic population, were howerver, dominated throughout.  
The microstructure of non-supplemented biofilms was shown to be complex, with 
stacks of bacteria developing over time, separated by clear channels. The 
heterogeneous nature of the biofilm structure was observed by CLSM and was in 
agreement with the study of Wood et al. (2002). Under conditions emulating peri-
implant mucositis, non-viable bacteria became more widely distributed throught 
the substratum. This was in agreement with the specific finding of Auschill et al. 
(2001) who reported that the dead layers of dental implant biofilms were adjacent 
to the substratum surface. Furthermore, material derived from dead 
microorganisms was proposed to be important in the initial development of 
dental plaque biofilms (Auschill et al., 2001).  
In the biofilms studied in this present research, the proportion of viable 
microorganisms was lower adjacent to the titanium surface and at the outer 
layers. A limited shift in the microbiota composition from health to peri-implant 
mucositis was unexpected; indeed the change of conditions was expected to 
elicit a greater change in the microbial population. It is possible that some 
members of the community were developed into a VBNC state or that perhaps 
the taxa that changed were part of the unculturable proportion of the population. 
The CLSM data relating to the changes in the populations did not agree with the 
culture data. The culture results showed that there was little or no differences 
between conditions, yet the CLSM data showed extensive differences in the 
structure and cell morphology in the biofilms.  
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The model was progressed from conditions associated with health, to those 
associated with mucositis and finally to conditions of peri-implantitis. The 
microbiological characterisation methods used were based on culturing the 
samples on a variety of media. The data showed no differences in the culture 
between peri-implant mucositis and peri-implantitis conditions. CLSM analysis 
showed that the biofilm associated with the anaerobic atmosphere had dense 
embedded clusters of long filaments on titanium disc surface. The culture data 
and the CLSM data did not agree in terms of community shifts associated with 
environmental changes. To more fully understand this, it was decided to analyse 
the biofilms by molecular techniques. It was thought that these culture 
independent methods should be able to resolve the issue and characterise the 
changing community.  
Comparative 16S rRNA gene cloning and sequencing was performed to detect 
community changes between the 3 different conditions. A number of commonly 
reported bacterial genera present in this study were identified. Mainly, 
Streptococcus mitis and Neisseria species were the dominant species under 
health conditions, constituting classical dental plaque pioneer species. This is in 
agreement with a previous study of the peri-implant microbiota of successful 
implants using anaerobic culture techniques (Mombelli et al., 1988), that showed 
that implants were colonized by Gram-positive cocci. Also, these results are in 
agreement with findings of Quirynen et al. (2002) and Romeo et al. (2004), who 
identified that the plaque around successful dental implants was mainly 
composed of Gram-positive cocci e.g. Streptococcus with low numbers of Gram-
negative anaerobes. These species are frequently detected in vivo in healthy 
dental implant biofilms (Lee et al., 1999) by culture independent techniques 
(Rams et al., 1984, Sanz et al., 1990).  
In peri-implant mucositis, the biofilms were dominated mainly with 
Capnocytophaga spp. Veillonella spp., Neisseria spp., with some Parvimonas 
micra and Streptococcus spp. These findings were similar to those reported by 
Maximo et al. (2009) who used a checkerboard DNA-DNA hybridization 
technique and detected S. sanguinis, S. gordonii, P. intermedia, Veillonella 
parvula at elevated levels in peri-implant mucositis conditions. The same authors 
identified N. mucosa, C. ochracea and Fusobacterium spp. at higher levels in 
peri-implantitis.  
In peri-implantitis, the microbial community was dominated by Capnocytophaga 
spp. and Veillonella parvula. Commensal gut species (e.g. Klebsiella pneumonia) 
were also detected in all conditions. Augthun and Conrads (1997) detected 
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Capnocytophaga, F. nucleatum and Eikenella corrodens, whilst Newman and 
Flemmig (1988) reported an increased incidence of Capnocytophaga spp. in 
infected implants. A further study by Alcoforado et al. (1991) reported potentially 
pathogenic bacteria such as P. micra, Fusobacterium sp. and P. intermedia 
associated with dental implants infections. The same authors reported significant 
numbers of enteric rods and Capnocytophaga spp. Using pyrosequencing, 
Kumar et al. (2012), showed lower levels of Prevotella spp. and Leptotrichia 
spp., and higher levels of Actinomyces spp., Peptococcus spp., Campylobacter 
spp., Butyrivibrio spp. and Streptococcus spp. in peri-implantitis. Another clinical 
study conducted by Koyanagi et al. (2010) found that the microbiota associated 
with peri-implantitis was more diverse than in healthy dental implants and 
included F. nucleatum and Granulicatella adiacens. These figures were also 
similar to those reported by Mombelli (2002) who detected higher levels of 
Fusobacterium spp. and Prevotella species in peri-implant infections.  
Differences at the species level were observed in all three states and some, as 
yet unreported bacteria, were also detected, for example TM7 and Vibrio spp. 
were identified by the PCR-cloning technique. These bacteria are difficult to grow 
or not cultivable and therefore are not well characterised (Al-Radha et al., 2012, 
Kumar et al., 2012). The main differences in the microbial profiles of diseased 
states compared with healthy implants are the higher levels of periodontal 
pathogens and the lower proportions of host-compatible bacteria (Shibli et al., 
2008). An important finding was the change in proportion of Gram-positive to 
Gram-negative species (67% under health condition, 43% under peri-implant 
mucositis condition and 30% under peri-implantitis condition). Several studies 
have indicated that during peri-implant biofilm formation the microbial 
composition shifts towards a higher proportion of Gram-negative anaerobes 
(Mombelli and Décaillet, 2011, Abrahamsson et al., 1998, Ericsson et al., 1992, 
Cortelli et al., 2013) and the results from the current study support this. 
 
9.1.2 Assessing the change in proportions and total of specific bacteria in 
biofilms of the three communities using multiplex qPCR assays 
There are a number of avenues which can be taken to progress this work and 
our understanding of peri-implantitis. To study the change in proportions of 
specific bacteria in biofilms of the three community’s types, the quantification of 
eight key taxa as well as a universal bacterial assay was used to allow total 
number of bacteria present and the proportion of each taxon to be determined in 
each community. Three triplex qPCR assays were established by Ciric et al. 
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(2010) to enumerate three organisms associated with gingivitis (F. nucleatum, A. 
naeslundii, P. intermedia), three organisms associated with oral health (S. 
sanguinis, V. dispar, N. subflava) and two organisms strongly implicated in 
dental caries (S. mutans, L. casei). A universal primer and probe were used to 
quantify total number of cells. The results showed that the most numerous taxa 
were N. subflava followed by F. nucleatum, S. sanguinis and V. dispar under 
healthy conditions. Under peri-implant mucositis conditions, the dominant taxa 
were N. subflava, F. nucleatum, V. dispar and. S. sanguinis. Under peri-
implantitis conditions the total numbers of organisms remained stable over the 
experiment. The number of L. casei, S. mutans, P. intermedia and A. naeslundii 
remained below the detectable limit through the course of the study. 
A previous study suggested that these taxa did not grow well in biofilms cultured 
in the CDFF without introduction of carbohydrates such as glucose and sucrose. 
The lack of glucose or sucrose could be therefore the cause of the lower 
detection of rates of these organisms in the present study (Ciric et al., 2011). 
The new multi-triplex qPCR method targeting microorganisms associated with 
dental implant health, peri-implant mucositis; and peri-implantitis has allowed for 
the quick and efficient targeted analysis of the microbial community structure. 
Based on the results, qPCR showed a significant difference between health and 
peri-implantitis conditions and between peri-implant mucositis and peri-
implantitis. The use of qPCR to assess the species and genus numbers in these 
populations allowed particular organisms to be assessed more accurately than 
by culture analysis.   
9.1.3 Design of novel TaqMan probe and primers to assess the proportions 
of Capnocytophaga species 
To assess the numbers of Capnocytophaga present in the biofilms during the 
changes in the community, novel qPCR probes and primers were developed. 
The 16S ribosome RNA gene sequences of oral Capnocytophaga species were 
retrieved from Ribosomal Data Base and a number of primer pairs were 
designed for the target organism. The specificity of the primers for the target 
sequence were tested initially on target and reference strains using conventional 
PCR technique. The results showed that some of primer pairs had cross 
reactivity with other strains and others did not work, so alternative forward and 
reverse primers were produced. These primers were specific when assessed by 
conventional PCR method and with a specific TaqMan probe in qPCR.  
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These new primers were used to determine the number of Capnocytophaga in 
the biofilm community through the biofilm development. The results showed that 
Capnocytophaga numbers were lowest under conditions emulating health whilst 
numbers were higher in peri-implant mucositis condition and peri-implantitis.  
This finding was also supported by the cell morphology observed in several of 
the CLSM images, where fusiform cells were observed in abundance (chapter 4, 
section 4.3.2.1, and figure 4.12). It is unclear why these data should not fit with 
the qPCR results. It may be that the CLSM images were not Capnocytophaga or 
indeed that there were, as yet, uncultured Capnocytophaga species present that 
did not amplify with the primer set used. The use of qPCR to assess the 
numbers of Capnocytophaga and other taxa in communities allows the fast and 
accurate assessment of the effects environmental changes on the population. It 
was shown that qPCR primer design for specific taxa has allowed analysis of 
complex communities. It also allows the primer set to be used in any in vitro or 
indeed ex vivo samples for detection and quantification of Capnocytophaga.  
 
9.1.4 Testing of current and future decontamination modalities  
The CDFF model was used to assess the effect of different commercial titanium 
surfaces on the community structure of biofilms. The biofilms were grown on 
three commercial titanium surfaces (polished, SLA and SLActive) then treated 
with one of four treatments protocols (PDT, TiBrush + PDT, TiBrush, CHX) or 
control untreated biofilms (RTF). Ti discs were subjected to traditional 
microbiological analysis, CLSM and biocompatibility analysis.  
It was shown that a combination of Ti brush and PDT was the most effective 
treatments for removing biofilms. The present results are in agreement with 
another in vitro PDT study that clearly demonstrated that PDT alone was able of 
killing oral bacteria species (Takasaki et al., 2009). CHX treatment resulted in 
bacterial reduction under peri-implant mucositis conditions only on polished 
surfaces when compared to control. The poor ability of chlorhexidine to remove 
the whole biofilm from the SLA and SLActive surfaces could be attributed to the 
presence of more mature biofilms, which are widely regarded as being less to 
antibacterial agents. The biofilm-EPS matrix has repeatedly been cited as a 
protective barrier which may buffer cells from the influence of a range of stress 
factors including antimicrobial agents. In order to kill bacteria in mature biofilm, 
the need to higher concentrations of antimicrobials with longer exposure times 
has been shown (Gera, 2008). For example, Oosterwaal et al. (1989) reported 
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that CHX had a bacteriostatic effect when used at low concentrations and a 
bactericidal effect when used at very high concentrations (0.5 - 2% for 10 min) 
against periodontal pathogens. Biofilm thickness may affect the transfer of 
essential nutrients into biofilms by increasing the diffusion length of penetration 
to the base of the film. A thinner biofilm may, therefore, have a faster growth rate 
due to possible increase in nutrients from increased penetration. A number of 
investigations have concluded that slowly growing cells are less susceptible to 
the action of harmful agents (Gilbert and Brown, 1980). Hence, if bacteria are 
growing faster in a thin biofilm compared to a thick biofilm they may be more 
susceptible to the action of antibacterial agents.  
The results of a study by Henderson et al. (2012) support the current findings in 
that 0.2% CHX had significant effects on the biofilms when applied for 2 min on 
the contaminated mirror polished surface covered with biofilms of 
Staphylococcus epidermidis. The effects on biofilm thickness were investigated 
by comparing three titanium surfaces of different roughness. One of the surfaces 
had an Ra value < 0.5 µm and therefore was classified as smooth (Albrektsson 
and Wennerberg, 2004). The biofilm thickness ranged between 49 µm – 55 µm 
on all surfaces and controls. The polished surface showed greatest reduction in 
biofilm thickness following the combined treatment (Ti and PDT) and least with 
CHX. The other two surfaces also followed this trend. The differences between 
the three surfaces was supported by the fact that on the moderate rough 
surfaces much of the biofilm thickness remained after mechanical removal with a 
titanium brush, whereas almost all the bacteria were removed from the polished 
surface. Also the observed differences were supported based on total biomass 
volume proportions. Results from a previous in vivo study also showed that 
rough titanium surfaces retained significantly more bacteria than smooth 
surfaces (Amarante et al., 2008).  
Surface biocompatibility was assessed on decontaminated Ti discs for both 
communities using MG-63 cells and assessed by SEM. The apparent high 
biocompatibility of the cells on surfaces treated with all decontamination regimes 
was difficult to explain. However, it is thought that the assays were contaminated 
with bacteria. The fluorescence/absorbance endpoint quantification procedure of 
the Alamar blue assay is related to total cell activity and that in this case it may 
well have been the sum of bacterial and MG-63 cells activity. This therefore may 
mean that the figures for the number of cells are a sum of MG-63 cells activity 
plus bacterial biofilm activity. Hence, the interpretation of the Alamar blue results 
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should be taken with caution. In addition, the results from the SEM study 
revealed the presence of residual biofilm in the Alamar blue assay. There are 
many factors that could influence this study, such as the low number of samples, 
and the conditions used for UV irradiation. In the case of the latter, it was likely 
that an insufficient time of UV exposure was employed to eliminate the mature 
and complex biofilm (Renier et al., 2011). The previous study found that the 
mortality increased with an increase in the duration of irradiation dose 
(Nandakumar et al., 2006). The exact proportion of each of these contributing 
factors is not quantifiable in the current data set. Therefore, very few meaningful 
conclusions can be drawn from these data.   
9.1.5 To assess the initial attachment of bacterial biofilm on novel 
nanocoatings surfaces  
NanoHA and NanoZnO or combined ZnO + HA nanoparticles were used. 
Samples were taken at 6 h, 24 h and 96 h and processed. Analysis of biofilms 
sampled at 6 h showed a reduction of Streptococcus spp. on ZnO compared with 
control. Older biofilms, (24 h) showed a reduced number of anaerobic spp., 
aerobes spp. and streptococci on the discs coated with ZnO. At 96 h, there was 
a reduction of both aerobic and anaerobic bacteria on the ZnO, combined ZnO + 
HA surfaces compared with control. The confocal micrographs revealed that 
dense layers of viable and non viable bacteria were present at 24 h and 96 h. 
The cells were seemingly randomly distributed over the control surface, whilst on 
other coated surfaces; the cells were more likely to form as chains. The major 
community changes in the biofilms were from one dominated by rods (24 h) to 
one dominated by fusiform bacteria (96 h). The total biomass of the 4 surfaces 
was highest on the control surface (ca. 30,000 µm3). Compared with 24 h 
samples, the dead or dying cells in the 96 h samples made up a greater 
proportion of the biofilm on the combined ZnO + HA surfaces. In conclusion, the 
culture-based data indicated limited antibacterial activity against initial bacterial 
attachment, but at 96 h antibacterial effects were apparent. Traditionally, it is 
generally considered that surface coatings tend to function at early stages of 
biofilm formation and it was therefore surprising that the antimicrobial effects of 
these were only detected at 96 h in this study. 
 
9.1.6 Conclusions 
Based on the results of this study, the CDFF model of peri-implantitis has been 
developed to simulate the three communities (health, peri-implant mucositis 
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progressing to peri-implantitis). CLSM was successfully employed to 
characterise the biofilm structure, spatial distribution of viable and non-viable 
cells within the depth of the biofilms, thickness and cell enumerating associated 
with dental implant conditions. The newly designed probe and primers allowed 
the primer set to be used in any in vitro or indeed ex vivo samples for detection 
and quantification of Capnocytophaga species. The CDFF model was used 
successfully to test and assess current and novel treatments modalities. The 
novel antibacterial nanocoatings on Ti surfaces tested successfully. Use of this 
model may be of considerable value by reducing the need for large numbers of 
expensive clinical trials by selecting patients with peri-implantitis conditions. The 
screening of potential commercial or nanocoatings antibacterial surfaces for use 
in preventing and/or treating plaque related disease. Overall, a working peri-
implantitis model has been developed.  
 
9.1.7 Clinical relevance 
A wide range of bacteria are associated with peri-implant diseases. The biofilm in 
peri-implantitis showed a more complex, aggressive microbial composition and 
several bacteria were identified as candidate pathogens in peri-implantitis. 
Decontamination of titanium surfaces is of key importance when trying to resolve 
peri-implantitis and obtain re-osseointegration.  
The challenge is to find a treatment protocol that balances decontamination of 
the titanium surface with the stimulation and promotion of healing in peri-implant 
tissues. The therapeutic strategies for managing and preventing peri-implantitis 
could focus on limiting/reducing bacterial load, with the aim of impeding biofilm 
formation.  
 
9.1.8 Future work 
Consequent to the findings of this study, the following investigations are 
proposed: 
1. To use new generation sequencing techniques (Mi-Seq system) to truly 
understand richness and diversity changes in biofilm development and 
the progression from healthy, peri-implant mucositis and peri-implantitis.  
 
2. Use the CLSM and fluorescent in situ hybridisation technique (FISH) to 
resolve the spatial distribution and temporal changes on specific 
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members of microbiota and population dynamics in health, peri-implant 
mucositis and peri-implantitis phases of biofilms. 
 
 
3. Design a new protocol for the biocompatibility test (MG-63 cells and 
Alamar blue assay); further develop an in vitro model of bone to 
understand the effect of infected titanium surfaces on proliferation and 
viability of osteoblasts and osteoclasts cells.  
 
4. Use the same technique to compare between clinical scenario and in 
vitro model of peri-implantitis. 
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